"companyid","keydevid","transcriptid","headline","mostimportantdateutc","keydeveventtypename","companyname","speakertypename","componenttextpreview","word_count","componenttext"
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Operator","Good morning and welcome to the Coventry Health Care Fourth Quarter 2009 Earnings Conference Call. [Operator Instructions] Today's call will begin with opening remarks by Chief Executive Officer of Coventry Health Care, Mr. Allen Wise, after a brief forwa",49,"Good morning and welcome to the Coventry Health Care Fourth Quarter 2009 Earnings Conference Call. [Operator Instructions] Today's call will begin with opening remarks by Chief Executive Officer of Coventry Health Care, Mr. Allen Wise, after a brief forward-looking statements read by Mr. Drew Asher. Please go ahead, Drew."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties as described in the company's filings with the SEC on Form 10-K for the year ended December 31, 2008, and Form 10-Q for the quarter ended Sept",64,"Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties as described in the company's filings with the SEC on Form 10-K for the year ended December 31, 2008, and Form 10-Q for the quarter ended September 30, 2009, may materially impact those statements and could cause actual future results to differ materially from those anticipated and discussed. Allen?"
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","Good morning. Good morning from snow-bound Maryland and thank you for your interest in our company. As you saw in our press release this morning, we just reported a strong finish for 2009, both for the fourth quarter and the full year.  The results were a",2085,"Good morning. Good morning from snow-bound Maryland and thank you for your interest in our company. As you saw in our press release this morning, we just reported a strong finish for 2009, both for the fourth quarter and the full year.  The results were a product of each of our seven major businesses performing at or in many cases, better than budget. I'm very pleased with the progress the company has made over the past year. And if you'll recall in prior calls, there were a number of initiatives and improvements we embarked on in January of 2009. And although we understand that you're interested in the future and that we're clearly focused on the future, I think it's instructive to go back and review the goals that we laid out for you and the accomplishments of the company during 2009 because they really set the foundation for the future and it's a strong future.First and foremost, we returned to the stable and predictable performance that you've come to expect from Coventry over the past decade. This is evident not only in our aggregate earnings performance but also in metrics, such as the commercial group, Medical Loss Ratio, which, as you can see, is better than our original and most recent guidance.  As you will recall, beginning in early 2009, we examined all of our businesses in terms of where we create the most value for our shareholders and where we provide the best value proposition for our customers. And as a result, we decided to place our focus on seven core businesses. And in that context, during 2009, we successfully divested First Health Services, a non-core asset which was effective in July of 2009. We also decided early in Q2 of 2009 to exit the private fee-for-service Medicare business, after evaluating the reimbursement pressures for 2010 and the legislation, which essentially eliminates the product in 2011. Our preparation for this exit went well as evidenced by the slight profitability of the product as we begin to wind it down. In the meantime, we repositioned our resources to focus on Medicare products where we provide a stronger value proposition to both our customers and the Federal government with the Medicare Advantage Coordinated Care product and Medicare Part D. As a result of exiting private fee-for-service, we should be able to dividend up to our parent, the $250 million or so of capital without -- was supporting this $3 billion revenue stream late this year or in early 2011.We'll also improve operational areas where necessary. The best example of this is the Medicare intake. Enrollment have been dramatically improved and improved our understanding of our SG&A expense attributed to each in all parts of the operations that support our business.  We also announced the acquisition of PHS, a locally based health plan in Wichita, Kansas with about 120,000 commercial risks and ASO members. We received all required federal and state approvals at the end of January, which allowed us to close a transaction in February 1. This not only added strength to our considerable Midwest regional presence, but allowed us to begin discussions on some interesting strategic initiatives with the Via Christi Health System.In terms of our balance sheet, we paid down over $300 million of debt for the full year and we still have a $500 million of free deployable cash on our balance sheet. And as promised, I reorganized and fortified the management team with an improved environment of accountability in focus.  The work outline and just mentioned resulted in the foundation which allowed us to achieve and exceed our EPS commitment to you for 2009. Let's move on to 2010. I agree with comments by many of my peers in our sector who have expressed their view that industry-wide headwinds will be evident this year. Some of these headwinds are obvious, such as pressure on the size of our commercial group insured pool, revenue reduction in Medicare and likely continuing pressure on Medicaid revenue.  Even so, we are forecasting EPS guidance of $2.10 to $2.25 per share for this year. While John Stelben, our CFO, will elaborate additionally on guidance, I did want to say that I'm comfortable that our strong results in quarter 2 and quarter 4 position us very well for 2010 even in a challenging environment.I have some comments about our Commercial business. I'm pleased with the results of the pricing corrections that were started in 2008 and continued through 2009 and the stability that this action has created with the margins. However, volume, our membership count is still a challenge. We expect membership to be slightly down in 2010 but significantly less than what we experienced in 2009.  We can and we'll improve both new business sales and retention of existing business. I'm encouraged with the early returns on our sales process and some leadership changes we have made in our health plans as we work to mitigate this macro headwind. Although our health plans are well positioned today, we're never satisfied with our cost structure and want to be able to provide our customers with the best possible value proposition. Each of our health plans have very specific medical cost structures set of initiatives that gets worked daily and with clear accountability. You have the small and mid-sized insured market has been a core strength of our company for well over a decade and this will continue in 2010 and beyond.With regard to Medicare, I am pleased with the early volume reads on our Medicare Advantage Coordinated Care business. As you will likely see in the next CMS membership file, we're down only slightly from 2009 membership goals, that recall that we exited certain SNPs and small subscale expansion markets, totaling of about 13,000 members right out of the gate. We may even be even and with this know more about that when we know more about the terms, but I think the coordinated care membership will essentially be even with the end of last year. And I consider this a very good result considering the level of benefits that needed to be adjusted for 2010 and given the weak revenue picture for 2010.We're working on improving the cost structure and our capabilities that we believe will be necessary in a leaner revenue environment which looks inevitable in one way or another. And as we have shared with you previously, we must improve in five areas to have a long-term future in Medicare Advantage. And as a reminder these are: Carefully modifying benefit designs in premium. We think that we've hit the sweet spot there and we've done that well. The second is best business practices for achieving proper risk-adjusted revenue. We believe we've have made a large improvement there and that that's going very well. The third is improving unit cost. I believe that substantially more work needs to be done in this area and I'm not satisfied with our 2009 progress and we must and we'll do better in 2010. The fourth area is, we must do a better job in managing our members' chronic care needs. And to that end, we've embarked on several initiatives and put considerable resources to improve this area. It's difficult to do but we understand that providing better care and more effective care for our members is basic to stay in this business. And last, and certainly not least, is SG&A. And that's something we can largely control. Our own cost will absolutely have to come down because of Medicare and Medicaid revenue pressures. We're making progress in this front. This company knows how to control costs and we will. In the long run, we continue to believe that Medicare Advantage can be a viable product with a reasonable margin. And quite frankly, if bending the cost curve is really the goal of our customer, the Federal government, then managed care is the best way to accomplish this goal while providing an enhanced value proposition for the senior population. So comments on Medicare Part D. Couldn't be more pleased with the 80% growth in this business during 2009 while achieving target markets. Remember, this is our fourth year of growth and on target or better performance from this business. I'm looking in our positioning in early membership results. Our best guess is we'll end up at about 1.6 million members, down a little bit less than 100,000 members. With regard to Medicaid, early in 2009, we told you we liked the Medicaid market and we'll pursue growth opportunities beyond our existing Medicaid footprint. I'd like to update you on that front. During 2009, we were qualified as a bidder in Pennsylvania to participate in the Medicaid program in the South East, in Lehigh capital regions. And since then, we have been finalizing our networks and going through readiness reviews. With respect to Southeast, we're very close and are working on finalizing the contract with the Commonwealth of Pennsylvania for a targeted entry in the second quarter of 2010. In the Lehigh capital area, we continue to work on building network toward readiness with the potential entry in the third quarter.  If we successfully enter these two regions, we would expect to build toward a 30,000 to 50,000 membership over the next 24 months. Sticking on the Medicaid subject, in Nebraska, you recall that we bid in the first half of 2009. And we were awarded, the RFP is one of the two entrants in the second quarter with an estimated 40,000 members. As we previously disclosed, the state decided to invalidate the RFP process, reject all proposals and restart the bidding process.  Although disappointing, it did give me some degree of confidence that our approach was professional and proper. And that we brought a value proposition to the business. We have therefore, since resubmitted our bid, present it to the state's rebid process and expect to hear the outcome very shortly.Given the penetration opportunities that, as I have stated, the long-term opportunity to help states better manage their cost, we will continue to devalue and selectively pursue growth opportunities in the Medicaid space. Some comments on our remaining businesses which is our Fee-based businesses. And that's our Workersâ€™ Compensation Services, our rental network and the federal, the FEHBA business which are all stable with improving results, well positioned and produce a diversified revenue, earnings and cash flow stream, while capitalizing on our core managed care capabilities.  During 2009, we spent time addressing the administrative cost structure for these areas and improvement will continue during 2010. Well, I can't predict where changes in government involvement will go, there are certain things we can and must do everyday. We can better manage our cost structure, and we will. This includes both medical and SG&A. We're beginning to lay out the design of new products, particularly individual, that should work better in the long run by bringing a better value equation to our members.  At the end of the day, cost structure by market is likely going to be the major factor in our ability to compete. Just like it is today, just like it has been for the last decade. On an unrelated subject, we tentatively scheduled March 4 of this year as the day to host our Investor Day. And I have decided not to proceed with this meeting this year. Frankly, we would not be able to add much more of any substance or comments than we have today. And therefore, we'd like to not to host the conference. We will stick with our traditional Investor Relations activities in 2010. We'll remain visible and available at investor conferences, starting with the end of March. And in addition, through Asher, John Stelben and I will be visiting investors over the next few quarters, both on the road and hosting meetings here in our offices in Bethesda.In closing, 2010 will be a year of continuing to refine our existing business, reduce our cost structure, work on tomorrow's product, enhance our new IT, add new development capability, develop systems and resources to care for our chronic need members and work toward development of new profitable revenue sources.  We clearly recognizes -- that recognize our challenges and work to be done. That we're very positive about our future and believe that new opportunities in our business will occur for well-managed companies just as they always have. And this concludes my opening comments. And John Stelben, our CFO, will now present the financial report."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","Good morning. As you have seen in the earnings release, we reported $0.74 of EPS for the fourth quarter and $2.14 of EPS for the year from continuing operations. We are very pleased with this strong result as we finish 2009 and move into 2010.  First, let",1771,"Good morning. As you have seen in the earnings release, we reported $0.74 of EPS for the fourth quarter and $2.14 of EPS for the year from continuing operations. We are very pleased with this strong result as we finish 2009 and move into 2010.  First, let me provide some details behind the favorable result to '09 guidance. Midpoint of our previous guidance implied a fourth quarter guidance midpoint of $0.56. While there are always a few moving parts, I will address the primary drivers of the $0.18 favorable variance. The Q4 commercial group loss ratio of 82.9% was better than previous guidance, primarily due to a much more moderate flu impact than expected and a leveling off of COBRA enrollment at 1.7% of commercial group enrollment versus the 2% we have built into guidance. And consistent with the prior quarters, we continue to see positive signs from our actions to set appropriate pricing. The net result of all these items is about $0.08 of favorability versus guidance in the quarter.In our Medicaid business, the Q4 loss ratio of 85.8% was also better than expected, primarily due once again to a much weaker than expected flu result. In guidance, we provided for a sequential quarterly flu impact of 300 basis points, the majority of which did not materialize. The Medicaid performance was worth about $0.05 of favorability versus guidance in the quarter.  Private fee added $0.06 in the quarter, as the MLR continue to run slightly favorable to plan in the first half of the year. As you may recall, last quarter, private fee produced $0.07. So the total for 2009 is $0.13 of EPS.  In summary, the $0.18 of outperformance is driven by the $0.06 of private fee, $0.05 in Medicaid due to better than expected flu results and $0.08 in commercial risk due to a better than expected flu and COBRA result, slightly offset by other normal activity including tax rate.Let me turn to balance sheet and cash flows. Total cash and investments stand at $3.85 billion. Our investment portfolio is in a net unrealized gain position at the end of the quarter. And the quality and diversity of our investments has never been stronger.  GAAP cash flow from operations for the year was strong at $882 million, fueled by the topline Medicare growth in '09. Health plan and private fee days and claims payable are 53.5, a decrease of about 1.3 days versus Q3. The decrease is about evenly split between health plan and private fee. In Q4, we worked our claim inventories down to create capacity in our customer service operations to handle expected increases in call volumes for the Medicare open enrollment season, as well as our transition to Medco, as a PBM for our Commercial businesses. Remember that our CSO personnel are cross trained so they can work claims as well as customer service calls.With respect to capital. We paid down $110 million on our revolving credit facility in the quarter and our debt to cap ratio now sits at 30.1%, that's 30.1%. Total deployable free cash at the parent is approximately $510 million. Aggregate RBC level is approximately 400%, consistent with prior periods.Turning to 2010 guidance, we are estimating EPS in the range of $2.10 to $2.25. To give some perspective, we had 2009 EPS of $2.14 from continuing ops, of which $0.13 was for 2009 private fee.  Our guidance range in 2010 then assumes an increase in EPS year-over-year. Consistent with our historical guidance, the low end of the range assumes no deployment of cash for share repurchase. And the high end of the range assumes use of free cash generated in 2010, continued progress on reducing administrative cost and results at the higher end of operating metrics. While there are clearly headwinds in the macro environment we operate in today, we are very pleased to forecast growth in operating earnings and EPS compared to 2009. The guidance and ranges in the press release do incorporate the PHS acquisition effective February 1, 2010, which we are still forecasting to be neutral to EPS and 2010. So let me provide a few more highlights on the guidance.  In the Commercial Risk business, we expect membership to be down for the year in the low- to mid- single digit range, excluding the addition of PHS commercial risk membership of about 100,000. This is a much better result than we experienced in '09.  The improvement is primarily due to improved sales execution in small group, coupled with better underwriting execution to attract or retain better risk. Our small group sales engine is performing fine, with small group sales in January, up slightly over January 2009. In terms of pricing, we are pricing the trend with our usual margin for error. We do not see any pervasive aggressive pricing across our markets. Consistent with our history, we will work to maintain margin and membership growth will be the variable.  The Commercial group loss ratio is expected to be flat to slightly down on a same-store basis. We are providing for a flu impact in the zone of slightly up year-over-year. We expect the COBRA impact to be higher in 2010 due to the annualization impact of our Q4 COBRA membership level, extension of the eligibility provisions and potential membership increase of up to 2% of group membership. These pressures are expected to be offset by the finalization of the pricing actions we began taking in 2008. Forecasted health plan group loss ratio is expected then to be in the range of 81.5% to 82% on a same-store basis, compared to the 81.9% result in '09. Although the 2010 impact from PHS is expected to be neutral to overall EPS, the addition of PHS, effective February 1, is forecasted to mathematically push the aggregate 2010 commercial MLR up by about 75 basis points. Therefore, we are forecasting the Commercial group MLR at a range of 82.25% to 82.75%. Our fundamental view of trend is that it is stable. While stability is positive, the absolute level of trend in the 8.5% to 9% range is not an acceptable result to us. We are executing on a number of national and local initiatives to reduce the trend line. But consistent with our prudent nature, we are not building these projected savings into our forward pricing until we can count to savings and believe they will be sustained.While our network-based Medicare health plan membership looks to be about flat compared to '09, it is important to remember that we exited several small underperforming markets that produced a 13,000 member drag going into 2010. This means we have positive growth in our same-store businesses. Given that we emphasized margin over growth in our 2010 bids, this is a nice early result. We expect the 2010 Medicare Advantage loss ratio to be in the mid-80s. On Medicaid, we expect continued modest membership growth, primarily due to economic conditions. Premium yield will be slightly lower than '09, driven by nominal rate increases, more than offset by the carve out of the pharmacy benefit in our Missouri plan that became effective October 1, 2009. Loss ratio is expected to be consistent with 2009 in the mid- to high-80s.On Part D, revenues grew 82% in 2009. And you will recall that we were certainly cautious about our outlook for '09 given this large increase in membership. So we approach the 2010 bids, emphasizing margin over growth.  As you may also recall, on the Q3 call, we discussed that we would lose some auto-assign regions along with some SPAP membership in those regions, roughly 100,000 members in total. Our retail sales appear to be tracking well so far. And coupled with growth in our remaining auto-assign regions, we expect to partially offset the aforementioned loss and end up with membership around 1.6 million, slightly down from '09.  Our margin expectations for '10 are consistent with the performance we saw in '09 with an MLR expected in the mid-80s. Given our very large growth in '09 and the pricing actions we took in the '10 bids, we are pleased with the these initial outcomes we are seeing in membership. On SG&A, the midpoint of 2010 guidance is $1.94 billion. Our total SG&A from continuing ops in '09 was $2.15 billion, which indicates a reduction of $210 million year-over-year. We previously expected total private fee, direct and indirect, to be about $180 million. The actual member for the year was closer to 200 million, given growth and allocation of overhead. There are other puts and takes, but we are pleased to be able to fully adjust our cost structure for the exit of private fee as promised without missing a beat.  Excluding private fee, SG&A percent of revenue is about flat year-over-year, which means we have been able to avoid negative leverage on the G&A given volume pressures. That being said, we need make more progress on SG&A cost and we can and we'll get better.As stated earlier, we ended the year with $510 million of deployable capital. We expect to generate approximately $250 million in free deployable corporate cash at the midpoint of guidance from 2010. We completed and paid for the PHS acquisition last week. And assuming we do not retire any debt or repurchase any shares, we would end 2010 with almost $700 million of deployable capital.  In addition, we anticipate freeing up an additional $250 million of capital as we run out the Private Fee business. That capital should free up by early '11 but we will certainly try to begin the dividend process to access that capital in late 2010.Our priorities for deployable cash are the same as they has always been, M&A opportunities and investing in tomorrow followed by opportunistic share repurchase and deleveraging.  So to conclude, so can expect that we will maintain our pricing discipline, focus on improving our medical and administrative cost structures and look for opportunistic ways to grow.  When I look at 2009 in the rearview mirror, I see many positives. In no particular order, I would recognize a renewed focus on our seven core businesses, improvement in our service operations with special kudos to the progress made in our Medicare enrollment operations, the addition of new management, proven talent and experience leaders to help navigate the waters ahead. And last but not least, a solid financial result in a tough environment. Given the progress we have made in 2009, we certainly have a better foundation to support profitable growth.  Allen do you have anything to add? Or would you like to turn the call over to questions?"
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, we'll open the call for questions at this time.",10,"No, we'll open the call for questions at this time."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Operator","[Operator Instructions] We'll go first to Doug Simpson of Morgan Stanley.",11,"[Operator Instructions] We'll go first to Doug Simpson of Morgan Stanley."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Allen, in your comments, you talked about working on retention and I'm just wondering, given the economy and your focus in the market, could you give us some color as what smaller employers are saying, and maybe walked it up to the larger accounts as well",81,"Allen, in your comments, you talked about working on retention and I'm just wondering, given the economy and your focus in the market, could you give us some color as what smaller employers are saying, and maybe walked it up to the larger accounts as well, just what types of things are on their mind? How are they thinking about product offerings and just how do you expect to really push the retention? How do you expect to drive that higher?"
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","I'd answer that in two ways, Doug. One, I probably have mentioned in the past, but I think our enrollment loss in 2009 was about 50% attributable to the environment, layoffs, people dropping benefits because of personal financials, and some Chapter 11s in",288,"I'd answer that in two ways, Doug. One, I probably have mentioned in the past, but I think our enrollment loss in 2009 was about 50% attributable to the environment, layoffs, people dropping benefits because of personal financials, and some Chapter 11s in small business, at least a half of it was really self-imposed. Sometime in 2007 and early 2008, we got a dysfunctional process between actuarial, and underwriting and our health plans had some weak leadership in some of the health plans. So clearly, half of it was self-induced and we have adjusted and corrected that. And I'm very pleased that we have, I think, the best leadership in the history of our company in the health plans. The person that runs those health plans ran our Utah business for eight years, is an underwriter and an actuary by training, and along with some new people in the health plans, it's just brought day and night better execution. So I'm comfortable that in doing a postmortem of business that we lost with the financial staff here, at least half of it was just our own fault. With regard to what's on people's mind, it hasn't changed. If they possibly can, employers still compete in spite of the unemployment numbers, they still compete for high quality workforce, just the way we do here. And that it's one of the last things that they drop, they are creative, and in terms of deductibles and co-pays, and benefit reductions, and I don't see that, that has changed a lot in the last 12 months. Clearly, the pool is challenging and clearly, we can and will do a better job. I don't think the environment itself has changed that much."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then maybe just updated comments on the Pennsylvania market and the changing -- is there any change in the backdrop there, given the cancellation of the merger plans last year...",31,"And then maybe just updated comments on the Pennsylvania market and the changing -- is there any change in the backdrop there, given the cancellation of the merger plans last year..."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think, I really believe without being unkind to anyone, but to be factual, I think that a lot of our challenges in Pennsylvania were self-induced. We just did not have the caliber of leadership that we needed there. We have a man that's running it now,",246,"I think, I really believe without being unkind to anyone, but to be factual, I think that a lot of our challenges in Pennsylvania were self-induced. We just did not have the caliber of leadership that we needed there. We have a man that's running it now, Tim Nolan, who has been with our -- known he has been with us since the U.S. health or I've been with him since the U.S. Healthcare days. He left the company briefly because of some personal issues that he had to take care of, and he's been back for most of the year. We had, in November, the first positive growth month in 46 month in the Commonwealth of PA, and we're just doing a lot better job there. PA has always been a difficult environment. The combination between Highmark, and UPMC and Western PA is just difficult. The Blues have a huge market share and are formal competitors, but we've always made a very good margin for our shareholders there. And I really believe that the pricing environment is better for us, it was super tough for a couple of years, that has turned slightly better, and we have a much better leadership there. And the last four months of new group, small or mid-sized group sales has turned, and we've been positive three of the last four months. So I think it's been through a tough time there and it's improving, and will improve this year."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then, John, you said the number was 250. Did you guys get pull from the subs after the Private Fee exit? Is that right?",25,"And then, John, you said the number was 250. Did you guys get pull from the subs after the Private Fee exit? Is that right?"
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","That's correct.",3,"That's correct."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Operator","Our next question will come from Charles Boorady of Citi.",10,"Our next question will come from Charles Boorady of Citi."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","One, just for some detail around medical cost trends, if you can share the unit cost and volume components of trend. And if you can give us a couple examples of the initiatives you alluded to, to improve the cost trends and whether that might include tigh",59,"One, just for some detail around medical cost trends, if you can share the unit cost and volume components of trend. And if you can give us a couple examples of the initiatives you alluded to, to improve the cost trends and whether that might include tighter networks, prior authorization, gatekeeping or is this more on the contracting side?"
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","Sure, Charles. On the trend, inpatient is in the high single-digits. And I would say that, that's really tilted primarily towards unit cost. Outpatient is low double digits. It's split about evenly but I'd say tilted towards a little more towards unit cos",172,"Sure, Charles. On the trend, inpatient is in the high single-digits. And I would say that, that's really tilted primarily towards unit cost. Outpatient is low double digits. It's split about evenly but I'd say tilted towards a little more towards unit cost. Physician, mid-single digits, split in Rx, mid to high single digits, about split. On the medical initiatives, there's a number of them. I would say at a high level, as you know, we're working with Magellan on radiology benefit management in several of our markets. And on oncology on drug cost, we're really looking at better control of lab costs, with some recontracting we did with Quest and LabCorp. And really, each health plan has a medical expense initiative list that's specific to that health plan's market and what they're seeing, that's got names and dates. And so really, across-the-board, I think there are some national initiatives and local initiatives, and I think it's about as well defined and as well controlled as I've ever seen in the company."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And in terms of what is in your expectations, I just want to be clear, because I think I heard you say that you're not budgeting that any of those initiatives are going to work in your pricing to your present view of trend. Do I have that right or you've",54,"And in terms of what is in your expectations, I just want to be clear, because I think I heard you say that you're not budgeting that any of those initiatives are going to work in your pricing to your present view of trend. Do I have that right or you've taken into consideration..."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","You do have that right, because I've watched good intentions and for a long time, and watched people priced for the good intentions, doesn't work. We always have done it to reverse it [ph]. We have a roadmap, and each of these marketplaces with where thin",126,"You do have that right, because I've watched good intentions and for a long time, and watched people priced for the good intentions, doesn't work. We always have done it to reverse it [ph]. We have a roadmap, and each of these marketplaces with where things are off-base and what we're going to do about it, who's responsible, but we're not going to count that money until we see it. Because it's like an inner tube sometimes, you work hard and fix one thing and it sticks out some place, so it's very difficult. Nice rhetoric, it's a lot of work and it's a lot of conflict in the marketplaces in some time, and we don't count it until we can count it. Nothing's changed there."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I'm glad we're back to the old conservatism, Allen, any way to just size up as you look at those initiatives and you've got a couple of decades in the industry, Allen. So you've got a gut checked on this, just sort of what it might mean and at what time o",71,"I'm glad we're back to the old conservatism, Allen, any way to just size up as you look at those initiatives and you've got a couple of decades in the industry, Allen. So you've got a gut checked on this, just sort of what it might mean and at what time of the year you'd be more comfortable sort of reevaluating your trend, based on the success of those initiatives?"
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, I think maybe next quarter or the quarter after that, we would be in a position to talk about where we've made progress and what areas, and what it yields but the real answer is I don't know.",39,"Well, I think maybe next quarter or the quarter after that, we would be in a position to talk about where we've made progress and what areas, and what it yields but the real answer is I don't know."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Operator","Our next question will come from John Rex of JPMorgan.",10,"Our next question will come from John Rex of JPMorgan."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I wonder if you could tell us how much reserve development you had in the quarter? And I think, John, particularly thinking about there's about a $100 million drop, I think in med payables, and I think you mentioned in your commentary, some pay down to cl",65,"I wonder if you could tell us how much reserve development you had in the quarter? And I think, John, particularly thinking about there's about a $100 million drop, I think in med payables, and I think you mentioned in your commentary, some pay down to claims inventory. So I'm just trying to kind of parse out how much impact were coming from different elements?"
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes. There's about three pieces to that. The first piece I would say, we had a payout related to our Part D standalone product for 2008 low income subsidy. That was about a third of the drop. I'd call the other third inventory reduction, and while the mat",70,"Yes. There's about three pieces to that. The first piece I would say, we had a payout related to our Part D standalone product for 2008 low income subsidy. That was about a third of the drop. I'd call the other third inventory reduction, and while the math isn't perfect here, you can think about the balance being that our volume has been decreasing as we've gone through the year."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","You mean just get your -- you're talking about just member volume on that?",14,"You mean just get your -- you're talking about just member volume on that?"
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So was there favorable development in the quarter, or again, can you quantify how much? Was it maybe -- I assume it was all intrayear at this point, in the 4Q.",31,"So was there favorable development in the quarter, or again, can you quantify how much? Was it maybe -- I assume it was all intrayear at this point, in the 4Q."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","John, we don't discuss or restate by quarter. Certainly, in the K that you'll see in a few weeks, we'll discuss our restatement for the year, but we don't discuss it by quarter. Restatements this year have been consistent quarter-to-quarter.",40,"John, we don't discuss or restate by quarter. Certainly, in the K that you'll see in a few weeks, we'll discuss our restatement for the year, but we don't discuss it by quarter. Restatements this year have been consistent quarter-to-quarter."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","The way to think about that, this is Allen, the way to think about that is, with the exception of a little stub in 2008, I came to the company in 1996 and our reserve process has always been prudent. And we've always taken that view and there's not been a",99,"The way to think about that, this is Allen, the way to think about that is, with the exception of a little stub in 2008, I came to the company in 1996 and our reserve process has always been prudent. And we've always taken that view and there's not been any change in that since 1996. And so in theory, there is always -- if it's an educated guess, which it is, there's always -- in 31 of 32 quarters, there's always been a little prior period positive development. And there's no change in our philosophy since 1996 here."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So I mean, can I take that as what you're saying is, in terms of kind of the run rate coming off the 4Q, favorable development was not a significant contributor?",31,"So I mean, can I take that as what you're saying is, in terms of kind of the run rate coming off the 4Q, favorable development was not a significant contributor?"
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think that's fair.",5,"I think that's fair."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think that's correct.",5,"I think that's correct."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then, what percent of your 2010 Commercial member month are already priced?",13,"And then, what percent of your 2010 Commercial member month are already priced?"
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","At this point, I would say it's in the neighborhood of 55% to 60%.",14,"At this point, I would say it's in the neighborhood of 55% to 60%."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then when we think about your 2010 and quarterly progression, what would be the things that would be altering from previous patterns you've had?",25,"And then when we think about your 2010 and quarterly progression, what would be the things that would be altering from previous patterns you've had?"
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think the pattern should be consistent. I mean the two biggest drivers are Part D and then the progression of deductible satisfaction on the Commercial side. So while we're not giving quarterly guidance, I think you could think about it as sort of in th",54,"I think the pattern should be consistent. I mean the two biggest drivers are Part D and then the progression of deductible satisfaction on the Commercial side. So while we're not giving quarterly guidance, I think you could think about it as sort of in the relative range of what we saw in '09."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I just didn't know if it would be altered somewhat just because of revenue mix change with PFFS being out of there, and not kind of having the acute seasonality like Part D, instead you'd see kind of actually a bit more seasonality because of that.",47,"I just didn't know if it would be altered somewhat just because of revenue mix change with PFFS being out of there, and not kind of having the acute seasonality like Part D, instead you'd see kind of actually a bit more seasonality because of that."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, I mean, I don't think it's going to be affected much, John.",13,"No, I mean, I don't think it's going to be affected much, John."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","No. It shouldn't be. With regard to Private-Fee-For-Service, if you remember, we had substantial volume and enrollment difficulties and we had a substantial challenge in the Q1 and Q2 getting our revenue and getting enrollment reconciled with CMS, and get",64,"No. It shouldn't be. With regard to Private-Fee-For-Service, if you remember, we had substantial volume and enrollment difficulties and we had a substantial challenge in the Q1 and Q2 getting our revenue and getting enrollment reconciled with CMS, and getting our revenue right. Private fee may have looked a little worse than it was, but there shouldn't be anything materially different about this year."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll now hear from Josh Raskin with Barclays.",9,"We'll now hear from Josh Raskin with Barclays."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Two questions just on the Medicare side, I guess on Private-Fee-For-Service. First, were any of those Private-Fee-For-Service lives retained by Coventry in some of your network products for 2010 and then...",31,"Two questions just on the Medicare side, I guess on Private-Fee-For-Service. First, were any of those Private-Fee-For-Service lives retained by Coventry in some of your network products for 2010 and then..."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes. Sorry, Josh, about 9,000 or so.",7,"Yes. Sorry, Josh, about 9,000 or so."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, were retained into the existing development [ph]. And then I guess, secondarily, on the cash flow, just thinking about Private-Fee-For-Service, my guess is your days in claims payable probably a little bit longer, more stretched on that business. Th",92,"Okay, were retained into the existing development [ph]. And then I guess, secondarily, on the cash flow, just thinking about Private-Fee-For-Service, my guess is your days in claims payable probably a little bit longer, more stretched on that business. The $3 billion of revenue, if it's, I don't know, 60 days in claims payable, about $500 million of sort of claims lag, should we think about cash flow from operations being negatively impacted in '10 because of that? And sort of how should we think about sort of first half cash flow?"
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes, I think your point is correct. The payout of those reserves will have a negative impact on cash flow from operations, but remember that all that cash is sitting in the regulated subsidiary. So from the standpoint of free cash generation to corporate,",56,"Yes, I think your point is correct. The payout of those reserves will have a negative impact on cash flow from operations, but remember that all that cash is sitting in the regulated subsidiary. So from the standpoint of free cash generation to corporate, it will be unaffected by the run-out of the Private Fee business."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Right. No, I understand you guys are sort of fully accrued at the sublevel. But when your report your GAAP cash flow numbers, I'm assuming there's going to be a big drag next year, is that correct?",37,"Right. No, I understand you guys are sort of fully accrued at the sublevel. But when your report your GAAP cash flow numbers, I'm assuming there's going to be a big drag next year, is that correct?"
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","That's correct.",3,"That's correct."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then, just any perspectives on 2011 MA [Medicare Advantage] rates and what you guys are expecting from the 45-day notice?",21,"And then, just any perspectives on 2011 MA [Medicare Advantage] rates and what you guys are expecting from the 45-day notice?"
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, it'll be out next week, and what we do is we plan that revenue gets leaner and so we're building our plans to be able to be profitable in a leaner revenue environment. But I'm not making any guesses on what the rates are looking like.",47,"Well, it'll be out next week, and what we do is we plan that revenue gets leaner and so we're building our plans to be able to be profitable in a leaner revenue environment. But I'm not making any guesses on what the rates are looking like."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","Plenty of guesses out there; my is guess is from one to two, but I don't know. We'll know soon. But John made a good point, when we come to work everyday, we think that it's going to be more challenging and we spend a lot of time thinking how we thrive in",55,"Plenty of guesses out there; my is guess is from one to two, but I don't know. We'll know soon. But John made a good point, when we come to work everyday, we think that it's going to be more challenging and we spend a lot of time thinking how we thrive in that environment."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll go next to Christine Arnold of Cowen and Company.",11,"We'll go next to Christine Arnold of Cowen and Company."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I'd like to parse out a little bit kind of what's happening in Medicare Advantage. I estimate about kind of a 93.6% private-fee-for-service MLR in 2009, is that about right?",31,"I'd like to parse out a little bit kind of what's happening in Medicare Advantage. I estimate about kind of a 93.6% private-fee-for-service MLR in 2009, is that about right?"
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","The range of that loss ratio is in the low 90s.",11,"The range of that loss ratio is in the low 90s."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","In the low 90s. Is it possible to get more specific just because you guys did it, and we're trying to parse it out and it kind of matters if it's 92% or 94%?",34,"In the low 90s. Is it possible to get more specific just because you guys did it, and we're trying to parse it out and it kind of matters if it's 92% or 94%?"
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","Christine, I would call it somewhere around 93%.",8,"Christine, I would call it somewhere around 93%."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So as we think about that, it's looks then like, if that's about 93%, then you're about 85% on the Coordinated Care. So you're kind of saying mid-single digits, again, kind of ranges matter because we're dealing with about $2 billion in revenue here. Can",120,"So as we think about that, it's looks then like, if that's about 93%, then you're about 85% on the Coordinated Care. So you're kind of saying mid-single digits, again, kind of ranges matter because we're dealing with about $2 billion in revenue here. Can you give me a sense of how much of the negative price cost spread you think you captured, with benefit design changes versus premiums? And how much you expect to get maybe with risk adjusters? And then how much maybe network changes and anything that 13,000 helped, and just kind of give me a sense for what's up in the air as kind of medical management may help or not, just give us some parameters?"
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","Christine, that would take half the morning, why don't you call after the meeting and we'll try and do a better job. To talk about the process that we undertook to get the benefits, deductibles, prematuring and what piece that is, can't answer that in the",90,"Christine, that would take half the morning, why don't you call after the meeting and we'll try and do a better job. To talk about the process that we undertook to get the benefits, deductibles, prematuring and what piece that is, can't answer that in the time we've got here. We've talked a whole bunch of times about the five things that we're doing to get that right, and we can make a guesstimate on what each of those produce over time but I don't think right at this time."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll go next to Ana Gupte with Sanford Bernstein.",10,"We'll go next to Ana Gupte with Sanford Bernstein."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","The question's again about the inpatient trend and you mentioned the high single-digits largely from unit cost. Is that mostly because of contracting or are you still seeing the facility coding, that was a problem for you and to many of your competitors,",73,"The question's again about the inpatient trend and you mentioned the high single-digits largely from unit cost. Is that mostly because of contracting or are you still seeing the facility coding, that was a problem for you and to many of your competitors, and is that behind you? And then a follow-up to that is, will the adoption of EMRs and conversion to ICD-10 make that again a problem for the industry?"
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","I would say that it's no worse than what we've said before. So I mean your out there everyday trying to recontract with these hospitals, you're trying to do your best job in it. We look at the chargemaster increases and we try to understand what those are",97,"I would say that it's no worse than what we've said before. So I mean your out there everyday trying to recontract with these hospitals, you're trying to do your best job in it. We look at the chargemaster increases and we try to understand what those are doing versus our contracts. On the ER side, we're pulling charts and we're trying to at least put in a fentanyl effect on any upcoding, and trying to reduce the number of levels there. So overall, I don't think we've really seen a whole lot of change there."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then on the contracts, you've established a low-cost organization, I believe. Are you seeing hospitals and facilities open to new approaches and might that -- what specifically, would get the industry and you to do something that's a little bit better",54,"And then on the contracts, you've established a low-cost organization, I believe. Are you seeing hospitals and facilities open to new approaches and might that -- what specifically, would get the industry and you to do something that's a little bit better on the inpatient side, because that just seems to be exacerbating year-over-year?"
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think one way to look at that, our company, and I think our industry, 10 years ago or certainly, 15 years ago, made a lot of attempts to do things collaboratively with health systems. And in many of the cases, that didn't work, but we've returned to tha",311,"I think one way to look at that, our company, and I think our industry, 10 years ago or certainly, 15 years ago, made a lot of attempts to do things collaboratively with health systems. And in many of the cases, that didn't work, but we've returned to that. I mentioned our association with Via Christi, which is an integrated system in central Kansas with a couple of thousand beds in six or eight hospitals. We will begin discussions for a Medicare product limited to their network. They have a lot resources in terms of medicine at home, monitoring at home, intermediate facilities between skilled nursing and inpatient. And I'd like to start with Via Christi and other organizations, doing something where we could offer a better value equation to the members; more benefits at resources that they have and then do some type of profit sharing with the facilities so that we're not fighting over per diems or not fighting over rates, but doing something that we're collaboratively together in. So that system is the first initiative. Our Medicaid leadership has much better numbers for getting what the cost per confinement or the cost per day, or on the total cost for different diagnosis is for inpa -- we've got a lot better information on the true cost, and where we need to direct traffic to get the best results. And we didn't do much for a long time. If you go back to eight or nine years ago, there was sort of an anti-managed care backlash, everyone wanted to see every provider. And I think that, that cycle has kind of run its course, and we'll do more with more limited, more efficient providers in more collaborative ways. Easy to talk about, it takes a long time, it's hard to do, but we're going to get started this year."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Operator","Our next question will come from Scott Fidel of Deutsche Bank.",11,"Our next question will come from Scott Fidel of Deutsche Bank."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just if you've identified any level of annualized SG&A savings that you think you can take out of the business, or maybe just as a percentage of SG&A, how much do you think you can reduce as you look to further rightsize for the lower Medicare revenue? An",114,"Just if you've identified any level of annualized SG&A savings that you think you can take out of the business, or maybe just as a percentage of SG&A, how much do you think you can reduce as you look to further rightsize for the lower Medicare revenue? And then just more conceptually, just interested, we've seen in the guidance for a lot of the MCOs for 2010, them guiding up for SG&A, so we're probably seeing some of the impact here from just the commercial market risk reductions. And just interested if you think the industry can reduce SG&A consistently, unless we do get a recovery in commercial risk enrollment in the market?"
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","Scott, the SG&A year-over-year, as I discussed earlier, we are going down in absolute terms. And so there's a lot of initiative that are underneath that to get there. And like medical, we have name dates and accountability for all those initiatives. We re",165,"Scott, the SG&A year-over-year, as I discussed earlier, we are going down in absolute terms. And so there's a lot of initiative that are underneath that to get there. And like medical, we have name dates and accountability for all those initiatives. We reduced the private fee year-over-year. And I think as we stated earlier on calls, I mean there was direct cost attributable to that and there was indirect costs, and we're able to get that out. At some point, if volume is continued to be pressured, there's a limit to how much fixed cost you can take out of the business. That being said, I think that we're looking and are always looking for ways to reduce that, through better use of technology and in more efficient ways to run our business. So I think there's a downward limit on this. I can't tell you where that is yet, but I can tell you we think we can continue to make more progress."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","John's been working on this for a year. It's not just when he assumed the CFO role here. We've got months -- every leader in the company has got targets. And as John pointed out, in our IT area, the leadership there is looking at more outsource, offshore,",157,"John's been working on this for a year. It's not just when he assumed the CFO role here. We've got months -- every leader in the company has got targets. And as John pointed out, in our IT area, the leadership there is looking at more outsource, offshore, new development and we have 150 things on the list. Just one of these things, you can't do it with a pencil, you can't do it with a meat ax because you'd cause damage to the organization but it's something that historically, we've done well. John has led that effort here over, on and off, over a 12-year period and we are comfortable that, not comfortable, we understand that it's sort of basic to our being able to thrive. And we have a plan that'll get significant results this year. And to try and -- John, I guess we could price a range, right, range in absolute terms?"
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, our goal would be to continue to try and drive down the SG&A rate over time. I mean, as I said before, we take out private fee and the other costs, our SG&A rate percent of revenue year-over-year is about flat. Don't forget, PHS adds some money into",59,"Well, our goal would be to continue to try and drive down the SG&A rate over time. I mean, as I said before, we take out private fee and the other costs, our SG&A rate percent of revenue year-over-year is about flat. Don't forget, PHS adds some money into the G&A, so we've made really good progress this year."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then, just had a follow-up just on the M&A pipeline at this point, and Allen, maybe how you're thinking about just keeping an eye on Washington, whether your priorities change if reform sort of falls away here or gets reinvigorated. And just in terms",83,"And then, just had a follow-up just on the M&A pipeline at this point, and Allen, maybe how you're thinking about just keeping an eye on Washington, whether your priorities change if reform sort of falls away here or gets reinvigorated. And just in terms of the markets that you would be prioritizing, are you looking more just at bottoms up in terms of individual properties? Or are you thinking about potential targets based on mix of business relative to potential reform outcomes?"
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think the best way to think about that, recognizing what I can comment on, I think the best way to think about that is, 2009 was a year where a lot of our focus was on getting our existing businesses running better, and that will continue. 2010, this ye",331,"I think the best way to think about that, recognizing what I can comment on, I think the best way to think about that is, 2009 was a year where a lot of our focus was on getting our existing businesses running better, and that will continue. 2010, this year, Drew and I will spend a considerable amount of effort trying to find some more profitable revenue. And I can't exactly save your way to prosperity. It wouldn't be inconsistent with what we've talked about earlier in the year. Even though there are challenges on the revenue side, we like the Medicaid space and have again, some initiatives that will hopefully produce some membership in the Commonwealth of PA and hopefully, Nebraska. We're absolutely committed to the Medicare Coordinated Care plan, and we would look at that space in rural areas. We will continue to look for opportunities, like the Kansas property. One, we want to get a stronger regional presence across state lines. We have a very strong Midwestern. It was basically Insured business, which I like better than ASO business. And more than that, it's a really innovative system with innovative leadership. So I think that not only do we get a very good cost structure with the acquisition for the region there, for that, and I'd like to find a way to drive more regional business to that system. But it's someone that's philosophically attuned that the world is changing, and they need to change and their tired of fighting over a nickel, so to speak. So on the M&A front, you can't ignore the government programs. We have to get better at that. While we love the insured business, we love the health plans. And so we will be -- we're getting our balance sheet in better shape and we will be working those things hard, but not just the health plan but with a system that we can do more with than just gain the membership."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Operator","That's all the time we have for questions. I'd like to turn the conference to Allen Wise for closing remarks.",21,"That's all the time we have for questions. I'd like to turn the conference to Allen Wise for closing remarks."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Executives","Thank you so much for your interest in our company, and that will conclude our call for today.",18,"Thank you so much for your interest in our company, and that will conclude our call for today."
27133,84103937,49097,"Coventry Health Care Inc., Q4 2009 Earnings Call, Feb 09, 2010",2010-02-09,"Earnings Calls","Coventry Health Care, Inc.","Operator","That does conclude today's conference. Thank you all for your participation.",12,"That does conclude today's conference. Thank you all for your participation."
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","Good morning and welcome to the Coventry Health Careâ€™s first quarter 2010 earnings conference call. Todayâ€™s conference is being recorded, and all participants are in a listen-only mode. Todayâ€™s call will begin with opening remarks by the Chief E",63,"Good morning and welcome to the Coventry Health Careâ€™s first quarter 2010 earnings conference call. Todayâ€™s conference is being recorded, and all participants are in a listen-only mode.
 
Todayâ€™s call will begin with opening remarks by the Chief Executive Officer of Coventry Health Care, Mr. Allen Wise, and after a brief forward-looking statement led by Mr. Drew Asher. Please go ahead, Drew.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Ladies and gentlemen, during this call we will make forward-looking statements, certain risks and uncertainties as described in the companyâ€™s filings with the SEC on Form 10-K for the year-ended December 31, 2009, and as maybe updated from time-to-time",66,"Ladies and gentlemen, during this call we will make forward-looking statements, certain risks and uncertainties as described in the companyâ€™s filings with the SEC on Form 10-K for the year-ended December 31, 2009, and as maybe updated from time-to-time and Coventryâ€™s quarterly reports on Form 10-Q may materially impact those statements and could cause actual future results to differ materially from those anticipated and discussed. Allen.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Good morning and thank you for joining us. Weâ€™ll follow our normal agenda. Iâ€™ll start off by providing some brief comments. John Stelben will provide more details on the financials and that will be followed by some time for some brief questions.My c",2541,"Good morning and thank you for joining us. Weâ€™ll follow our normal agenda. Iâ€™ll start off by providing some brief comments. John Stelben will provide more details on the financials and that will be followed by some time for some brief questions.
My comments will cover three areas this morning. The first is on Q1, then our outlook for the remainder of 2010, and finally Iâ€™ll provide some brief remarks on the post reform future of our company. 
With regard to the first quarter, this morning we announced EPS of $0.66. As we look beyond Q1 to the remainder of the year, we are providing full year guidance of $2.35 to $2.50 per share. Q1 was obviously a very strong start to 2010 for our company, and while our management group believes that our business is improving rapidly, the strength of the quarter was a bit unexpected.
I believe that Q1 results can best be explained with two to three comments. First and most important is the sharper focus on business fundamentals over the last 18 months. Our SG&A, our medical unit costs worked towards improving our membersâ€™ quality of healthcare, much better integration between our actuarial, underwriting and sales team, our government program execution, and the many areas I have discussed in my prior four quarters of conference calls. Simple stated, we are actually getting better on the basics of our business and we will continue to do so. 
I think the second area to describe Q1 results, is that we have some favorable, for lack of a better word, tailwind. There was little impact from the flu; and I think two, it cannot be quantified, severe weather in many of our markets undoubtedly influenced utilization to some extent. And the third factor explaining our results is very positive reserve development.
Under the subject of quarterly highlights, I have a few comments. We closed our preferred health system acquisition in Kansas on February 1. This property has further strengthened our mid west regional presence, and will allow us to improve care for our members with a very high quality delivery system. 
We are working and plan on completing a proprietary Medicare advantage product with the Via Christi healthcare system, which we hope weâ€™ll be able to market later this year, with January 1, 2011 effective dates. Within this product weâ€™ll provide excellent coverage and improved care for the Kansas senior population.
Staying with quarterly highlights, we were once again awarded a contract to provide care for Medicaid members in Nebraska, with an effective date of August 1. We completed a very orderly and positive Medicare private fee for service exit. We took a number of successful steps in the last step of 2009, to neutralize the SG&A impact. 
We are experiencing positive reserves developments, which at a minimum will create additional statutory capital and ultimately free cash flow. On April 1, we began enrolling Medicaid members in Pennsylvania. 

Turning to the outlook for the remainder of 2010, Iâ€™d like to address our core businesses. Commercial business, I believe that youâ€™ll see a merchant proved membership progression during the first quarter. Including the close of our strategic preferred health acquisition during the first quarter, we grew commercial risk membership by 83,000 members. 
On a same store basis we were down approximately 20,000 members, and although we would certainly prefer to grow the same store membership and plan to do in the future, this is the best Q1 sequential result that our company has reported since Q1 of 2006. Much of this improvement is just plain better execution. 
I think during last year, during 2009 where there was substantial membership erosion, that I previously told people and told all of you that half of it was the economy and the diminishing size of the block of business, but atleast half of it was internal. We have addressed the internal issues and our new business sales show that and have exceeded plan. The number of personnel and process improvements that we made during 2009 are beginning to pay off in 2010.
We are still vigilant in pricing to underwriting costs, our costs of goods sold if you will. This is evidenced by our financial metrics in the press release. As all of you know, the key to long term success in this business is managing the cost of goods sold or the medical cost, along with SG&A, on behalf of our employer and individual customers. 
While we made improvement in patient care and the underlying cost structure in the past few quarters, we recognize that we have a lot more work to do in this area, and it will remain an area of focus. Itâ€™s especially necessary to have this focus as we navigate reform and prepare for the many new requirements there.
Moving from the commercial block to Medicare, the membership in our Medicare advantaged coordinated care plan reached 190,000 members, up from 186,000 at years end. This is 2% better than our flat forecast, but beyond that a very good result considering that we exit from a number of S&P plans and subscale markets which totaled about 13,000 members. 
Our medical loss ratio of 85.7 was 120 basis points improvement from the full year in 2009, and while this trend is positive, it was undoubtedly helped by a mild flu season and we recognize thereâ€™s a lot of work to be done, heading into the post reform payment environment. In short, we can do better in this business and we will. 
Iâ€™m pleased to report that new initiatives are underway to improve care coordination for the chronically ill, and are on target to be continually rolled out through the balance of the year. These are initiatives that began in 2009 regarding the frail elderly and they are showing some early promise. 
As explained earlier in my comments about Via Christi, we have developed a new model of care. We believe that more innovative reimbursement arrangements that align incentives to improve patient care with better outcomes are increasingly necessary in tomorrowâ€™s environment, and a substantial amount of resources will be directed towards models in that end.
As you all know too, I am sure that weâ€™re preparing our bids on the Medicare front for 2011, and given the recently announced and anticipated fact or revenue raise, and the reform related reductions that began in 2012, we must continue to intensify our focus there. We will continue to make progress on medical costs and contracting efficiencies along with other areas. These obviously include intelligent plan design, best practices for risk-adjusted revenue, SG&A improvement. 
Proving the quality of care for members is basic and fundamental for all of our efforts. Overall we are please with Q1 results for this business and we feel that we are doing the right things to prepare for changes in 2011 and 2012. In fact we anticipated the revenue environment, regardless of the reform movement, and spent a lot of time and energy and resources working on this effort beginning in 2009.
With regard to Medicare Part D, we have a solid stable business. We knew that quarter of 1.6 million Part D members are on track with our guidance. Once again I feel this is a good results because of our exit from nine auto assigned regions. From a pharmacy cost perspective, Q1 results are inline or slightly better than our expectations.
Moving to Medicaid, our Medicaid business is demonstrating very significant progress, both in terms of growth and better management of our members. From a growth view weâ€™ve added two new areas of business in Nebraska and Pennsylvania. Our Nebraska as I announced earlier is scheduled to commence in August this year, and should result in 30,000 to 40,000 new members. 
As discussed in our last call, we qualify to enter southeastern Pennsylvania and began receiving auto assigned members at the beginning of this month. We are continuing our efforts to finish our medical delivery system in central PA and hope to qualify in that region in the near future. We see opportunities to service this population and will continue to seek new opportunities in this space, especially given the long-term expansion of the population. 
With regard to our fee-based businesses, network rental, FEHP and the workers compensation, we are performing at or better than expectations. This business has provided predictable and consistent results. While the soft economy and the employment market has provided some headwinds for our workers compensation business, our strong sales execution and SG&A control has largely offset this headwind.
Let me give you some few comments about the post reform environment. What bout the environment? Well, we understand that regulations here have to be finalized, it will determine much of the future, but nevertheless the less the broad outlines are known and consistent with how we positioned our company during the past year. 
Our commercial group business, our $5 billion business is about evenly split, with about 50% of our enrolment below 100 subscribers and about 50% over 100. With a little progress in broker costs, which needed to be addressed regardless of reform, the weighted medical loss ratio average on our book of business should be in the low 80â€™s. Assuming a reasonable set of regulations, this positions us decently for the new rules and should allow a fair margin, and especially so we can find the 100 basis points of SG&A from a variety of sources.
The Medicare advantage coordinated care product is one that weâ€™ve always believed in. If you follow our companyâ€™s history back to the balance budget in the mid to late 90â€™s, a lot of people in our space abandoned this line of business; we did not and we have always believed itâ€™s the best way to provide care for seniors, and we are dedicated to put the effort and resources at best business practices in this line. 
As I previously announced in several calls, we have five ongoing initiatives to improve our results in this product line. We feel like the 2011 race announced early in April are manageable for us, and we are planning for the new payment system that starts getting payees down for 2012.
With regard to post reform, we have focused on Medicaid, again putting additional resources in that in 2009, both in improving our unit cost and caring better for our members. 
We understand that revenue will be a challenge as states struggle with their own revenue shortfalls, but low cost, both unit and SG&A along with better care for the member wins. Requirements for success, our skill sets that we have and thatâ€™s demonstrated in our recent medical loss rational progress. We are going to work hard to grow membership in Medicaid and this will continue to be a priority in our company. 
We are well aware of the many of the challenges in the post-reform environment and in shot we believe tomorrowâ€™s environment will create plenty of challenges, and also opportunities. We believe that organizations that are thoughtful, nimble, creative and have the industry tools and cost structure will succeed. 
We feel we are entering the reform environment as a well diversified resource, with a capable manager group and that we are well prepared for the evolving landscape. What about the tools for the future? We should have about a $1 billion in per cash by the middle of next year if we donâ€™t find other opportunities like preferred health. 
With regard to tools itâ€™s our senior team. One of our most significant accomplished over the past year has been the formation of a senior management team, who have proven records of success and are exceeding capability in their areas of responsibilities. A lot of these have been announced in the past, but Iâ€™ll take them in a minute, and I will remind you of some of the additions that weâ€™ve made to our organization. 
Staying with tools for the future to lower cost structure, its important to compete in the past and itâ€™s going to be critical in the future, and where we have delivery systems we think that our cost structure will generally be second to no one. A diversified, well positioned business and the nimbus and know-how to adapt is the fourth tool for the future, and I think that in general that we have the tools and resources to run a better company in tomorrows environment. 
I want to stay on our management group a bit, and a few comments and their commitments to the company I believe is appropriate. Weâ€™ve had a lot of experienced individuals. All have demonstrated records of success. People have proven their skills well previously, and more importantly during the last 15 months. In the end itâ€™s really about the quality of our management team in our business. 
In our operations and IT area, Harv DeMovick has been with the company for many years retuned a year ago and is committed to stay with our company through 2011. Our Medicare advantage in Part D is headed by Nancy Cocozza. She was with our company in the past, the best of what she does and is a building block that we need to do more of this business. 
Paul Conlin joined us this year. His responsibility is Medicaid. Heâ€™s added to our foundation for the future; has demonstrated early success both in unit cost and with new business during the last six months. 
Mick Bahr has been with our company for eight years and is part of our Altius and western operation and headed that up. Mikeâ€™s a underwriter and actuary, and he assumed the responsibility for all of our health plans about six months ago, and is uniquely qualified, to add a new group and individual business at the correct cost structure and revenue. 
Dr. Patricia Mueller, our senior medical officer joint us last year and is leading the efforts for better patient care. Matt Isles is our new addition in government policy and brings insights in the policy area that our company simply hasnâ€™t had in the past. I can continue the list but my point is that the best management team is basic to tomorrowâ€™s success and weâ€™ve got a very solid team. As our company has always done previously, the search for additional talent will continue. 
My own commitment is at a minimum though 2011 and Iâ€™ve stated earlier that the search for best people will not end, and I need to add that this will include a through and very thoughtful search for my successor. 
Closing though. Well there is a lot left to play out in 2010, but our management group feels very good about the year. Lot of work to be done to prepare for 2011 and beyond, but Iâ€™m excited and positive about our progress. In my own view there is a very high likelihood of future consolidation in our business in the not too distant future, and we feel very positive about our ability to participate in that consolidation process. In the end, change almost always brings opportunity. 
With that, that concludes my comments. John Stelben is going to provide a financial report and then weâ€™ll open the call for questions. John.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives"," Good mornings. As Allen said, we are pleased to report EPS for the first quarter of $0.66. This is a strong result embedded in our plan for the quarter. In addition as you have seen in the earnings release, we are increasing our full year guidance to a",1912," 
Good mornings. As Allen said, we are pleased to report EPS for the first quarter of $0.66. This is a strong result embedded in our plan for the quarter. In addition as you have seen in the earnings release, we are increasing our full year guidance to a range of $2.35 to $2.50, up from the previous guidance range of 210 to 225. 
First I am going to provide some highlights on the quarterly performance and then turn to the increase in guidance for the full year. At a macro level as Allan mentioned, we had some tailwind as we look back on the quarter. 
First, our Medicare advantage private key product line, which we exited January 1, produced $0.17 in the quarter, due primarily to prior period reserve development. While we set reserves with an expectation of favorable development, recall that we did not incorporate any private key run our earnings in our previous guidance. So this $0.17 is an upside to 2010 expectations. 
In our commercial risk business, membership was a little out of expectations due primarily to small group sales activity, which is ahead of Q1 2009 results. This is really the result of better sales execution, coupled with products that demonstrate better value. Our preferred health acquisition came online February 1 and that was a little over 100,000 commercial risk members. 
Premium yields our inline with expectations and are up 5.3% over the prior year quarter. The commercial group medical loss ratio of 80.2% is slightly better than expected, primarily due to lower than expected impact from flu. We previously guided to about 15 basis points of additional flue pressure on the 2010 full year group loss ratio, but it was front end loaded in Q1, and none of it really materialized during the quarter.
It maybe fair to say weather had some impact, but thatâ€™s pretty hard to quantify and it would be prudent to assume that elective procedures will get rescheduled at some future point. COBRA membership levels ticked up slightly to 1.8% from about 1.7% of total commercial group membership, which is consisted with our expectation that COBRA would climb to 2% during 2010. 
Our view of fundamental challenges continued stability in the 8.5% to 9% range. While our Q1 result was slightly better than expected, one quarter does not make a trend and while we are implementing unit cost in utilization of prudent initiatives across all our businesses, it is still too early to count the impact as I think about 2010. Our preferred health acquisition as Allan mention is performing as expected, both operationally and financially. 
Moving on to Medicare, the coordinated care results in Q1 are inline with our expectations for the quarter and the comments we made on the Q4 â€™09 earnings call. Membership is up slightly above where we ended â€™09 which is a very positive result given the 15,000 member blocks of business we exited coming into the year. Medicare Part D results as well were inline with our plan, and Iâ€™d like to provide a little more prospective on the loss ratio.
You will note in the last couple of years that Q1 loss ratios were generally in the range of 100%, higher than the 95.3% we reported this quarter. In 2010 we introduced deductibles on about 70% of the members, who had no deductible in 2009. The introduction of deductibles will alter the historical slope of earnings, but not the annual result. Given all the changes we made coming into 2010 with pricing and product design, we are very pleased with our membership results, and are on track for our full year Part D loss ratio guidance of mid 80â€™s.
Medicaid produced a very good Q1 loss ratio of 84%, to lead a better management of patient care, especially in-patient care and lower than expected flu. This result is several hundred basis points better than the annual loss ratio guidance. While we are very pleased with the results and the changeable progress we are making in patient management, we do see some late headwind that I will address later in my comments on guidance.
Turning to the balance sheet and cash flows, total cash in investments stand at $3.85 billion. Our investment portfolio is in a net unrealized gain position of $66 million at March 31, virtually unchanged from year-end. GAAP cash flow from operations for the quarter was a negative $187 million. This result includes a $297 million outflow for the run out of the private fee product line. As a reminder, we have cash and short-term liquid securities in our statutory entities matching private declines liability.
Adjusting for the private key run out in Q1, adjusted cash flow from operations would have been $110 million or over 150% of net income. More importantly, free deployable cash at the parent was $450 million versus $510 million at year-end, the main driver of the difference between the funds used for the preferred health acquisition net of some other ins and outs. Our normal statutory dividend process to parents starts in the second quarter.
Days in claims payable displayed in the press release exclude private key for service for all periods presented. The increase in DCP of 4.7 days over the prior quarter is due primarily to seasonal timing, timing of Part D subsidies and a small increase in claims inventory. Debt to cap ratio now stands at 29.5%, driven by the addition of Q1 earnings. We did not repay any debt in the quarter.
Turning to updated 2010 guidance, we are forecasting EPS in the range of 235 to 250. As a reminder, this includes the $0.17 of earnings generated by private gain in the first quarter, but does not assume any further private fee impact for the remainder of the year.
In summary, we are adding our view of Q1 out performance to the prior full year guidance, while essentially maintaining our prior aggregate view of Q2 through Q4, while recognizing some new facts we now know about. For simplicity, our work through the guidance changes using the mid point of the range for both prior and revised guidance. 
The mid point of prior guidance was $2.17 and the mid point of revised is $2.42 an increase of $0.25. As I just explained $0.17 of this increase was related to private fee, which leaves about $0.08 for our seven core businesses. Now, let me provide a few highlights on that. 
Starting with commercial risk, we still expect same store membership to be down for the year in the low single digit. When we include the addition of 100,000 preferred help commercial risk members total growth should be in the range of 4.5% to 5%. While our Q1 small group sales performance is better than expected, it is still early and the macro economic issue still exists. That being said we are very pleased with the same store sales results, and believe that volume will be slightly more favorable in the range than our previous expectation.
Forecasted commercial group risk MLR, including preferred health is expected to be in the range of 82% to 82.5%. This is a 25 basis point reduction from previous guidance, driven largely by the benign flue season. It also incorporates our fundamental view of forward trend stable. Together we believe these two items account for about $0.08 of the increased guidance. For Medicare CCP our view of guidance is unchanged. We continue to expect the0 Medicare Advantages loss ratio to be in the mid 80s.
Part D has also performed consisted with our expectations so far in 2010. As a result, our annual view of this business is unchanged from prior guidance. Membership is in the $1.6 million range and our loss ratio in the mid 80s. For Medicaid, from an earnings standpoint our annual view of this business is unchanged from prior guidance. While we had better expected Q1 results and we see improvement in patient management, we see raised headwinds in the second half of the year.
In our Missouri based health care US subsidiary, which accounts for almost half our Medicaid membership, we will be receiving a rate increase just under 1% in July, and this is around two points lower than expected. While our Medicaid team has multiple networking utilization initiatives underway to mitigate trend, we donâ€™t count things until we can physically count them. I would not be surprised given state revenue challenges of other rate actions in other space, and I have nothing definitive at this point and time. 
Our guidance has been adjusted to incorporate the addition of the Southeast PA and Nebraska market. We are underway in Southeast PA with auto-assignments beginning in April, and as Allen said, in Nebraska the contract begins August 1, with an expectation to reach 30,000 to 40,000 members by year-end. We expect a mutual impact over our earnings in 2010 for these new Medicaid markets. Our fee-based businesses will be up about $0.02 based on stronger than expected revenues. 
On SG&A, midpoint of the 2010 guidance is $1.96 billion. The new midpoint is up about $20 million to recognize volume related SG&A for our better commercial membership and the addition of the southeast PA, Nebraska Medicaid businesses. Note that at the midpoint of SG&A guidance, the percent of revenue is 17.3% down slightly from the 17.5% previous guidance. Given we have not repurchased any shares year-to-date, we have adjusted the share count in our 2010 guidance to reflect deployment in the back half of the year. 
So, let me just re-summarize those points. Private fee Q1 earnings of $0.17 growth grew for the full year. Commercial group risk out performance, both our improved unit loss ratio as well as higher expected volume drives about 8%, $0.08 of the increase. 
Medicare CCP and Part D are unchanged from an earnings perspective. Medicaid earnings are unchanged for the year. Q1 out performance will be offset by lower than expected rating increases in Missouri. Fee-based businesses will be up about $0.02 based on stronger than expected revenues, and lastly our more conservative view of share repurchase has an impact of negative $0.02. 
On free cash and capital, as stated earlier, we have $450 million of deployable cash on hand, and expect to generate over $250 million of free cash from our seven core businesses in 2010. In addition, we expect to dividend out the capital supporting the private fee product line, which during Q1 results would be approximately $275 million. 
We will seek to partially dividend this up in late 2010, with the remainder in the first half of 2011. Assuming no additional deployment of cash, we could end 2010 with $700 million to $800 million of deployable capital. In adding to that the remainder of the private fee dividend in 2011, we could have total deployable capital of approximately $1 billion by mid 2011. Our priorities for deployable cash are the same as always, growing the business through acquisition followed by opportunistic share repurchase and delevering. 
To conclude, Q1 was a strong but early result. We see changeable progress and better sales execution, and in managing all of our expenses better. While we all know the challenges ahead, we continue to focus on improving our overall cost structure. A low cost structure will be the key differentiator in succeeding in the reform world, really as it had always been in this business. 
Allen, do you have anything else to add?
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, lets open the call up for questions please.",9,"No, lets open the call up for questions please.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","(Operator Instructions) Your first question comes from John Rex - JPMorgan.",11,"(Operator Instructions) Your first question comes from John Rex - JPMorgan.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So I appreciate your comments on thinking about reform and the minimum MCRâ€™s for 2011. So just going a little deeper on that, you mentioned making some progress on commission structures as you look out to 2011. If you could tell what you are doing now f",87,"So I appreciate your comments on thinking about reform and the minimum MCRâ€™s for 2011. So just going a little deeper on that, you mentioned making some progress on commission structures as you look out to 2011. If you could tell what you are doing now for that, and what you would anticipate -- how much you would need to do in terms of progress or commission structure, maybe focusing first on some of that and then a couple of questions on your individual book also.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","John, unfortunately we are not doing much now. A year ago, there was a plan in place but we havenâ€™t made much progress on it. We will make progress and we are redoubling our efforts towards that, but its sort of a slippery slope. If you get out too fa",205,"John, unfortunately we are not doing much now. A year ago, there was a plan in place but we havenâ€™t made much progress on it. We will make progress and we are redoubling our efforts towards that, but its sort of a slippery slope. 
If you get out too far in front of all that and donâ€™t do it in a reasonable and thoughtful way, and consistent with the competition, you are going to lose some of your profitable book, but regardless of reform, the amount of commissions have continued to creep in the commercial arena, with a decreasing block of business out there and people increasingly eager to preserve market share. So its just going in the wrong direction and that has to change. 
We have not made much progress and will be redoubling our efforts to go with the people that are most helpful to us and to their clients. Thatâ€™s something that is consistent with the realties of tomorrow and we just havenâ€™t done very well, and its some thing that we probably would not pre-announce and it will vary obviously market by market. So its an area that the whole sector needs to do better on, and we havenâ€™t done much.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I guess in just thinking, if we can get to the low 80s you are talking about, with the progress in broker costs, do broker costs have to essentially cut in half to do that? I mean that is the kind of the right range to think about for a small group at lea",54,"I guess in just thinking, if we can get to the low 80s you are talking about, with the progress in broker costs, do broker costs have to essentially cut in half to do that? I mean that is the kind of the right range to think about for a small group at least?
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I donâ€™t know about half, but if you talk about 100 basis points of SG&A, some of which would be broker efforts and some the continuing efforts that we have internally to manage our own cost, and just do a better job. The weighted average of our book of",83,"I donâ€™t know about half, but if you talk about 100 basis points of SG&A, some of which would be broker efforts and some the continuing efforts that we have internally to manage our own cost, and just do a better job. The weighted average of our book of business is somewhere in the low 80s now, and so I think we are making a 100 basis points of improvement, that we are not so far off from where we are now.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, and then on youâ€™re individual book, so we see about maybe just under $300 million in individual premium revenue. I wondering if thatâ€™s kind of still accurate, and then we would see that at a 71% loss ratio, this is thinking about â€™09 statutory",75,"Okay, and then on youâ€™re individual book, so we see about maybe just under $300 million in individual premium revenue. I wondering if thatâ€™s kind of still accurate, and then we would see that at a 71% loss ratio, this is thinking about â€™09 statutory filings actually. So, how about on the key, just because of the gap from where that sits today, would suggest almost as much impact as a small group could reserve.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, individual is about 3% of our revenue and miniscule part of our profits and once again John regardless of reform, I think that I have explained before that one of our initiatives beginning last year, is to start with a clean piece of paper on the in",154,"Well, individual is about 3% of our revenue and miniscule part of our profits and once again John regardless of reform, I think that I have explained before that one of our initiatives beginning last year, is to start with a clean piece of paper on the individual product that would give a better value equation for our customers, and that would incorporate a different distribution system. 
So its a small part of our company and I would say something that needs attention first, and one of these days soon we will be announcing a new addition to our company in product development with this person; one or two things that the person is going to do in the company, but we have been working on that. We are working on from an IT perspective, a clean piece of paper and a different distribution system, because what we have today doesnâ€™t work for tomorrow.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Iâ€™m just summarizing, your view being for 2011, at this point you donâ€™t necessarily expect any drag from the implementation there with MCRâ€™s. You think about your commercial book overall, is that the correct way to walk away with that thought?",42,"Iâ€™m just summarizing, your view being for 2011, at this point you donâ€™t necessarily expect any drag from the implementation there with MCRâ€™s. You think about your commercial book overall, is that the correct way to walk away with that thought?
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, its kind of a leap of faith. I think the things we began a year ago in terms of our internal cost, in terms of a better delivery system, there is a huge difference in some markets between the quality and efficiency and outcome and the cost of some of",179,"No, its kind of a leap of faith. I think the things we began a year ago in terms of our internal cost, in terms of a better delivery system, there is a huge difference in some markets between the quality and efficiency and outcome and the cost of some of the delivery business. 
So the efforts that we started to give a better value equation for our membership and everything started a long time ago, and the new reg as I understand, or the new law about the regs as I understand them and a look at the distribution of our business, sort of 5050; 50% falling in that minimum of 80, and 50% in the minimum of 85, Iâ€™m not complacent or anything, I just donâ€™t see any tremendous hurdles that we canâ€™t deal with. 
We have to get more cost out of the place. I told you a year ago we are going to get cost out of the place and now you can count it, and we will get more cost out of the place.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","Your next question comes from Matthew Borsch - Goldman Sachs.",9,"Your next question comes from Matthew Borsch - Goldman Sachs.

"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I would like to just ask on a non-reform question. You alluded to some pricing action in the market, maybe by competitors. Iâ€™m wondering, have you actually seen an uptick in price competition in the commercial risk area or is that just a continuation fr",67,"I would like to just ask on a non-reform question. You alluded to some pricing action in the market, maybe by competitors. Iâ€™m wondering, have you actually seen an uptick in price competition in the commercial risk area or is that just a continuation from what youâ€™ve seen last year and any further geographic or other color you can give us and that will be great.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, I donâ€™t think I said price. What I said was for broker commission, our sector as a group. What I said six months ago or something, when I was addressing our loss of commercial membership in 2009. I said that half of it was a condition of the economy",160,"No, I donâ€™t think I said price. What I said was for broker commission, our sector as a group. What I said six months ago or something, when I was addressing our loss of commercial membership in 2009. I said that half of it was a condition of the economy. We kept a group, but there were layoffs, our people couldnâ€™t afford the product anymore or Chapter 11s on their small group of business, and half of it was self-induced that we introduced some new underwriting actions in the end of 2007 and 2008. 
When we got a new team, there was a certain amount of dysfunctionality in the communication between actuarial underwriting and our sales team. When we looked to the mirror and corrected our own decisions, we are having much more success in the market place, and if anything, I would say the pricing environment, the competitive environment is a bit better than it was a year ago.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay great, and actually this is on reform. As you referred to the individual product is about 33% of revenue and contributing miniscule amounts to the earnings, can we take it from miniscule that its substantially less than 3% from an earnings contributi",45,"Okay great, and actually this is on reform. As you referred to the individual product is about 33% of revenue and contributing miniscule amounts to the earnings, can we take it from miniscule that its substantially less than 3% from an earnings contribution on that 
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","If you add 3% of our revenue, then the margin is under 5%, its just not a big deal.",19,"If you add 3% of our revenue, then the margin is under 5%, its just not a big deal.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","Your next question comes from Ana Gupte - Sanford Bernstein.",9,"Your next question comes from Ana Gupte - Sanford Bernstein.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I was wondering if you could give us some color on the recent rate pressures in Massachusetts, Maine, and California, and your perspective on states that you are participating in. Will this slightly become an agent in terms of the regulatory or legislativ",48,"I was wondering if you could give us some color on the recent rate pressures in Massachusetts, Maine, and California, and your perspective on states that you are participating in. Will this slightly become an agent in terms of the regulatory or legislative pressures on small group rates?
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","In terms of group, down to any business in any of those states and I kind of know what I read about that, I donâ€™t see anything today in any of our markets that suggest that there are any movements like what we are seeing in those three areas.",49,"In terms of group, down to any business in any of those states and I kind of know what I read about that, I donâ€™t see anything today in any of our markets that suggest that there are any movements like what we are seeing in those three areas.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","When the state regulatory commissioners are deciding rates, would they restrict or consider restricting the dividending of cash to the parent and thereby they can keep pressure on the rates while still keeping you adequately reserved. Do you see any sort",48,"When the state regulatory commissioners are deciding rates, would they restrict or consider restricting the dividending of cash to the parent and thereby they can keep pressure on the rates while still keeping you adequately reserved. Do you see any sort of conversations or trends in that direction?
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","No.",1,"No.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Then, finally on the small group and individual, the restricted underwritings that you are seeing right now coming into being prior to reform restricted underwriting in terms of its medical condition, recession and so on, are you seeing any impact on that",45,"Then, finally on the small group and individual, the restricted underwritings that you are seeing right now coming into being prior to reform restricted underwriting in terms of its medical condition, recession and so on, are you seeing any impact on that in 2011 margins?
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","On the recession front, we have been looking at that several quarters now. That would be under 500 recessions a year in our company, maybe under 400, so the impact is not great. Our legal and regulatory people are reviewing now whether or not for the re",224,"On the recession front, we have been looking at that several quarters now. That would be under 500 recessions a year in our company, maybe under 400, so the impact is not great. 
Our legal and regulatory people are reviewing now whether or not for the remainder of the year that we would want to go to a third party to also review the recessions, but we have a pretty arduous process within our company. 100% of the recessions go to a legal team who review the facts, the information and so we donâ€™t do that many right now. Only in extreme cases of beyond misrepresentation of fraud, so not a huge impact. 
The question has always been with anything less than universal coverage, what kind of product you are going to be able to have if you canâ€™t do any underwriting, and we just have to wait and see what the details and see where are the niche is there. 
If we canâ€™t do that in a business, likely we donâ€™t that in the product, but I think a of whatâ€™s coming is going to come out in the regs and may vary by state and the devil is going to be in the details. So the real answer is in the short term, no not any impact, longer-term weâ€™ll have to see.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And on the baby end of the market are you seeing any changes in the way these employers or responding to reform. Are they more likely to subsidize in light of tax credit or are they sort of pulling back from getting into this phase?",45,"And on the baby end of the market are you seeing any changes in the way these employers or responding to reform. Are they more likely to subsidize in light of tax credit or are they sort of pulling back from getting into this phase?
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I donâ€™t know, except what weâ€™ve talk about in Q1, in our smaller mid-sized group; whether its more of the markets improving slightly or its because of our own efforts our quotes up. We are running more business than we have in a while and I canâ€™t at",75,"I donâ€™t know, except what weâ€™ve talk about in Q1, in our smaller mid-sized group; whether its more of the markets improving slightly or its because of our own efforts our quotes up. We are running more business than we have in a while and I canâ€™t at this stage really know how much of that, because we got a better team with better focus out there or if the environment is improving slightly.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","Your next question comes from Justin Lake - UBS.",8,"Your next question comes from Justin Lake - UBS.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Allen you talked about the expectation for significant consolidation in the industry post reform. I am just curious to get your view on the, how important are the attribution with regards to the scale of local level versus having just international scale?",42,"Allen you talked about the expectation for significant consolidation in the industry post reform. I am just curious to get your view on the, how important are the attribution with regards to the scale of local level versus having just international scale?
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, the comments of our consolidation is educated guests or may be a guess, but we all acknowledge that the things we did yesterday arenâ€™t enough for tomorrow. The revenue environment is going to be more difficult and you just have to be better with w",169,"Well, the comments of our consolidation is educated guests or may be a guess, but we all acknowledge that the things we did yesterday arenâ€™t enough for tomorrow. The revenue environment is going to be more difficult and you just have to be better with what you do and I think if you are in the business and donâ€™t have best business practices, best information, best people, best focus and a reasonable cost structure, you arenâ€™t going to be able to compete. 
So I would be surprised if there werenâ€™t other opportunities like the preferred healthcare of Kansas where people focus on doing what their primary business is, and so weâ€™ll see where that comes out a year from now. If you look at the balance sheets and margins, itâ€™s going to get more difficult, so I donâ€™t see how you avoid consolidation in all the lines of businesses; certainly Medicare Advantage, certainly some of the small private Medicate plans and some of the commercial plans and weâ€™ll see.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, and just as you are seeing that shift happen, you mentioned the acquisition you did there. Do you see that happening in a way where there is going to be opportunities to be the best, smaller markets where you donâ€™t feel like you have scale or to b",70,"Okay, and just as you are seeing that shift happen, you mentioned the acquisition you did there. Do you see that happening in a way where there is going to be opportunities to be the best, smaller markets where you donâ€™t feel like you have scale or to be purchased; thinking of making acquisitions like this, or do you think itâ€™s just going to be happening naturally for competitive pressures? 
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think the latter. We are a regional company, a multi regional company. We are not national, not going to be national and canâ€™t be. Where we have health plans, where we have HMO type networks, our cost structure has always been competitive with the bes",301,"I think the latter. We are a regional company, a multi regional company. We are not national, not going to be national and canâ€™t be. Where we have health plans, where we have HMO type networks, our cost structure has always been competitive with the best, and letâ€™s say competitive means within 500 basis points of the best, and that hasnâ€™t changed. 
I think that we have to be better in selecting maybe something. Networks are not as broad as they once where, in return for picking a delivery system with good outcomes and high quality care for the members, which always means usually a better-cost structure. I think that within the places that we do business there will be a narrower products. 
The one that we are working on with Via Christi on Medicare Advantage, and the Central Kansas area will be a product for the Via Christi system only. They have a huge amount of resources including 26 primary care physicians that are employees of the system and I think that will just allow us to get better benefits, better resources to help those physicians manage the care better, and I think that is going to happen on the commercial side as well. 
Just the problem with our product is no one can afford it, and Iâ€™m talking about our sector, our investment, so we are going to have to do a better job on the cost front. So I think its going to get tougher for everybody, and if you donâ€™t have best business practices and a good balance sheet, and the information and the insights it takes to manage the patients; that people are going to opt out, but weâ€™ll see. I have no evidence of that at this stage, but maybe in a quarter or two.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts"," So you donâ€™t see the need to take that $1 billion that you talked about and keep that as a [warchest] to go out there and buy smaller plans. You think most of what youâ€™ll be doing is more organic; is that fair to say?",46," 
So you donâ€™t see the need to take that $1 billion that you talked about and keep that as a [warchest] to go out there and buy smaller plans. You think most of what youâ€™ll be doing is more organic; is that fair to say?
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, this company has always been opportunistic. If we find a property that fits our criteria, which is, do we understand the business, is it fairly priced, and third thing is do we know how to make it better; is our cost structure better in having one IT",166,"No, this company has always been opportunistic. If we find a property that fits our criteria, which is, do we understand the business, is it fairly priced, and third thing is do we know how to make it better; is our cost structure better in having one IT system, can we do better, we would always do that. 
Its accretive, it helps our presence in the marketplace, and we did that for a long time, but consolidation kind of stopped and I believe that its likely on all those fronts we talked about, the Medicare advantage and registered with a small private Medicaid plans, but sort of into commercial I think that that will return. 
One of the reasons that we didnâ€™t do any share repurchases in Q1 is just to your point. I want to keep our powder dry and I think that buying businesses that we understand and no one make it better, and can make a fairer margin is good use of capital.

"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","Your next question comes from Scott Fidel - Deutsche Bank.",9,"Your next question comes from Scott Fidel - Deutsche Bank.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just to address it first; if your 2010 guidance at this point has any healthcare reform related expenses, and just things like some of the early implementation of some of the market reforms or higher taxes shared with some of the reforms, bill changes, ju",50,"Just to address it first; if your 2010 guidance at this point has any healthcare reform related expenses, and just things like some of the early implementation of some of the market reforms or higher taxes shared with some of the reforms, bill changes, just if you could summarize that?
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Sure Scott. Yes it does, and those impacts we donâ€™t believe are material to this year, but our guidance does account for them.",23,"Sure Scott. Yes it does, and those impacts we donâ€™t believe are material to this year, but our guidance does account for them.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, and then do you have any estimate on how much membership that you can add in Pennsylvania Medicaid this year?",21,"Okay, and then do you have any estimate on how much membership that you can add in Pennsylvania Medicaid this year?
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes, that we added about 2000 orders signed in the month of April, and I think for the year that number is probably about 10,000.",25,"Yes, that we added about 2000 orders signed in the month of April, and I think for the year that number is probably about 10,000.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then just one last question John, just if you have an update on the cost components and John if there is any change in view on any of them.",30,"And then just one last question John, just if you have an update on the cost components and John if there is any change in view on any of them.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Sure. As I said earlier, its really stable, so I will just rip through the components. Now in-patient, thatâ€™s running in the range of high single digits. Really unique cost driven. Out patient, low double digits split but tilted a little more towards un",78,"Sure. As I said earlier, its really stable, so I will just rip through the components. Now in-patient, thatâ€™s running in the range of high single digits. Really unique cost driven. Out patient, low double digits split but tilted a little more towards unit cost. On our physician I would say its mid single digits split. In an OpEx, itâ€™s mid to high single digit again split. So again, a stable view of what we just discussed before.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","Your final question comes from Kevin Fischbeck - Banc of America, Merill Lynch",12,"Your final question comes from Kevin Fischbeck - Banc of America, Merill Lynch
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I guess I wanted to go back to the comments you made there on the acquisition front. Really it sounds like you think consolidation is inevitable. Are you seeing anything from just smaller plans embracing that view? Are you seeing proximity from them appro",48,"I guess I wanted to go back to the comments you made there on the acquisition front. Really it sounds like you think consolidation is inevitable. Are you seeing anything from just smaller plans embracing that view? Are you seeing proximity from them approaching you; any update there?
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","  You have to keep my comments in proper perspective; one closed deal in the quarter doesnâ€™t make a trend. We see a thought process out there in several fronts where people are at least bringing new subjects to the table in their organizations. Obviousl",147,"  You have to keep my comments in proper perspective; one closed deal in the quarter doesnâ€™t make a trend. We see a thought process out there in several fronts where people are at least bringing new subjects to the table in their organizations. Obviously, if I had anything definitive there, I would announce it, but keep my comments in perspective. One, its my view, there is what I would characterize as some slight evidence in terms of people that we know that are sort of thinking about it, but thatâ€™s all.
As things get more difficult, as the revenue is harder to come by, I donâ€™t see, if you donâ€™t have best practices and a strong balance sheet and its not your primary business, I donâ€™t see how you survive, certainly not thrive, I donâ€™t see how anything else happens, but we will see. Itâ€™s my guess.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. So it sounds like, just about that last comment, you are talking more about kind of like the Christi type deals in companies that arenâ€™t. Its part of their business, but not a focus of their business, and looking to sell that off rather than have",50,"Okay. So it sounds like, just about that last comment, you are talking more about kind of like the Christi type deals in companies that arenâ€™t. Its part of their business, but not a focus of their business, and looking to sell that off rather than have a fixed plan.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think thatâ€™s right.",5,"I think thatâ€™s right. 
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I didnâ€™t hear anything in particular about the Medicaid acquisition. Have you thought about growing that plan?",18,"I didnâ€™t hear anything in particular about the Medicaid acquisition. Have you thought about growing that plan?
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Not beyond what I said. When I returned early in 2009, the second day I was here, I traveled to Nebraska, because an RFE was in process, and my view was that the government already represents over 50% of the healthcare spend. My view is that we needed to",189,"Not beyond what I said. When I returned early in 2009, the second day I was here, I traveled to Nebraska, because an RFE was in process, and my view was that the government already represents over 50% of the healthcare spend. My view is that we needed to redouble our efforts in the Medicaid area. We have, and have successfully landed two pieces of new opportunity there, and so we would get Medicaid payers just the same way we would in commercial and continue to seek new business. 
I think with the skill set we have; weâ€™ve been in the business for 15 years. We just, I think got a little bit distracted with several other large acquisitions and we kind of returned to our rits, and so, we are very bullish, and we understand the challenges and we understand the right revenue, but it is an area of focus for the company. We are going to do our best by whatever means to grow revenue there. Whatever means meaning, either obtaining new business or if an acquisition opportunity would present itself, we would certainly look at it. 
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts"," Okay. Thatâ€™s really helpful. This is just to clarify, on the Medicare advantage, the 85, that excludes the development right.",20," 
Okay. Thatâ€™s really helpful. This is just to clarify, on the Medicare advantage, the 85, that excludes the development right.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","That is the pure CCP loss ratio.",7,"That is the pure CCP loss ratio.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","And that does conclude our question-and-answer session. I would now turn the conference back over to Mr. Allen Wise for any closing or additional remarks.",26,"And that does conclude our question-and-answer session. I would now turn the conference back over to Mr. Allen Wise for any closing or additional remarks.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","That concludes our comments today and thank you very much for joining us.",13,"That concludes our comments today and thank you very much for joining us.
"
27133,100327066,58710,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","And that does conclude our conference call. Thank you for your participation.",12,"And that does conclude our conference call. Thank you for your participation.

"
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","Good morning, and welcome to the Coventry Health Care's First Quarter 2010 Earnings Conference Call. [Operator Instructions] Todayâ€™s call will begin with opening remarks by the Chief Executive Officer of Coventry Health Care, Mr. Allen Wise and after a",51,"Good morning, and welcome to the Coventry Health Care's First Quarter 2010 Earnings Conference Call. [Operator Instructions] Todayâ€™s call will begin with opening remarks by the Chief Executive Officer of Coventry Health Care, Mr. Allen Wise and after a brief forward-looking statement read by Mr. Drew Asher.  Please go ahead, Drew."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Ladies and gentlemen, during this call we will make forward-looking statements. Certain risks and uncertainties as described in the companyâ€™s filings with the SEC on Form 10-K for the year ended December 31, 2009, and as maybe updated from time to time",69,"Ladies and gentlemen, during this call we will make forward-looking statements. Certain risks and uncertainties as described in the companyâ€™s filings with the SEC on Form 10-K for the year ended December 31, 2009, and as maybe updated from time to time in Conventry's quarterly reports on Form 10-Q, may materially impact those statements and could cause actual future results to differ materially from those anticipated and discussed. Allen?"
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Good morning, and thank you for joining us. We'll follow our normal agenda. I'll start off by providing some brief comments. John Stelben, will provide more details on the financials and that will be followed by some time for some brief questions. My comm",2518,"Good morning, and thank you for joining us. We'll follow our normal agenda. I'll start off by providing some brief comments. John Stelben, will provide more details on the financials and that will be followed by some time for some brief questions. My comments will cover three areas this morning. The first is on Q1, then our outlook for the remainder of 2010. And finally, I'll provide some brief remarks on the post-reform future of our company.
With regard to the first quarter, this morning we announced an EPS of $0.66. And as we look beyond Q1 to the remainder of the year, we're providing full year guidance of $2.35 to $2.50 per share. Q1 was obviously a very strong start 2010 for our company. And while our management group believes that our business is improving rapidly, the strength of the quarter was a bit unexpected. 
I believe that Q1 results can best be explained with two or three comments. First and most important is the sharper focus on business fundamentals over the last 18 months. Our SG&A, our medical unit cost work toward improving our members' quality of healthcare, much better integration between our actuarial, underwriting and sales team, our government program execution and the many areas I have discussed in my prior four quarters of conference calls. Simply stated, we're executing better in the basics of our business and we will continue to do so. 
I think the second area to describe Q1 results is that we have some favorable, for lack of a better word, tailwind. There was little impact from the flu. And I think, too, while it cannot be quantified, severe weather in many of our markets undoubtedly influenced utilization to some extent. And the third factor explaining our results is a very positive reserve development.
Under the subject of quarterly highlights, I have a few comments. We closed our Preferred Health Systems acquisition in Kansas on February 1. This property has further strengthened our Midwest regional presence and will allow us to improve care for our members with a very high quality delivery system. We're working and planning on completing a proprietary Medicare Advantage product with the Via Christi Healthcare System, which we hope we'll be able to market later this year with January 1, 2011, effective dates. We believe this product will provide excellent coverage and improved care for the Kansas senior population.
On staying with quarterly highlights, we were once again awarded the contract to provide care for Medicaid members in Nebraska with an effective date of August 1. We completed a very orderly and positive Medicare Private Fee-For-Service exit. We took a number of successful steps in the last step of 2009 to neutralize the SG&A impact. We're experiencing positive reserves developments, which at a minimum will create additional statutory capital and ultimately, free cash flow. On April 1, we began enrolling Medicaid members in Pennsylvania.
Turning to the outlook for the remainder of 2010, I'd like to address our core businesses. Commercial business, I believe, that you'll see a much improved membership progression during the first quarter, including the close of our strategic Preferred Health acquisitions during the first quarter. We grew commercial risk membership by 83,000 members. 
On a same-store basis, we were down approximately 20,000 members. And although we would certainly prefer to grow same-store membership and plan to do in the future, this is the best Q1 sequential result that our company has reported since Q1 of 2006. Much of this improvement is just plain better execution. I think during last year, during 2009, where there was substantial membership erosion that I've previously told people and told all of you that half of it was the economy and the diminishing size of the lack of business, but at least half of it was internal. And we have addressed the internal issues and our new business sales showed that and have exceeded plan. And the number of personnel in process of improvements that we made during 2009 are beginning to pay off in 2010.
We're still vigilant in pricing to underlying cost, our cost of goods sold, if you will. This is evidenced by our financial metrics in the press release. As all of you know, the key to long-term success in this business is managing the cost of goods sold or the medical costs along with SG&A on behalf of our employer and individual customers. While we've made improvement in patient care and underlying cost structure in the past few quarters, we recognize that we have a lot more work to do in this area and that it will remain an area of focus.
It's especially necessary have this focus as we navigate reform and prepare for the many new requirements there. 
Moving from the commercial block to Medicare, the membership in our Medicare Advantage Coordinated Care Plan reached 190,000 members, up from 186,000 at years end. This was 2% better than our flat forecast but beyond that, a very good result considering that we exit from a number of SNP [Special Needs Plans] plans and subscale markets, which totaled about 13,000 members. 
Our medical loss ratio of 85.7 was 120 basis points improvement from the full year in 2009. And while this trend is positive, it was an undoubtedly helped by a mild flu season and we recognize there's a lot of work to be done heading into the post-reform payment environment. In short, we can do better in this business and we will. 
I'm pleased to report the new initiatives are underway to improve care coordination for the chronically ill, and are on target to be continually rolled out through the balance of the year. These are initiatives that began in 2009 regarding the frail elderly and they are showing some early promise. 
As explained earlier in my comments about Via Christi, we have developed a new model of care. We believe that more innovative reimbursement arrangements that align incentives to improve patient care with better outcomes are increasingly necessary in tomorrow's environment, and a substantial amount of resources will be directed toward models in that end. 
As you all know too, I'm sure that we are preparing our bids on the Medicare front for 2011. And given the recently announced, an anticipated VAT revenue raise and the reform-related reductions that began in 2012, we must continue to intensify our focus there. We will continue to make progress on medical cost and contracting efficiencies along with other areas. These obviously include intelligent plan design, best practices for risk-adjusted revenue, SG&A improvement.
Proving the quality of care for members is basic and fundamental to all of our efforts. Overall, we're pleased with Q1 results for this business and we feel that we are doing the right things to prepare for changes in 2011 and 2012. In fact, we anticipated the revenue environment regardless of the reform movement, and spent a lot of time and energy and resources working on these efforts beginning in 2009. 
With regard to Medicare Part D, we have a solid stable business. We ended the quarter at $1.6 million Part D members, on track with our guidance. Once again, we feel this was a good result because of our exit from nine auto-assigned regions. From the pharmacy cost perspective, Q1 results are in-line or slightly better than our expectations. 
Moving to Medicaid, our Medicaid business is demonstrating very significant progress both in terms of growth and better management of our members. From a growth view, we've added two new areas of business in Nebraska and Pennsylvania. Our Nebraska business, as announced earlier, is scheduled to commence in August of this year and should result in 30,000 to 40,000 new members. 
As discussed in our last call, we qualified to enter southeastern Pennsylvania and began receiving auto-assign members at the beginning of this month. We are continuing our efforts to finish the medical delivery system in central PA and hope to qualify in that region in the near future. We see opportunities to service this population and we'll continue to seek new opportunities in this space, especially given the long-term expansion of the population. 
With regard to our Fee-Based businesses, Network Rental, FEHB [Federal Employees Health Benefits]and the Workers' Compensation were performing at or better than expectations. These businesses provide predictable and consistent results. While the soft economy and the employment market has provided some headwinds for our Workers' Compensation business, our strong sales execution and SG&A control has largely offset this headwind. 
Maybe some few comments about the post-reform environment. What about the environment? Well, we understand that regulations yet to be finalized will determine much of the future, but nevertheless, the broad outlines are known and consistent with how we position our company during the past year. 
Our Commercial Group business, a $5 billion business is about evenly split with about 50% of our enrollment below 100 subscribers and about 50% over 100. With a little progress in broker cost, which needed to be addressed regardless of reform, the weighted medical loss ratio average on our book of business should be in the low 80s. Assuming a reasonable set of regulations, this positions us decently for the new rules and should allow a fair margin, and as basically so, we can find 100 basis points of SG&A from a variety of sources.
The Medicare Advantage Coordinated Care product is one that we've always believed in. You follow our company's history back to the balanced budget in the mid-to-late '90s, a lot of people in our space abandoned this line of business, we did not. And we have always believed it's the best way to provide care for seniors, and we're dedicated to put the effort and resources to have best business practices in this line. 
And as I previously announced in several calls, we have five ongoing initiatives to improve our results in this product line. We feel like the 2011 race announced early in April are manageable for us, and we're planning for the new payment system that starts getting payees down for 2012.
With regard to post reform, we have focused on Medicaid, began putting additional resources in that in 2009 both in improving our unit cost and caring better for our members. We understand that revenue will be a challenge as states struggle with their own revenue shortfalls. That low cost, both unit and SG&A, along with better care for the member, wins. Requirements for success our skill sets that we have and that's demonstrated in our recent medical loss ratio progress. We're going to work hard to grow membership in Medicaid and this will continue to be a priority in our company.
We're well aware of many of the challenges in the post-reform environment and in short, we believe tomorrow's environment will create plenty of challenges and also opportunities. We believe that organizations that are thoughtful, nimble, creative and have the industry tools and cost structure will succeed. And we feel we're entering the reform environment as a well-diversified, resourceful, with a capable manager group and that we're well prepared for the evolving landscape. But what about the tools for the future? Well, we should have about $1 billion in free cash by the middle of next year if we don't find the other opportunities like Preferred Health. 
And with regard to tools, it's our senior team. One of our most significant accomplishment over the past year has been the formulation of our senior management team, who have proven records of success and are exceedingly capable in their areas of responsibilities. A lot of these have been announced in the past, but I'll take them in a minute, I will remind you of some of the additions that we've made to our organization. 
Staying with tools for the future to low cost structure, it's important to compete in the past and it's going to be critical in the future. And where we have delivery systems, we think that our cost structure will generally be second to no one's.
A diversified, well-positioned business and the nimbleness and know-how to adapt is the fourth tool for the future. And I think that in general, that we have the tools and resources to run a better company in tomorrow's environment.
I want to stay on our management group a bit, and a few comments in their commitments to the company, I believe, is appropriate. We've had a lot of experienced individuals, all have demonstrated records of success, people have proven their skills well previously, and more importantly, during the last 15 months. In the end, it's really about the quality of your management team and our business.  
In our operations on IT area, Harv DeMovick has been with the company for many years, returned a year ago and is committed to stay with our company through 2011. Our Medicare Advantage and Part D is headed by Nancy Cocozza. She was with our company in the past, the best of what she does and is a building block that we need to do more of this business. Paul Conlin joined us this year. His responsibility  is Medicaid. He's added to our foundation for the future and has demonstrated early success both in unit cost and with new business during the last six months. Mike Bahr has been with our company for eight years and was part of our Altius and Western operation or headed that up. Mike's an underwriter and actuary, and he assumed the responsibility for all of our health plans about six months ago and is uniquely qualified to add new group and individual business at the correct cost structure and revenue. Dr. Patricia Mueller, our Senior Medical Officer, joined us last year and is leading the efforts for better patient care. And Matt Eyles is a new addition in government policy and bring insights in the policy area that our company simply hasn't had in the past. I could continue the list but my point is that the best management team is basic for tomorrow success and we've got a very solid team. And as our company has always done previously, the search for additional talent will continue. 
My own commitment is at minimum through 2011, and I have stated earlier that the search for best people were not end, and I need to add that this will include a thorough and very thoughtful search for my successor. 
Closing thought. Well there's a lot left to play out in 2010 but our management group feels very good about the year. A lot of work to be done to prepare for 2011 and beyond, but I'm excited and positive about our progress. In my own view, there's a very high likelihood of future consolidation in our business in the not-too-distant future, and we feel very positive about our ability to participate in that consolidation process. In the end, change almost always brings opportunity. 
With that, that concludes my comments. John Stelben is going to provide a financial report and then we'll open the call for questions. John?"
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Good morning. As Allen said, we are pleased to report EPS for the first quarter of $0.66. This is a strong result and better than our plan for the quarter. In addition, as you have seen in the earnings release, we are increasing our full year guidance to",1899,"Good morning. As Allen said, we are pleased to report EPS for the first quarter of $0.66. This is a strong result and better than our plan for the quarter. In addition, as you have seen in the earnings release, we are increasing our full year guidance to a range of $2.35 to $2.50, up from the previous guidance range of $2.10 to $2.25. First I'm going to provide some highlights on the quarterly performance, and then turn to the increase in guidance for the full year.
At a macro level, as Allen mentioned, we had some tailwind as we look back in the quarter. First, our Medicare Advantage Private Fee product line, which we exited January 1, produced $0.17 in the quarter due primarily to prior period reserve development. While we set reserves with an expectation of favorable development, recall that we did not incorporate any Private Fee run out earnings in our previous guidance. So this $0.17 is an upside to 2010 expectations.
In our Commercial Risk business, membership was a little ahead of expectations due primarily to small group sales activity, which is ahead of Q1 2009 results. This is really the result of better sales execution, coupled with products that demonstrate better value. Our Preferred Health acquisition came on line February 1 and added a little over 100,000 Commercial Risk members. 
Premium yields are in-line with expectations and are a 5.3% over the prior year quarter. The commercial group medical loss ratio of 80.2% is slightly better than expected primarily due to lower than expected impact from flu. We previously guided to about 15 basis points of additional flu pressure on the 2010 full year group loss ratio, but it was front-end loaded in Q1 and none of it really materialized during the quarter. 
It may be fair to say weather had some impact, but that's pretty hard to quantify and it would be prudent to assume that elective procedures will get rescheduled at some future point. COBRA membership levels ticked up slightly to 1.8% from about 1.7% of total Commercial Group membership, which is consistent with our expectation that COBRA would climb to 2% during 2010. 
Our view of fundamental trend has continued stability in the 8.5% to 9% range. While our Q1 result was slightly better than expected, one quarter does not make a trend. And while we are implementing unit cost and utilization improvement initiatives across all our businesses, it is still too early to count the impact as I think about 2010. Our Preferred Health acquisition, as Allen mentioned, is performing as expected both operationally and financially. 
Moving on to Medicare, the coordinated care results in Q1 were in line with our expectations for the quarter and the comments we made on the Q4 '09 earnings call. Membership is now slightly above where we ended '09, which is a very positive result given the 13,000 member blocks of business we exited coming into the year. 
Medicare Part D results as well were in-line with our plan and I'd like to provide a little more perspective on the loss ratio. You will note in the last couple of years that Q1 loss ratios were generally in the range of 100%, higher than the 95.3% we reported this quarter.
In 2010, we introduced deductibles on about 70% of the members who had no deductible in 2009. The introduction of deductibles will alter the historical slope of earnings but not the annual result. Given all the changes we made coming into 2010 with pricing and product design, we are very pleased with our membership results and are on track for our full year Part D loss ratio guidance of mid-80s.
Medicaid produced a very good Q1 loss ratio of 84% due to better management of patient care, especially in patient care, and lower than expected flu. This result is several hundred basis points better than the annual loss ratio guidance. While we are very pleased with the results and the tangible progress we are making in patient management, we do see some ray [ph](25:00) headwind that I will address later in my comments on guidance.
Turning to the balance sheet and cash flows. Total cash and investments stand at $3.85 billion. Our investment portfolio is in a net unrealized gain position of $66 million at March 31, virtually unchanged from year end. GAAP cash flow from operations for the quarter was a negative $187 million. This result includes a $297 million outflow for the run out of the Private Fee product line. As a reminder, we have cash and short-term liquid securities in our statutory entities, matching the Private Fee claims liability.
Adjusting for the Private Fee run out in Q1, adjusted cash flow from operations would've been $110 million or over 150% of net income. More importantly, free deployable cash at the parent was $450 million versus $510 million at year end, the main driver of the difference being the funds used for the Preferred Health acquisition, net of some other ins and outs. Our normal statutory dividend processed to parent starts in second quarter.
Days in claims payable displayed in the press release exclude Private Fee-For-Service for all periods presented. The increase in DCP [days in claims payable] of 4.7 days over prior quarter is due primarily to seasonal timing, timing of Part D subsidies and a small increase in claims inventory. Debt to cap ratio now stands at 29.5% driven by the addition of Q1 earnings. We did not repay any debt in the quarter.
Turning to updated 2010 guidance, we are forecasting EPS in the range of $2.35 to $2.50. As a reminder, this includes the $0.17 of earnings generated by Private Fee in the first quarter, but does not assume any further Private Fee impact for the remainder of the year. 
In summary, we are adding our review of Q1 outperformance to the prior full year guidance, while essentially maintaining our prior aggregate view of Q2 through Q4 while recognizing some new facts we now know about.
For simplicity, I will walk through the guidance changes using the midpoint of the range for both prior and revised guidance. The midpoint of prior guidance was $2.17,and the midpoint of revised is $2.42 or an increase of $0.25. As I just explained, $0.17 of this increase was related to Private Fee, which leaves about $0.08 for our seven core businesses. Let me provide a few highlights on that.
Starting with Commercial Risk, we still expect same-store membership to be down for the year in the low single digits. When we include the addition of 100,000 Preferred Health commercial risk members, total growth will be in the range of 4.5% to 5%. While our Q1 small group sales performance was better than expected, it is still early and the macroeconomic issue still exists. That being said, we are very pleased with the same-store sales results and believe that volume will be slightly more favorable in the range than our previous expectation.
Forecasted commercial group risk MLR, including Preferred Health is expected to be in the range of 82% to 82.1/2%. This is a 25 basis point reduction from previous guidance driven largely by the benign flu season. It also incorporates our fundamental view of forward trend stable. Together we believe these two items account for about $0.08 of the increased guidance. 
For Medicare CCP, our view of guidance is unchanged. We continue to expect the Medicare Advantage loss ratio to be in the mid-80s. Part D has also performed consistent with our expectations so far in 2010. As a result, our annual view of this business is unchanged from prior guidance, with a membership in the 1.6 million range and a loss ratio in the mid-80s.
For Medicaid, from an earnings standpoint, our annual view of this business is unchanged from prior guidance. While we had better-expected Q1 results and we see improvement patient management, we see raised headwinds in the second half of the year. 
In our Missouri-based HealthCare USA subsidiary, which accounts for almost half our Medicaid membership, we will be receiving a rate increase of just under 1% in July, and this is around two points lower than expected. While our Medicaid team has multiple networking utilization initiatives underway to mitigate trends, we don't count things until we can physically count them. I will not be surprised given state revenue challenges of other rate actions in other states, but I have nothing definitive at this point in time.
Our guidance has been adjusted to incorporate the additional of the Southeast PA and Nebraska markets. We are underway in Southeast PA with auto-assignments beginning in April. And as Allen said, in Nebraska, the contract begins August 1, with an expectation to reach 30,000 to 40,000 members by year end. We expect a neutral impact to overall earnings in 2010 for these new Medicaid markets.
Our Fee-Based businesses will be up about $0.02 based on stronger-than-expected revenues. On SG&A, the midpoint of the 2010 guidance is $1.96 billion. The new midpoint is up about $20 million to recognize volume-related SG&A for a better Commercial membership and the addition of the Southeast PA and Nebraska Medicaid businesses. Note that at the midpoint of SG&A guidance, the percent of revenue is 17.3%, down slightly from the 17.5% previous guidance. Given we have not repurchased any shares year-to-date, we have adjusted the share count in our 2010 guidance to reflect deployment in the back half of the year. 
So let me just re-summarize those points. Private Fee Q1 earnings of $0.17 flow through for the full year. Commercial Group Risk outperformance, both our improved view of loss ratio as well as higher expected volume, drives about $0.08 of the increase. Medicare CCP and Part D are unchanged from an earnings perspective. Medicaid earnings are unchanged for the year. Q1 outperformance will be offset by lower-than-expected rate increase in Missouri. Fee-Based businesses will be up about $0.02 based on stronger-than-expected revenues. And lastly, our more conservative view of share repurchase has an impact of negative $0.02.
On free cash and capital, as stated earlier, we have $450 million of deployable cash on hand, and expect to generate over $250 million of free cash from our seven core businesses in 2010. In addition, we expect to dividend out the capital supporting the Private Fee product line, which given Q1 results, would be approximately $275 million. We will seek to partially dividend this up in late 2010, with the remainder in the first half of 2011. 
Assuming no additional deployment of cash, we could end 2010 with $700 million to $800 million of deployable capital. And adding to that, the remainder of the Private Fee dividend in 2011, we could have total deployable capital of approximately $1 billion by mid-2011. Our priorities for deployable cash are the same as always: Growing the business through acquisition, followed by opportunistic share repurchase and delevering. 
To conclude, Q1 was a strong but early result. We see tangible progress in better sales execution and in managing all of our expenses better. While we all know the challenges ahead, we continue to focus on improving our overall cost structure. Our low cost structure will be the key differentiator in succeeding in the reform world, really, as it has always been in this business. Allen, do you have anything else to add, or..."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, let's open the call up for questions, please.",9,"No, let's open the call up for questions, please."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","[Operator Instructions] Our first question today will come from John Rex with JPMorgan.",13,"[Operator Instructions] Our first question today will come from John Rex with JPMorgan."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So I appreciate your comments on thinking about reform and the minimum MCRs for 2011. So just going a little deeper on that. You mentioned making some progress on commission structures as you look out to '11. If you could tell us kind of what you're doing",88,"So I appreciate your comments on thinking about reform and the minimum MCRs for 2011. So just going a little deeper on that. You mentioned making some progress on commission structures as you look out to '11. If you could tell us kind of what you're doing now for that and what you would anticipate? How much you would need to do in terms of progress on commission structures, maybe focusing first on small group? And then I have a couple of questions on your individual book also."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, John, unfortunately, we're not doing much now. When I assumed the responsibility a year ago, there was a plan in place, but we haven't made much progress on. We will make progress, and we're redoubling our efforts towards that. But it's sort of a sl",205,"Well, John, unfortunately, we're not doing much now. When I assumed the responsibility a year ago, there was a plan in place, but we haven't made much progress on. We will make progress, and we're redoubling our efforts towards that. But it's sort of a slippery slope. If you get out too far in front of all of that and don't do it in a reasonable and thoughtful way and consistent with the competition, you're going to lose some of your profitable book. But regardless of reform, the amount of commissions have continued to creep in the Commercial arena, with a decreasing block of business out there and people increasingly eager to preserve market share. So it's going the wrong direction, and that has to change. But we have not made much progress, and we'll be redoubling our efforts to go with the people that are most helpful to us and to their clients. That's something that is consistent with the realities of tomorrow. And we just haven't done very well back, and it's something that we probably would not pre-announce. And it'll vary, obviously, market by market. So it's an area that our whole sector needs to do better on. We haven't done much."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And I guess I'm just thinking, so to get to the low-80s you're talking about with progress in broker costs. I mean do broker costs essentially have to be cut in half to do that? I mean, is that the kind of the right range to think about for small group at",54,"And I guess I'm just thinking, so to get to the low-80s you're talking about with progress in broker costs. I mean do broker costs essentially have to be cut in half to do that? I mean, is that the kind of the right range to think about for small group at least?"
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I don't know about half, but let's -- if you talk about 100 basis points of SG&A, some of which would be broker efforts and some, the continuing efforts that we have internally to manage our own cost and just do a better job. The weighted average of our b",81,"I don't know about half, but let's -- if you talk about 100 basis points of SG&A, some of which would be broker efforts and some, the continuing efforts that we have internally to manage our own cost and just do a better job. The weighted average of our book of business is somewhere in the low-80s now. And so, I think, we're making 100 basis points of improvement, that we're not so far off from where we are now."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then on your individual book. So we see about maybe just $300 million in individual premium revenues. I'm just wondering if that's kind of still accurate? And then we would see that at about 71% loss ratio? This is thinking about '09 statutory filings",73,"And then on your individual book. So we see about maybe just $300 million in individual premium revenues. I'm just wondering if that's kind of still accurate? And then we would see that at about 71% loss ratio? This is thinking about '09 statutory filings actually. So how about on that piece, just because the gap from where that sits today would suggest almost as much impact as the small group could insert?"
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, the individual is about 3% of our revenue and miniscule part of our profits. And once again, John, regardless of reform, I think that I have explained before that one of our initiatives beginning last year is to start with a clean piece of paper on",153,"Well, the individual is about 3% of our revenue and miniscule part of our profits. And once again, John, regardless of reform, I think that I have explained before that one of our initiatives beginning last year is to start with a clean piece of paper on the individual product that would give a better value equation for our customers and that would incorporate a deeper distribution system. So it's a small part of our company, and I would say something that needs attention first. And one of these days soon, we'll be announcing a new addition to our company, and product development will be this person's -- one of two things this person is going to do in the company. But we've been working on that. We're working on, from an IT perspective, a clean piece of paper and a different distribution system because what we have today doesn't work for tomorrow."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So I'm just summarizing, I mean, your view being for 2011. At this point, you don't necessarily expect any drag from the implementation of minimum MCRs as you think about your Commercial book, overall. Is that the correct way to walk away with that though",46,"So I'm just summarizing, I mean, your view being for 2011. At this point, you don't necessarily expect any drag from the implementation of minimum MCRs as you think about your Commercial book, overall. Is that the correct way to walk away with that thought?"
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, it's kind of a leap of faith. I think the things that we began a year ago in terms of our internal costs, in terms of a better delivery system, there's a huge difference in some of our markets between the quality and efficiencies and outcomes and the",192,"No, it's kind of a leap of faith. I think the things that we began a year ago in terms of our internal costs, in terms of a better delivery system, there's a huge difference in some of our markets between the quality and efficiencies and outcomes and the cost of some of the delivery business. So the efforts that we started to give a better value equation for our membership and everything started a long time ago. And the new Regs, as I understand them, are the new law. Without the Regs being out there as I understand them and then look at the distribution of our business, sort of 50-50, 50% falling in the minimum of 80, and 50% in the minimum of 85. I'm not complacent or anything. I just don't see any tremendous hurdles that we can't deal with. We're going to keep doing what we're doing. We have to get more costs out of the place. I told you a year ago, we're going to get costs out of the place. And now you can count it, and we will get more costs out of the place."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","And our next question will come from Matthew Borsch with Goldman Sachs.",12,"And our next question will come from Matthew Borsch with Goldman Sachs."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I'd like to just ask kind of a non-reform question. You alluded to some pricing actions in the market, maybe by competitors. I'm wondering have you actually seen an uptick in price competition in the Commercial Risk area? Or is that just a continuation fr",67,"I'd like to just ask kind of a non-reform question. You alluded to some pricing actions in the market, maybe by competitors. I'm wondering have you actually seen an uptick in price competition in the Commercial Risk area? Or is that just a continuation from what you've seen last year? And any further geographic or other color you can give us on that would be great."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, I don't think I said price. What I said were broker commissions and our sector as a group. What I said six months ago or something or when I was addressing then our loss of Commercial membership in 2009, I said that half of it was a condition of the e",161,"No, I don't think I said price. What I said were broker commissions and our sector as a group. What I said six months ago or something or when I was addressing then our loss of Commercial membership in 2009, I said that half of it was a condition of the economy. We kept the group. But there were layoffs. So our people couldn't afford the product anymore or Chapter 11s on their small group of business. And half of it was self-induced, that we introduced some new underwriting actions in the end of 2007 and 2008. When we got a new team, there was a certain amount of disfunctionality in the communication between actuarial underwriting and our sales team. When we looked to the mirror and corrected our own deficiencies, we're having much more success in the marketplaces. And if anything, I would say the pricing environment, the competitive environment is a bit better than it was a year ago."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And actually, this is on reform. As you referred to the individual product, it's about 3% of revenue and contributing miniscule amounts to the earnings. Should we take it for miniscule that it's substantially less than 3% from an earnings contribution on",43,"And actually, this is on reform. As you referred to the individual product, it's about 3% of revenue and contributing miniscule amounts to the earnings. Should we take it for miniscule that it's substantially less than 3% from an earnings contribution on that?"
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","If you add 3% of our revenue, then the margin is under 5%. It's just not a big deal.",19,"If you add 3% of our revenue, then the margin is under 5%. It's just not a big deal."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","And next, we'll take a question from Ana Gupte with Sanford Bernstein.",12,"And next, we'll take a question from Ana Gupte with Sanford Bernstein."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I was wondering if you could give us some color on the recent rate pressures in Massachusetts, Maine and California, and your perspective on the states that you're participating in. Will this likely become a contagion in terms of a regulatory or legislati",48,"I was wondering if you could give us some color on the recent rate pressures in Massachusetts, Maine and California, and your perspective on the states that you're participating in. Will this likely become a contagion in terms of a regulatory or legislative pressures on small group rates?"
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","In terms of group, don't do any business in any of those states, and I kind of know what I read about that. I don't see anything today in any of our markets to suggest that there are any movements like what we're seeing in those three areas.",48,"In terms of group, don't do any business in any of those states, and I kind of know what I read about that. I don't see anything today in any of our markets to suggest that there are any movements like what we're seeing in those three areas."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And when you look at these then, when the state regulatory commissioners are sort of deciding rates, would they restrict or consider restricting the dividending of cash to the parent and thereby, they can keep rates or pressures on the rates while still k",59,"And when you look at these then, when the state regulatory commissioners are sort of deciding rates, would they restrict or consider restricting the dividending of cash to the parent and thereby, they can keep rates or pressures on the rates while still keeping you adequately reserved? Do you see any sort of conversations or trends in that direction?"
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","No.",1,"No."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Then finally, on the small group and individual, the restricted underwriting that you're seeing right now coming into being prior to reform, restricted underwriting in terms of kids with medical conditions, rescissions or so on, are you seeing any impact",45,"Then finally, on the small group and individual, the restricted underwriting that you're seeing right now coming into being prior to reform, restricted underwriting in terms of kids with medical conditions, rescissions or so on, are you seeing any impact on that in 2011 margins?"
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","On the rescission front, we have been looking at that for several quarters now. There would be something under 500 rescissions a year in our company, maybe under 400. So the impact is not great. Our legal and regulatory people are reviewing now whether or",226,"On the rescission front, we have been looking at that for several quarters now. There would be something under 500 rescissions a year in our company, maybe under 400. So the impact is not great. Our legal and regulatory people are reviewing now whether or not for the remainder of the year that we would want to go to a third party to also review the rescissions. But we have fairly arduous process within our company. 100% of rescissions go to a legal team. They review the facts, the information, and so -- we don't do that many right now, only in extreme cases of beyond misrepresentation of fraud, so not a huge impact. And the question has always been, with anything less than universal coverage, what kind of product that you're going to be able to have if you can't do any underwriting, and we just have to wait and see what the details and see where are the niches there. If we can't do that in a business, likely we won't do the product. But I think a lot of what's coming is going to come out in the Regs and may vary by state, and the devil is going to be in the details. So the real answer is in the short term, no, not any impact; longer term, we'll have to see."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And on the baby end of the market, are you seeing any changes in the way these employers are responding to reform? Are they more likely to subsidize in light of tax credits? Or are they sort of pulling back from getting into this space?",45,"And on the baby end of the market, are you seeing any changes in the way these employers are responding to reform? Are they more likely to subsidize in light of tax credits? Or are they sort of pulling back from getting into this space?"
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I don't know, except what we've talked about in Q1, in our small or mid-sized group, that whether the market is improving slightly or it's because of our own efforts, our quotes up, we're running more business than we have in a while. And I can't, at this",75,"I don't know, except what we've talked about in Q1, in our small or mid-sized group, that whether the market is improving slightly or it's because of our own efforts, our quotes up, we're running more business than we have in a while. And I can't, at this stage, really know how much of that is because we got a better team with better focus out there or if the environment is improving slightly."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","And our next question will come from Justin Lake with UBS.",11,"And our next question will come from Justin Lake with UBS."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Allen, you talked about the expectation for significant consolidation in the industry post-reform. I'm just curious to get your view on the -- how important are the attributes with regards to scale at the local level versus having just greater national sc",42,"Allen, you talked about the expectation for significant consolidation in the industry post-reform. I'm just curious to get your view on the -- how important are the attributes with regards to scale at the local level versus having just greater national scale?"
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, the comments about consolidation is an educated guess or maybe a guess. But we all acknowledge that the things that we did yesterday aren't enough for tomorrow. That the revenue environment is going to be more difficult and you just have to be bette",171,"Well, the comments about consolidation is an educated guess or maybe a guess. But we all acknowledge that the things that we did yesterday aren't enough for tomorrow. That the revenue environment is going to be more difficult and you just have to be better with what you do. And I think if you are in the business and don't have best business practices, best information, best people, best focus and a reasonable cost structure, you aren't going to be able to complete. So I would be surprised if there weren't other opportunities not unlike the Preferred Health System in Kansas, where people focus on doing what their primary business is. And so we'll see where that comes out a year from now. But if you look at the balance sheets and margins, it's going to get more difficult. So I don't see how you avoid consolidation in all the lines of businesses: Certainly, Medicare Advantage; certainly, some of the small-private Medicaid plans and some of the Commercial plans. We'll see."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And as you're seeing that shift happen, you mentioned the acquisition you did there. Do you see that happening in a way where there's going to be opportunities to either divest smaller markets where you don't feel like you have scale or to be purchasing,",70,"And as you're seeing that shift happen, you mentioned the acquisition you did there. Do you see that happening in a way where there's going to be opportunities to either divest smaller markets where you don't feel like you have scale or to be purchasing, making acquisitions like this? Or do you think it's just going to be happening naturally through competitive pressures? Or will you take market share?"
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think the latter. We are a regional company or a multi-regional company. We are not national, not going to be national, and can't be. Where we have health plans, where we have HMO-type networks, our cost structure has always been competitive with the be",303,"I think the latter. We are a regional company or a multi-regional company. We are not national, not going to be national, and can't be. Where we have health plans, where we have HMO-type networks, our cost structure has always been competitive with the best. And let's say, competitive means within 500 basis points of the best, and that hasn't changed. I think that we have to be better at selecting maybe something -- networks that aren't as broad as they once were, and return for picking a delivery system with good outcomes and high-quality care for the members, which always mean usually a better cost structure. So I think that within the places that we do business, there will be narrower products. The one that we are working on with Via Christi, on Medicare Advantage in the Central Kansas area will be a product that fits for the Via Christi System only. They have a huge amount of resources, including 26 primary care physicians that are employees of the system. And I think that will just allow us to get better benefits, put better resources to help those physicians manage the care better. So I think that's going to happen on the Commercial side as well. Just the problem with our product is no one can afford it. And I am talking about our sector, our industry. So we're going to have to do a better job on the cost front. So I think it's going to get tougher for everybody. And if you don't have best business practices and a good balance sheet and the information and the insights it takes to manage the patients, that people are going to opt out, but we'll see. I have no evidence of that at this stage, but maybe in a quarter or two."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So you don't see the need to take that billion dollars that you talked about and leave that as a war chest to go out there and buy smaller plans. Do you think most of what you'll be doing is more organic? Is that fair to say?",48,"So you don't see the need to take that billion dollars that you talked about and leave that as a war chest to go out there and buy smaller plans. Do you think most of what you'll be doing is more organic? Is that fair to say?"
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","No. This company has always been opportunistic. If we find a property that fits our criteria, which is do we understand the business, is it fairly priced, and the third thing is do we know how to make it better, is our cost structure better and having one",176,"No. This company has always been opportunistic. If we find a property that fits our criteria, which is do we understand the business, is it fairly priced, and the third thing is do we know how to make it better, is our cost structure better and having one IT system, can we do it better, we would always do that. It's accretive. It helps our presence in the marketplace, and we did that for a long time. The consolidation kind of -- not kind of, it stopped. And I believe that it's likely on all of those fronts we talked about, the Medicare Advantage and maybe some of the small-private Medicaid plans. But certainly, in the Commercial, I think that, that will return. And one of the reasons that we didn't do any share repurchase this Q1 is, just to your point, I want to keep our powder dry. And I think that buying businesses that we understand and know we can make better and can make a fair margin is a good use of capital."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","And our next question will come from Scott Fidel with Deutsche Bank.",12,"And our next question will come from Scott Fidel with Deutsche Bank."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just interested first if your 2010 guidance at this point has any health reform related expenses in it? Just things like some of the early implementation of some of the market reforms or higher taxes associated with some of the reform, bill changes? Just",49,"Just interested first if your 2010 guidance at this point has any health reform related expenses in it? Just things like some of the early implementation of some of the market reforms or higher taxes associated with some of the reform, bill changes? Just if you could summarize that."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Sure, Scott. Yes, it does. And those impacts, we don't believe are material to this year, but our guidance does account for them.",23,"Sure, Scott. Yes, it does. And those impacts, we don't believe are material to this year, but our guidance does account for them."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then, do you have an estimate on how much membership you think you can add in Pennsylvania Medicaid this year?",21,"And then, do you have an estimate on how much membership you think you can add in Pennsylvania Medicaid this year?"
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes, we added about 2,000 through auto-assigns in the month of April. And I think for the year, that number is probably about 10,000.",24,"Yes, we added about 2,000 through auto-assigns in the month of April. And I think for the year, that number is probably about 10,000."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then just one last question, John, just if you have an update on the cost components and trend, and if there is any change in view on any of them.",31,"And then just one last question, John, just if you have an update on the cost components and trend, and if there is any change in view on any of them."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Sure, as I said earlier, it's really stable. So I'll just rip through the components: On in-patient, that's running in the range of high single digits, really unit-cost driven; outpatient, low double digits, split but tilted  a little more towards unit co",73,"Sure, as I said earlier, it's really stable. So I'll just rip through the components: On in-patient, that's running in the range of high single digits, really unit-cost driven; outpatient, low double digits, split but tilted  a little more towards unit cost; on in-house physician, I would say it's mid-single digits, split; and on Rx, it's mid to high single digit, again split. So again, a stable view of what we've discussed before."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","Today's final question is from Kevin Fischbeck with Bank of America Merrill Lynch.",14,"Today's final question is from Kevin Fischbeck with Bank of America Merrill Lynch."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I guess, I wanted to go back to the comments you made there on the acquisition front. Clearly, it sounds like you think consolidation is inevitable. Are you seeing anything from the smaller plans embracing that view? Or are you seeing more activity from t",50,"I guess, I wanted to go back to the comments you made there on the acquisition front. Clearly, it sounds like you think consolidation is inevitable. Are you seeing anything from the smaller plans embracing that view? Or are you seeing more activity from them approaching you? Any update there?"
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","You have to keep my comment in proper perspective. One closed deal in the quarter doesn't make a trend, but we see a thought process out there in several fronts where people are at least bringing new subject to the table in their organizations. Obviously,",154,"You have to keep my comment in proper perspective. One closed deal in the quarter doesn't make a trend, but we see a thought process out there in several fronts where people are at least bringing new subject to the table in their organizations. Obviously, if I have anything definitive there, I would announced. But can keep my comments in perspective. One, it's my view. There is what I would characterize as some slight evidence in terms of the people that we know that are sort of thinking about it, but that's all. I don't see as things get more difficult as the revenue is harder to come by, I don't see -- if you don't have best practices and a strong balance sheet and if it's not your primary business, I don't see how you survive or certainly, not provide. I don't see how anything else happens, but we'll see. It's my guess."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And it sounds like -- just about that last comment, you're talking more about kind of the Christi type of deal, where companies that are, it's part of their business but not a focus of their business, looking to sell that off rather than to simply plan.",47,"And it sounds like -- just about that last comment, you're talking more about kind of the Christi type of deal, where companies that are, it's part of their business but not a focus of their business, looking to sell that off rather than to simply plan."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think that's right.",5,"I think that's right."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And I didn't hear anything in particular about like Medicaid acquisition. Any thought about growth that way?",18,"And I didn't hear anything in particular about like Medicaid acquisition. Any thought about growth that way?"
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Not beyond what I've said. When I returned early in 2009, the second day I was here, I traveled to Nebraska because an RFE was in process, and my view was that the government already represents over 50% of the healthcare spend. My view is that we needed t",194,"Not beyond what I've said. When I returned early in 2009, the second day I was here, I traveled to Nebraska because an RFE was in process, and my view was that the government already represents over 50% of the healthcare spend. My view is that we needed to redouble our efforts in the Medicaid are. We have, and have successfully landed two pieces of new opportunity there. And so we would kick Medicaid tires just the same way that we would Commercial, and continue to seek new business on our own. I think with the skills that we have -- we've been in the business for 15 years. We just, I think, got a little bit distracted with several other large acquisitions and we kind of returned to our roots. And so we're very bullish. And we understand the challenges. And we understand the raid revenue. But it is an area of focus for the company. We're going to do our best by whatever means to grow revenue there. By whatever means, meaning either winning new business or if an acquisition opportunity would present itself, then we would certainly look at it."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I guess just to clarify, on the Medicare Advantage, the 85.7%, that's a pure -- that excludes the favorable development, right, from [indiscernible] restated number?",25,"I guess just to clarify, on the Medicare Advantage, the 85.7%, that's a pure -- that excludes the favorable development, right, from [indiscernible] restated number?"
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","That is a pure CCP-loss ratio.",7,"That is a pure CCP-loss ratio."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","And that does conclude our question-and-answer session. I would now turn the conference back over to Mr. Allen Wise for any closing or additional remarks.",26,"And that does conclude our question-and-answer session. I would now turn the conference back over to Mr. Allen Wise for any closing or additional remarks."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","That concludes our comments for today, and thank you very much for joining us.",14,"That concludes our comments for today, and thank you very much for joining us."
27133,100327066,58949,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","And that does conclude our conference call. Thank you for your participation.",12,"And that does conclude our conference call. Thank you for your participation."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","Good morning, and welcome to the Coventry Health Care's First Quarter 2010 Earnings Conference Call. [Operator Instructions] Todayâ€™s call will begin with opening remarks by the Chief Executive Officer of Coventry Health Care, Mr. Allen Wise and after a",51,"Good morning, and welcome to the Coventry Health Care's First Quarter 2010 Earnings Conference Call. [Operator Instructions] Todayâ€™s call will begin with opening remarks by the Chief Executive Officer of Coventry Health Care, Mr. Allen Wise and after a brief forward-looking statement read by Mr. Drew Asher.  Please go ahead, Drew."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Ladies and gentlemen, during this call we will make forward-looking statements. Certain risks and uncertainties as described in the companyâ€™s filings with the SEC on Form 10-K for the year ended December 31, 2009, and as maybe updated from time to time",69,"Ladies and gentlemen, during this call we will make forward-looking statements. Certain risks and uncertainties as described in the companyâ€™s filings with the SEC on Form 10-K for the year ended December 31, 2009, and as maybe updated from time to time in Conventry's quarterly reports on Form 10-Q, may materially impact those statements and could cause actual future results to differ materially from those anticipated and discussed. Allen?"
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Good morning, and thank you for joining us. We'll follow our normal agenda. I'll start off by providing some brief comments. John Stelben, will provide more details on the financials and that will be followed by some time for some brief questions. My comm",2522,"Good morning, and thank you for joining us. We'll follow our normal agenda. I'll start off by providing some brief comments. John Stelben, will provide more details on the financials and that will be followed by some time for some brief questions. My comments will cover three areas this morning. The first is on Q1, then our outlook for the remainder of 2010. And finally, I'll provide some brief remarks on the post-reform future of our company.
With regard to the first quarter, this morning we announced an EPS of $0.66. And as we look beyond Q1 to the remainder of the year, we're providing full year guidance of $2.35 to $2.50 per share. Q1 was obviously a very strong start 2010 for our company. And while our management group believes that our business is improving rapidly, the strength of the quarter was a bit unexpected. 
I believe that Q1 results can best be explained with two or three comments. First and most important is the sharper focus on business fundamentals over the last 18 months. Our SG&A, our medical unit cost work toward improving our members' quality of healthcare, much better integration between our actuarial, underwriting and sales team, our government program execution and the many areas I have discussed in my prior four quarters of conference calls. Simply stated, we're executing better in the basics of our business and we will continue to do so. 
I think the second area to describe Q1 results is that we have some favorable, for lack of a better word, tailwind. There was little impact from the flu. And I think, too, while it cannot be quantified, severe weather in many of our markets undoubtedly influenced utilization to some extent. And the third factor explaining our results is a very positive reserve development.
Under the subject of quarterly highlights, I have a few comments. We closed our Preferred Health Systems acquisition in Kansas on February 1. This property has further strengthened our Midwest regional presence and will allow us to improve care for our members with a very high quality delivery system. We're working and planning on completing a proprietary Medicare Advantage product with the Via Christi Healthcare System, which we hope we'll be able to market later this year with January 1, 2011, effective dates. We believe this product will provide excellent coverage and improved care for the Kansas senior population.
On staying with quarterly highlights, we were once again awarded the contract to provide care for Medicaid members in Nebraska with an effective date of August 1. We completed a very orderly and positive Medicare Private Fee-For-Service exit. We took a number of successful steps in the last step of 2009 to neutralize the SG&A impact. We're experiencing positive reserves developments, which at a minimum will create additional statutory capital and ultimately, free cash flow. On April 1, we began enrolling Medicaid members in Pennsylvania.
Turning to the outlook for the remainder of 2010, I'd like to address our core businesses. Commercial business, I believe, that you'll see a much improved membership progression during the first quarter, including the close of our strategic Preferred Health acquisitions during the first quarter. We grew commercial risk membership by 83,000 members. 
On a same-store basis, we were down approximately 20,000 members. And although we would certainly prefer to grow same-store membership and plan to do in the future, this is the best Q1 sequential result that our company has reported since Q1 of 2006. Much of this improvement is just plain better execution. I think during last year, during 2009, where there was substantial membership erosion that I've previously told people and told all of you that half of it was the economy and the diminishing size of the lack of business, but at least half of it was internal. And we have addressed the internal issues and our new business sales showed that and have exceeded plan. And the number of personnel in process of improvements that we made during 2009 are beginning to pay off in 2010.
We're still vigilant in pricing to underlying cost, our cost of goods sold, if you will. This is evidenced by our financial metrics in the press release. As all of you know, the key to long-term success in this business is managing the cost of goods sold or the medical costs along with SG&A on behalf of our employer and individual customers. While we've made improvement in patient care and underlying cost structure in the past few quarters, we recognize that we have a lot more work to do in this area and that it will remain an area of focus.
It's especially necessary have this focus as we navigate reform and prepare for the many new requirements there. 
Moving from the commercial block to Medicare, the membership in our Medicare Advantage Coordinated Care Plan reached 190,000 members, up from 186,000 at years end. This was 2% better than our flat forecast but beyond that, a very good result considering that we exit from a number of SNP [Special Needs Plans] plans and subscale markets, which totaled about 13,000 members. 
Our medical loss ratio of 85.7 was 120 basis points improvement from the full year in 2009. And while this trend is positive, it was an undoubtedly helped by a mild flu season and we recognize there's a lot of work to be done heading into the post-reform payment environment. In short, we can do better in this business and we will. 
I'm pleased to report the new initiatives are underway to improve care coordination for the chronically ill, and are on target to be continually rolled out through the balance of the year. These are initiatives that began in 2009 regarding the frail elderly and they are showing some early promise. 
As explained earlier in my comments about Via Christi, we have developed a new model of care. We believe that more innovative reimbursement arrangements that align incentives to improve patient care with better outcomes are increasingly necessary in tomorrow's environment, and a substantial amount of resources will be directed toward models in that end. 
As you all know too, I'm sure that we are preparing our bids on the Medicare front for 2011. And given the recently announced, an anticipated VAT revenue raise and the reform-related reductions that began in 2012, we must continue to intensify our focus there. We will continue to make progress on medical cost and contracting efficiencies along with other areas. These obviously include intelligent plan design, best practices for risk-adjusted revenue, SG&A improvement.
Improving the quality of care for members is basic and fundamental to all of our efforts. Overall, we're pleased with Q1 results for this business and we feel that we are doing the right things to prepare for changes in 2011 and 2012. In fact, we anticipated the revenue environment regardless of the reform movement and spent a lot of time and energy and resources working on these efforts beginning in 2009. 
With regard to Medicare Part D, we have a solid stable business. We ended the quarter at 1.6 million Part D members, on track with our guidance. Once again, we feel this was a good result because of our exit from nine auto-assigned regions. From a pharmacy cost perspective, Q1 results are in-line or slightly better than our expectations. 
Moving to Medicaid, our Medicaid business is demonstrating very significant progress both in terms of growth and better management of our members. From a growth view, we've added two new areas of business in Nebraska and Pennsylvania. Our Nebraska business, as I announced early, is scheduled to commence in August of this year and should result in 30,000 to 40,000 new members. 
As discussed in our last call, we qualified to enter southeastern Pennsylvania and began receiving auto-assign members at the beginning of this month. We are continuing our efforts to finish the medical delivery system in central PA and hope to qualify in that region in the near future. We see opportunities to service this population, and we'll continue to seek new opportunities in this space, especially given the long-term expansion of the population. 
With regard to our Fee-Based businesses, Network Rental, FEHB [Federal Employees Health Benefits] and the Workers' Compensation were performing at or better than expectations. These businesses provide predictable and consistent results. While the soft economy and the employment market has provided some headwinds for our Workers' Compensation business, our strong sales execution and SG&A control has largely offset this headwind. 
Maybe some few comments about the post-reform environment. What about the environment? Well, we understand that regulations yet to be finalized will determine much of the future, but nevertheless, the broad outlines are known and consistent with how we position our company during the past year. 
Our Commercial Group business, a $5 billion business is about evenly split with about 50% of our enrollment below 100 subscribers and about 50% over 100. With a little progress in broker cost, which needed to be addressed regardless of reform, the weighted medical loss ratio average on our book of business should be in the low 80s. Assuming a reasonable set of regulations, this positions us decently for the new rules and should allow a fair margin, and as basically so, we can find 100 basis points of SG&A from a variety of sources.
The Medicare Advantage Coordinated Care product is one that we've always believed in. If you follow our company's history back to the balanced budget in the mid-to-late '90s, a lot of people in our space abandoned this line of business, we did not. And we have always believed it's the best way to provide care for seniors, and we're dedicated to put the effort and resources to have best business practices in this line. 
And as I previously announced in several calls, we have five ongoing initiatives to improve our results in this product line. We feel like the 2011 race announced early in April are manageable for us, and we're planning for the new payment system that starts getting payees down for 2012.
With regard to post reform, we have focused on Medicaid, began putting additional resources in that in 2009 both in improving our unit cost and caring better for our members. We understand that revenue will be a challenge as states struggle with their own revenue shortfalls. That low cost, both unit and SG&A, along with better care for the member, wins. Requirements for success our skill sets that we have and that's demonstrated in our recent medical loss ratio progress. We're going to work hard to grow membership in Medicaid and this will continue to be a priority in our company.
We're well aware of many of the challenges in the post-reform environment and in short, we believe tomorrow's environment will create plenty of challenges and also opportunities. We believe that organizations that are thoughtful, nimble, creative and have the industry tools and cost structure will succeed. And we feel we're entering the reform environment as a well-diversified, resourceful, with a capable management group and that we're well prepared for the evolving landscape. But what about the tools for the future? Well, we should have about $1 billion in free cash by the middle of next year if we don't find the other opportunities like Preferred Health. 
And with regard to tools, it's our senior team. One of our most significant accomplishment over the past year has been the formulation of our senior management team, who have proven records of success and are exceedingly capable in their areas of responsibilities. A lot of these have been announced in the past, but I'll take them in a minute, I will remind you of some of the additions that we've made to our organization. 
Staying with tools for the future to low cost structure, it's important to compete in the past and it's going to be critical in the future. And where we have delivery systems, we think that our cost structure will generally be second to no one's.
A diversified, well-positioned business and the nimbleness and know-how to adapt is the fourth tool for the future. And I think that in general, that we have the tools and resources to run a better company in tomorrow's environment.
I want to stay on our management group a bit, and a few comments in their commitments to the company, I believe, is appropriate. We've had a lot of experienced individuals, all have demonstrated records of success, people have proven their skills well previously, and more importantly, during the last 15 months. In the end, it's really about the quality of your management team and our business.  
In our operations on IT area, Harv DeMovick has been with the company for many years, returned a year ago and is committed to stay with our company through 2011. Our Medicare Advantage and Part D is headed by Nancy Cocozza. She was with our company in the past, the best of what she does and is a building block that we need to do more of this business. Paul Conlin joined us this year. His responsibility  is Medicaid. He's added to our foundation for the future and has demonstrated early success both in unit cost and with new business during the last six months. Mike Bahr has been with our company for eight years and was part of our Altius and Western operation or headed that up. Mike's an underwriter and actuary, and he assumed the responsibility for all of our health plans about six months ago and is uniquely qualified to add new group and individual business at the correct cost structure and revenue. Dr. Patricia Mueller, our Senior Medical Officer, joined us last year and is leading the efforts for better patient care. And Matt Eyles is a new addition in government policy and bring insights in the policy area that our company simply hasn't had in the past. I could continue the list but my point is that the best management team is basic for tomorrow success and we've got a very solid team. And as our company has always done previously, the search for additional talent will continue. 
My own commitment is at a minimum through 2011, and I have stated earlier that the search for best people will not end, and I need to add that this will include a thorough and very thoughtful search for my successor. 
Closing thought. Well there's a lot left to play out in 2010 but our management group feels very good about the year. A lot of work to be done to prepare for 2011 and beyond, but I'm excited and positive about our progress. In my own view, there's a very high likelihood of future consolidation in our business in the not-too-distant future, and we feel very positive about our ability to participate in that consolidation process. In the end, change almost always brings opportunity. 
With that, that concludes my comments. John Stelben is going to provide a financial report and then we'll open the call for questions. John?"
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Good morning. As Allen said, we are pleased to report EPS for the first quarter of $0.66. This is a strong result and better than our plan for the quarter. In addition, as you have seen in the earnings release, we are increasing our full year guidance to",1899,"Good morning. As Allen said, we are pleased to report EPS for the first quarter of $0.66. This is a strong result and better than our plan for the quarter. In addition, as you have seen in the earnings release, we are increasing our full year guidance to a range of $2.35 to $2.50, up from the previous guidance range of $2.10 to $2.25. First I'm going to provide some highlights on the quarterly performance, and then turn to the increase in guidance for the full year.
At a macro level, as Allen mentioned, we had some tailwind as we look back in the quarter. First, our Medicare Advantage Private Fee product line, which we exited January 1, produced $0.17 in the quarter due primarily to prior period reserve development. While we set reserves with an expectation of favorable development, recall that we did not incorporate any Private Fee run out earnings in our previous guidance. So this $0.17 is an upside to 2010 expectations.
In our Commercial Risk business, membership was a little ahead of expectations due primarily to small group sales activity, which is ahead of Q1 2009 results. This is really the result of better sales execution, coupled with products that demonstrate better value. Our Preferred Health acquisition came on line February 1 and added a little over 100,000 Commercial Risk members. 
Premium yields are in-line with expectations and are a 5.3% over the prior year quarter. The commercial group medical loss ratio of 80.2% is slightly better than expected primarily due to lower than expected impact from flu. We previously guided to about 15 basis points of additional flu pressure on the 2010 full year group loss ratio, but it was front-end loaded in Q1 and none of it really materialized during the quarter. 
It may be fair to say weather had some impact, but that's pretty hard to quantify and it would be prudent to assume that elective procedures will get rescheduled at some future point. COBRA membership levels ticked up slightly to 1.8% from about 1.7% of total Commercial Group membership, which is consistent with our expectation that COBRA would climb to 2% during 2010. 
Our view of fundamental trend has continued stability in the 8.5% to 9% range. While our Q1 result was slightly better than expected, one quarter does not make a trend. And while we are implementing unit cost and utilization improvement initiatives across all our businesses, it is still too early to count the impact as I think about 2010. Our Preferred Health acquisition, as Allen mentioned, is performing as expected both operationally and financially. 
Moving on to Medicare, the coordinated care results in Q1 were in line with our expectations for the quarter and the comments we made on the Q4 '09 earnings call. Membership is now slightly above where we ended '09, which is a very positive result given the 13,000 member blocks of business we exited coming into the year. 
Medicare Part D results as well were in-line with our plan and I'd like to provide a little more perspective on the loss ratio. You will note in the last couple of years that Q1 loss ratios were generally in the range of 100%, higher than the 95.3% we reported this quarter.
In 2010, we introduced deductibles on about 70% of the members who had no deductible in 2009. The introduction of deductibles will alter the historical slope of earnings but not the annual result. Given all the changes we made coming into 2010 with pricing and product design, we are very pleased with our membership results and are on track for our full year Part D loss ratio guidance of mid-80s.
Medicaid produced a very good Q1 loss ratio of 84% due to better management of patient care, especially in patient care, and lower than expected flu. This result is several hundred basis points better than the annual loss ratio guidance. While we are very pleased with the results and the tangible progress we are making in patient management, we do see some ray [ph](25:00) headwind that I will address later in my comments on guidance.
Turning to the balance sheet and cash flows. Total cash and investments stand at $3.85 billion. Our investment portfolio is in a net unrealized gain position of $66 million at March 31, virtually unchanged from year end. GAAP cash flow from operations for the quarter was a negative $187 million. This result includes a $297 million outflow for the run out of the Private Fee product line. As a reminder, we have cash and short-term liquid securities in our statutory entities, matching the Private Fee claims liability.
Adjusting for the Private Fee run out in Q1, adjusted cash flow from operations would've been $110 million or over 150% of net income. More importantly, free deployable cash at the parent was $450 million versus $510 million at year end, the main driver of the difference being the funds used for the Preferred Health acquisition, net of some other ins and outs. Our normal statutory dividend processed to parent starts in second quarter.
Days in claims payable displayed in the press release exclude Private Fee-For-Service for all periods presented. The increase in DCP [days in claims payable] of 4.7 days over prior quarter is due primarily to seasonal timing, timing of Part D subsidies and a small increase in claims inventory. Debt to cap ratio now stands at 29.5% driven by the addition of Q1 earnings. We did not repay any debt in the quarter.
Turning to updated 2010 guidance, we are forecasting EPS in the range of $2.35 to $2.50. As a reminder, this includes the $0.17 of earnings generated by Private Fee in the first quarter, but does not assume any further Private Fee impact for the remainder of the year. 
In summary, we are adding our review of Q1 outperformance to the prior full year guidance, while essentially maintaining our prior aggregate view of Q2 through Q4 while recognizing some new facts we now know about.
For simplicity, I will walk through the guidance changes using the midpoint of the range for both prior and revised guidance. The midpoint of prior guidance was $2.17,and the midpoint of revised is $2.42 or an increase of $0.25. As I just explained, $0.17 of this increase was related to Private Fee, which leaves about $0.08 for our seven core businesses. Let me provide a few highlights on that.
Starting with Commercial Risk, we still expect same-store membership to be down for the year in the low single digits. When we include the addition of 100,000 Preferred Health commercial risk members, total growth will be in the range of 4.5% to 5%. While our Q1 small group sales performance was better than expected, it is still early and the macroeconomic issue still exists. That being said, we are very pleased with the same-store sales results and believe that volume will be slightly more favorable in the range than our previous expectation.
Forecasted commercial group risk MLR, including Preferred Health is expected to be in the range of 82% to 82.1/2%. This is a 25 basis point reduction from previous guidance driven largely by the benign flu season. It also incorporates our fundamental view of forward trend stable. Together we believe these two items account for about $0.08 of the increased guidance. 
For Medicare CCP, our view of guidance is unchanged. We continue to expect the Medicare Advantage loss ratio to be in the mid-80s. Part D has also performed consistent with our expectations so far in 2010. As a result, our annual view of this business is unchanged from prior guidance, with a membership in the 1.6 million range and a loss ratio in the mid-80s.
For Medicaid, from an earnings standpoint, our annual view of this business is unchanged from prior guidance. While we had better-expected Q1 results and we see improvement patient management, we see raised headwinds in the second half of the year. 
In our Missouri-based HealthCare USA subsidiary, which accounts for almost half our Medicaid membership, we will be receiving a rate increase of just under 1% in July, and this is around two points lower than expected. While our Medicaid team has multiple networking utilization initiatives underway to mitigate trends, we don't count things until we can physically count them. I will not be surprised given state revenue challenges of other rate actions in other states, but I have nothing definitive at this point in time.
Our guidance has been adjusted to incorporate the addition of the Southeast PA and Nebraska markets. We are underway in Southeast PA with auto-assignments beginning in April. And as Allen said, in Nebraska, the contract begins August 1, with an expectation to reach 30,000 to 40,000 members by year end. We expect a neutral impact to overall earnings in 2010 for these new Medicaid markets.
Our Fee-Based businesses will be up about $0.02 based on stronger-than-expected revenues. On SG&A, the midpoint of the 2010 guidance is $1.96 billion. The new midpoint is up about $20 million to recognize volume-related SG&A for a better Commercial membership and the addition of the Southeast PA and Nebraska Medicaid businesses. Note that at the midpoint of SG&A guidance, the percent of revenue is 17.3%, down slightly from the 17.5% previous guidance. Given we have not repurchased any shares year-to-date, we have adjusted the share count in our 2010 guidance to reflect deployment in the back half of the year. 
So let me just re-summarize those points. Private Fee Q1 earnings of $0.17 flow through for the full year. Commercial Group Risk outperformance, both our improved view of loss ratio as well as higher expected volume, drives about $0.08 of the increase. Medicare CCP and Part D are unchanged from an earnings perspective. Medicaid earnings are unchanged for the year. Q1 outperformance will be offset by lower-than-expected rate increase in Missouri. Fee-Based businesses will be up about $0.02 based on stronger-than-expected revenues. And lastly, our more conservative view of share repurchase has an impact of negative $0.02.
On free cash and capital, as stated earlier, we have $450 million of deployable cash on hand, and expect to generate over $250 million of free cash from our seven core businesses in 2010. In addition, we expect to dividend out the capital supporting the Private Fee product line, which given Q1 results, would be approximately $275 million. We will seek to partially dividend this up in late 2010, with the remainder in the first half of 2011. 
Assuming no additional deployment of cash, we could end 2010 with $700 million to $800 million of deployable capital. And adding to that the remainder of the Private Fee dividend in 2011, we could have total deployable capital of approximately $1 billion by mid-2011. Our priorities for deployable cash are the same as always: Growing the business through acquisition, followed by opportunistic share repurchase and delevering. 
To conclude, Q1 was a strong but early result. We see tangible progress in better sales execution and in managing all of our expenses better. While we all know the challenges ahead, we continue to focus on improving our overall cost structure. Our low cost structure will be the key differentiator in succeeding in the reform world, really, as it has always been in this business. Allen, do you have anything else to add, or..."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, let's open the call up for questions, please.",9,"No, let's open the call up for questions, please."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","[Operator Instructions] Our first question today will come from John Rex with JPMorgan.",13,"[Operator Instructions] Our first question today will come from John Rex with JPMorgan."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So I appreciate your comments on thinking about reform and the minimum MCRs for 2011. So just going a little deeper on that. You mentioned making some progress on commission structures as you look out to '11. If you could tell us kind of what you're doing",88,"So I appreciate your comments on thinking about reform and the minimum MCRs for 2011. So just going a little deeper on that. You mentioned making some progress on commission structures as you look out to '11. If you could tell us kind of what you're doing now for that and what you would anticipate? How much you would need to do in terms of progress on commission structures, maybe focusing first on small group? And then I have a couple of questions on your individual book also."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, John, unfortunately, we're not doing much now. When I assumed the responsibility a year ago, there was a plan in place, but we haven't made much progress on. We will make progress, and we're redoubling our efforts towards that. But it's sort of a sl",205,"Well, John, unfortunately, we're not doing much now. When I assumed the responsibility a year ago, there was a plan in place, but we haven't made much progress on. We will make progress, and we're redoubling our efforts towards that. But it's sort of a slippery slope. If you get out too far in front of all of that and don't do it in a reasonable and thoughtful way and consistent with the competition, you're going to lose some of your profitable book. But regardless of reform, the amount of commissions have continued to creep in the Commercial arena, with a decreasing block of business out there and people increasingly eager to preserve market share. So it's going the wrong direction, and that has to change. But we have not made much progress, and we'll be redoubling our efforts to go with the people that are most helpful to us and to their clients. That's something that is consistent with the realities of tomorrow. And we just haven't done very well back, and it's something that we probably would not pre-announce. And it'll vary, obviously, market by market. So it's an area that our whole sector needs to do better on. We haven't done much."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And I guess I'm just thinking, so to get to the low-80s you're talking about with progress in broker costs. I mean do broker costs have to essentially get cut in half to do that? I mean, is that the kind of the right range to think about for small group a",54,"And I guess I'm just thinking, so to get to the low-80s you're talking about with progress in broker costs. I mean do broker costs have to essentially get cut in half to do that? I mean, is that the kind of the right range to think about for small group at least?"
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I don't know about half, but let's -- if you talk about 100 basis points of SG&A, some of which would be broker efforts and some, the continuing efforts that we have internally to manage our own cost and just do a better job. The weighted average of our b",81,"I don't know about half, but let's -- if you talk about 100 basis points of SG&A, some of which would be broker efforts and some, the continuing efforts that we have internally to manage our own cost and just do a better job. The weighted average of our book of business is somewhere in the low-80s now. And so, I think, we're making 100 basis points of improvement, that we're not so far off from where we are now."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then on your individual book. So we see about maybe just $300 million in individual premium revenues. I'm just wondering if that's kind of still accurate? And then we would see that at about 71% loss ratio? This is thinking about '09 statutory filings",73,"And then on your individual book. So we see about maybe just $300 million in individual premium revenues. I'm just wondering if that's kind of still accurate? And then we would see that at about 71% loss ratio? This is thinking about '09 statutory filings actually. So how about on that piece, just because the gap from where that sits today would suggest almost as much impact as the small group could insert?"
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, the individual is about 3% of our revenue and miniscule part of our profits. And once again, John, regardless of reform, I think that I have explained before that one of our initiatives beginning last year is to start with a clean piece of paper on",153,"Well, the individual is about 3% of our revenue and miniscule part of our profits. And once again, John, regardless of reform, I think that I have explained before that one of our initiatives beginning last year is to start with a clean piece of paper on the individual product that would give a better value equation for our customers and that would incorporate a deeper distribution system. So it's a small part of our company, and I would say something that needs attention first. And one of these days soon, we'll be announcing a new addition to our company, and product development will be this person's -- one of two things this person is going to do in the company. But we've been working on that. We're working on, from an IT perspective, a clean piece of paper and a different distribution system because what we have today doesn't work for tomorrow."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So I'm just summarizing, I mean, your view being for 2011. At this point, you don't necessarily expect any drag from the implementation of minimum MCRs as you think about your Commercial book, overall. Is that the correct way to walk away with that though",46,"So I'm just summarizing, I mean, your view being for 2011. At this point, you don't necessarily expect any drag from the implementation of minimum MCRs as you think about your Commercial book, overall. Is that the correct way to walk away with that thought?"
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, it's kind of a leap of faith. I think the things that we began a year ago in terms of our internal costs, in terms of a better delivery system, there's a huge difference in some of our markets between the quality and efficiencies and outcomes and the",192,"No, it's kind of a leap of faith. I think the things that we began a year ago in terms of our internal costs, in terms of a better delivery system, there's a huge difference in some of our markets between the quality and efficiencies and outcomes and the cost of some of the delivery business. So the efforts that we started to give a better value equation for our membership and everything started a long time ago. And the new Regs, as I understand them, are the new law. Without the Regs being out there as I understand them and then look at the distribution of our business, sort of 50-50, 50% falling in the minimum of 80, and 50% in the minimum of 85. I'm not complacent or anything. I just don't see any tremendous hurdles that we can't deal with. We're going to keep doing what we're doing. We have to get more costs out of the place. I told you a year ago, we're going to get costs out of the place. And now you can count it, and we will get more costs out of the place."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","And our next question will come from Matthew Borsch with Goldman Sachs.",12,"And our next question will come from Matthew Borsch with Goldman Sachs."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I'd like to just ask kind of a non-reform question. You alluded to some pricing actions in the market, maybe by competitors. I'm wondering have you actually seen an uptick in price competition in the Commercial Risk area? Or is that just a continuation fr",67,"I'd like to just ask kind of a non-reform question. You alluded to some pricing actions in the market, maybe by competitors. I'm wondering have you actually seen an uptick in price competition in the Commercial Risk area? Or is that just a continuation from what you've seen last year? And any further geographic or other color you can give us on that would be great."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, I don't think I said price. What I said were broker commissions and our sector as a group. What I said six months ago or something or when I was addressing then our loss of Commercial membership in 2009, I said that half of it was a condition of the e",161,"No, I don't think I said price. What I said were broker commissions and our sector as a group. What I said six months ago or something or when I was addressing then our loss of Commercial membership in 2009, I said that half of it was a condition of the economy. We kept the group. But there were layoffs. So our people couldn't afford the product anymore or Chapter 11s on their small group of business. And half of it was self-induced, that we introduced some new underwriting actions in the end of 2007 and 2008. When we got a new team, there was a certain amount of dysfunctionality in the communication between actuarial underwriting and our sales team. When we looked to the mirror and corrected our own deficiencies, we're having much more success in the marketplaces. And if anything, I would say the pricing environment, the competitive environment is a bit better than it was a year ago."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And actually, this is on reform. As you referred to the individual product, it's about 3% of revenue and contributing miniscule amounts to the earnings. Should we take it for miniscule that it's substantially less than 3% from an earnings contribution on",43,"And actually, this is on reform. As you referred to the individual product, it's about 3% of revenue and contributing miniscule amounts to the earnings. Should we take it for miniscule that it's substantially less than 3% from an earnings contribution on that?"
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","If you add 3% of our revenue, then the margin is under 5%. It's just not a big deal.",19,"If you add 3% of our revenue, then the margin is under 5%. It's just not a big deal."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","And next, we'll take a question from Ana Gupte with Sanford Bernstein.",12,"And next, we'll take a question from Ana Gupte with Sanford Bernstein."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I was wondering if you could give us some color on the recent rate pressures in Massachusetts, Maine and California, and your perspective on the states that you're participating in. Will this likely become a contagion in terms of a regulatory or legislati",48,"I was wondering if you could give us some color on the recent rate pressures in Massachusetts, Maine and California, and your perspective on the states that you're participating in. Will this likely become a contagion in terms of a regulatory or legislative pressures on small group rates?"
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","In terms of group, don't do any business in any of those states, and I kind of know what I read about that. I don't see anything today in any of our markets to suggest that there are any movements like what we're seeing in those three areas.",48,"In terms of group, don't do any business in any of those states, and I kind of know what I read about that. I don't see anything today in any of our markets to suggest that there are any movements like what we're seeing in those three areas."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And when you look at these then, when the state regulatory commissioners are sort of deciding rates, would they restrict or consider restricting the dividending of cash to the parent and thereby, they can keep rates or pressures on the rates while still k",59,"And when you look at these then, when the state regulatory commissioners are sort of deciding rates, would they restrict or consider restricting the dividending of cash to the parent and thereby, they can keep rates or pressures on the rates while still keeping you adequately reserved? Do you see any sort of conversations or trends in that direction?"
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","No.",1,"No."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Then finally, on the small group and individual, the restricted underwriting that you're seeing right now coming into being prior to reform, restricted underwriting in terms of kids with medical conditions, rescissions or so on, are you seeing any impact",45,"Then finally, on the small group and individual, the restricted underwriting that you're seeing right now coming into being prior to reform, restricted underwriting in terms of kids with medical conditions, rescissions or so on, are you seeing any impact on that in 2011 margins?"
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","On the rescission front, we have been looking at that for several quarters now. There would be something under 500 rescissions a year in our company, maybe under 400. So the impact is not great. Our legal and regulatory people are reviewing now whether or",226,"On the rescission front, we have been looking at that for several quarters now. There would be something under 500 rescissions a year in our company, maybe under 400. So the impact is not great. Our legal and regulatory people are reviewing now whether or not for the remainder of the year that we would want to go to a third party to also review the rescissions. But we have fairly arduous process within our company. 100% of rescissions go to a legal team. They review the facts, the information, and so -- we don't do that many right now, only in extreme cases of beyond misrepresentation of fraud, so not a huge impact. And the question has always been, with anything less than universal coverage, what kind of product that you're going to be able to have if you can't do any underwriting, and we just have to wait and see what the details and see where are the niches there. If we can't do that in a business, likely we won't do the product. But I think a lot of what's coming is going to come out in the Regs and may vary by state, and the devil is going to be in the details. So the real answer is in the short term, no, not any impact; longer term, we'll have to see."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And on the baby end of the market, are you seeing any changes in the way these employers are responding to reform? Are they more likely to subsidize in light of tax credits? Or are they sort of pulling back from getting into this space?",45,"And on the baby end of the market, are you seeing any changes in the way these employers are responding to reform? Are they more likely to subsidize in light of tax credits? Or are they sort of pulling back from getting into this space?"
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I don't know, except what we've talked about in Q1, in our small or mid-sized group, that whether the market is improving slightly or it's because of our own efforts, our quotes up, we're running more business than we have in a while. And I can't, at this",75,"I don't know, except what we've talked about in Q1, in our small or mid-sized group, that whether the market is improving slightly or it's because of our own efforts, our quotes up, we're running more business than we have in a while. And I can't, at this stage, really know how much of that is because we got a better team with better focus out there or if the environment is improving slightly."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","And our next question will come from Justin Lake with UBS.",11,"And our next question will come from Justin Lake with UBS."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Allen, you talked about the expectation for significant consolidation in the industry post-reform. I'm just curious to get your view on the -- how important are the attributes with regards to scale at the local level versus having just greater national sc",42,"Allen, you talked about the expectation for significant consolidation in the industry post-reform. I'm just curious to get your view on the -- how important are the attributes with regards to scale at the local level versus having just greater national scale?"
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, the comments about consolidation is an educated guess or maybe a guess. But we all acknowledge that the things that we did yesterday aren't enough for tomorrow. That the revenue environment is going to be more difficult and you just have to be bette",171,"Well, the comments about consolidation is an educated guess or maybe a guess. But we all acknowledge that the things that we did yesterday aren't enough for tomorrow. That the revenue environment is going to be more difficult and you just have to be better with what you do. And I think if you are in the business and don't have best business practices, best information, best people, best focus and a reasonable cost structure, you aren't going to be able to complete. So I would be surprised if there weren't other opportunities not unlike the Preferred Health System in Kansas, where people focus on doing what their primary business is. And so we'll see where that comes out a year from now. But if you look at the balance sheets and margins, it's going to get more difficult. So I don't see how you avoid consolidation in all the lines of businesses: Certainly, Medicare Advantage; certainly, some of the small-private Medicaid plans and some of the Commercial plans. We'll see."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And as you're seeing that shift happen, you mentioned the acquisition you did there. Do you see that happening in a way where there's going to be opportunities to either divest smaller markets where you don't feel like you have scale or to be purchasing,",70,"And as you're seeing that shift happen, you mentioned the acquisition you did there. Do you see that happening in a way where there's going to be opportunities to either divest smaller markets where you don't feel like you have scale or to be purchasing, making acquisitions like this? Or do you think it's just going to be happening naturally through competitive pressures? Or will you take market share?"
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think the latter. We are a regional company or a multi-regional company. We are not national, not going to be national, and can't be. Where we have health plans, where we have HMO-type networks, our cost structure has always been competitive with the be",303,"I think the latter. We are a regional company or a multi-regional company. We are not national, not going to be national, and can't be. Where we have health plans, where we have HMO-type networks, our cost structure has always been competitive with the best. And let's say, competitive means within 500 basis points of the best, and that hasn't changed. I think that we have to be better at selecting maybe something -- networks that aren't as broad as they once were, and return for picking a delivery system with good outcomes and high-quality care for the members, which always mean usually a better cost structure. So I think that within the places that we do business, there will be narrower products. The one that we are working on with Via Christi, on Medicare Advantage in the Central Kansas area will be a product that fits for the Via Christi System only. They have a huge amount of resources, including 26 primary care physicians that are employees of the system. And I think that will just allow us to get better benefits, put better resources to help those physicians manage the care better. So I think that's going to happen on the Commercial side as well. Just the problem with our product is no one can afford it. And I am talking about our sector, our industry. So we're going to have to do a better job on the cost front. So I think it's going to get tougher for everybody. And if you don't have best business practices and a good balance sheet and the information and the insights it takes to manage the patients, that people are going to opt out, but we'll see. I have no evidence of that at this stage, but maybe in a quarter or two."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So you don't see the need to take that billion dollars that you talked about and leave that as a war chest to go out there and buy smaller plans. Do you think most of what you'll be doing is more organic? Is that fair to say?",48,"So you don't see the need to take that billion dollars that you talked about and leave that as a war chest to go out there and buy smaller plans. Do you think most of what you'll be doing is more organic? Is that fair to say?"
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","No. This company has always been opportunistic. If we find a property that fits our criteria, which is do we understand the business, is it fairly priced, and the third thing is do we know how to make it better, is our cost structure better and having one",176,"No. This company has always been opportunistic. If we find a property that fits our criteria, which is do we understand the business, is it fairly priced, and the third thing is do we know how to make it better, is our cost structure better and having one IT system, can we do it better, we would always do that. It's accretive. It helps our presence in the marketplace, and we did that for a long time. The consolidation kind of -- not kind of, it stopped. And I believe that it's likely on all of those fronts we talked about, the Medicare Advantage and maybe some of the small-private Medicaid plans. But certainly, in the Commercial, I think that, that will return. And one of the reasons that we didn't do any share repurchase this Q1 is, just to your point, I want to keep our powder dry. And I think that buying businesses that we understand and know we can make better and can make a fair margin is a good use of capital."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","And our next question will come from Scott Fidel with Deutsche Bank.",12,"And our next question will come from Scott Fidel with Deutsche Bank."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just interested first if your 2010 guidance at this point has any health reform related expenses in it? Just things like some of the early implementation of some of the market reforms or higher taxes associated with some of the reform, bill changes? Just",49,"Just interested first if your 2010 guidance at this point has any health reform related expenses in it? Just things like some of the early implementation of some of the market reforms or higher taxes associated with some of the reform, bill changes? Just if you could summarize that."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Sure, Scott. Yes, it does. And those impacts, we don't believe are material to this year, but our guidance does account for them.",23,"Sure, Scott. Yes, it does. And those impacts, we don't believe are material to this year, but our guidance does account for them."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then, do you have an estimate on how much membership you think you can add in Pennsylvania Medicaid this year?",21,"And then, do you have an estimate on how much membership you think you can add in Pennsylvania Medicaid this year?"
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes, we added about 2,000 through auto-assigns in the month of April. And I think for the year, that number is probably about 10,000.",24,"Yes, we added about 2,000 through auto-assigns in the month of April. And I think for the year, that number is probably about 10,000."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then just one last question, John, just if you have an update on the cost components and trend, and if there is any change in view on any of them.",31,"And then just one last question, John, just if you have an update on the cost components and trend, and if there is any change in view on any of them."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Sure, as I said earlier, it's really stable. So I'll just rip through the components: On in-patient, that's running in the range of high single digits, really unit-cost driven; outpatient, low double digits, split but tilted  a little more towards unit co",73,"Sure, as I said earlier, it's really stable. So I'll just rip through the components: On in-patient, that's running in the range of high single digits, really unit-cost driven; outpatient, low double digits, split but tilted  a little more towards unit cost; on in-house physician, I would say it's mid-single digits, split; and on Rx, it's mid to high single digit, again split. So again, a stable view of what we've discussed before."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","Today's final question is from Kevin Fischbeck with Bank of America Merrill Lynch.",14,"Today's final question is from Kevin Fischbeck with Bank of America Merrill Lynch."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I guess, I wanted to go back to the comments you made there on the acquisition front. Clearly, it sounds like you think consolidation is inevitable. Are you seeing anything from the smaller plans embracing that view? Or are you seeing more activity from t",50,"I guess, I wanted to go back to the comments you made there on the acquisition front. Clearly, it sounds like you think consolidation is inevitable. Are you seeing anything from the smaller plans embracing that view? Or are you seeing more activity from them approaching you? Any update there?"
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","You have to keep my comment in proper perspective. One closed deal in the quarter doesn't make a trend, but we see a thought process out there in several fronts where people are at least bringing new subject to the table in their organizations. Obviously,",154,"You have to keep my comment in proper perspective. One closed deal in the quarter doesn't make a trend, but we see a thought process out there in several fronts where people are at least bringing new subject to the table in their organizations. Obviously, if I have anything definitive there, I would announced. But can keep my comments in perspective. One, it's my view. There is what I would characterize as some slight evidence in terms of the people that we know that are sort of thinking about it, but that's all. I don't see as things get more difficult as the revenue is harder to come by, I don't see -- if you don't have best practices and a strong balance sheet and if it's not your primary business, I don't see how you survive or certainly, not provide. I don't see how anything else happens, but we'll see. It's my guess."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And it sounds like -- just about that last comment, you're talking more about kind of the Christi type of deal, where companies that are, it's part of their business but not a focus of their business, looking to sell that off rather than to simply plan.",47,"And it sounds like -- just about that last comment, you're talking more about kind of the Christi type of deal, where companies that are, it's part of their business but not a focus of their business, looking to sell that off rather than to simply plan."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think that's right.",5,"I think that's right."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And I didn't hear anything in particular about like Medicaid acquisition. Any thought about growth that way?",18,"And I didn't hear anything in particular about like Medicaid acquisition. Any thought about growth that way?"
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Not beyond what I've said. When I returned early in 2009, the second day I was here, I traveled to Nebraska because an RFE was in process, and my view was that the government already represents over 50% of the healthcare spend. My view is that we needed t",194,"Not beyond what I've said. When I returned early in 2009, the second day I was here, I traveled to Nebraska because an RFE was in process, and my view was that the government already represents over 50% of the healthcare spend. My view is that we needed to redouble our efforts in the Medicaid are. We have, and have successfully landed two pieces of new opportunity there. And so we would kick Medicaid tires just the same way that we would Commercial, and continue to seek new business on our own. I think with the skills that we have -- we've been in the business for 15 years. We just, I think, got a little bit distracted with several other large acquisitions and we kind of returned to our roots. And so we're very bullish. And we understand the challenges. And we understand the raid revenue. But it is an area of focus for the company. We're going to do our best by whatever means to grow revenue there. By whatever means, meaning either winning new business or if an acquisition opportunity would present itself, then we would certainly look at it."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I guess just to clarify, on the Medicare Advantage, the 85.7%, that's a pure -- that excludes the favorable development, right, from [indiscernible] restated number?",25,"I guess just to clarify, on the Medicare Advantage, the 85.7%, that's a pure -- that excludes the favorable development, right, from [indiscernible] restated number?"
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","That is a pure CCP-loss ratio.",7,"That is a pure CCP-loss ratio."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","And that does conclude our question-and-answer session. I would now turn the conference back over to Mr. Allen Wise for any closing or additional remarks.",26,"And that does conclude our question-and-answer session. I would now turn the conference back over to Mr. Allen Wise for any closing or additional remarks."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","That concludes our comments for today, and thank you very much for joining us.",14,"That concludes our comments for today, and thank you very much for joining us."
27133,100327066,60681,"Coventry Health Care Inc., Q1 2010 Earnings Call, Apr-30-2010",2010-04-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","And that does conclude our conference call. Thank you for your participation.",12,"And that does conclude our conference call. Thank you for your participation."
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","Good morning and welcome to the Coventry Health Careâ€™s second quarter 2010 earnings conference call. Todayâ€™s conference is being recorded and all participants are in a listen-only mode. Todayâ€™s call will begin with opening remarks by the Chief Execu",63,"Good morning and welcome to the Coventry Health Careâ€™s second quarter 2010 earnings conference call. Todayâ€™s conference is being recorded and all participants are in a listen-only mode. Todayâ€™s call will begin with opening remarks by the Chief Executive Officer of Coventry Health Care, Mr. Allen Wise, and after a brief forward-looking statement read by Mr. John Kunkle. Please go ahead, John.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties including those described in the Companyâ€™s filings with the SEC on Form 10-K for the year-ended December 31, 2009 and Form 10-Q for the quar",77,"Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties including those described in the Companyâ€™s filings with the SEC on Form 10-K for the year-ended December 31, 2009 and Form 10-Q for the quarter-ended March 31, 2010, as may be further updated from time-to-time in our quarterly reports on Form 10-Q may materially impact those statements and could cause actual future results to differ materially from those anticipated and discussed. Allen?
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Good morning and thank you for your interest in Coventry Health Care. As you saw in our press release, the Companyâ€™s core operations produced another very strong quarter. My comments today will center around what I will call the adjusted results, exclud",2170,"Good morning and thank you for your interest in Coventry Health Care. As you saw in our press release, the Companyâ€™s core operations produced another very strong quarter. My comments today will center around what I will call the adjusted results, excluding the one-time litigation charge that we communicated to you on our July 2 press release.
We are still working hard and pursuing all avenues of appeal for the Louisiana court decision, which we believe is not supported by either the law or the facts, and you should refer to our SEC disclosures for the background on this case.
Importantly, the fundamentals of our business are very, very strong. Weâ€™ve had sharper focus over the past 18 months and the fruits of our labor have certainly been evident during the past couple of quarters.
These strong results are Companywide across our seven core businesses, and Iâ€™ll cover that in a minute. I believe we can best explain the extraordinarily strong results for the last six months in three ways.
First and most important is our focus on making our seven businesses better over the last 18 months. The last few quarters for our business were essentially better in most every way; sales, SG&A, unit cost, patient management, and all the fundamental building blocks that make a good business.
The second piece of the description is the positive reserve run-out in our Private Fee-for-Service business. Itâ€™s not every day that we close down a $3 billion block of business and when we did so, we wanted to make certain that our reserve was adequate. The result of making certain left us with a significant prior-period positive development.
Third way to explain this is medical utilization, which appears to be favorable across most, if not all, of our markets. Weâ€™ve analyzed this carefully and have some theories, but to be honest, we simply do not know why this is occurring. Some of the decreased utilization can be attributed to our focus on taking better care of our members but certainly not all of it. Unfortunately, I donâ€™t know what the last half of this year will bring on this subject.
My comments will cover the quarter and our businesses and then Iâ€™ll provide some perspective on the remainder of 2010 and positioning for the future as we prepare for Phase I of health care reform.
In Q2, the adjusted earnings of our businesses, excluding the litigation charge, was $1.19 per diluted share and $1.01 per share when you exclude the Private Fee-For-Service contribution. This is an outstanding result and it is typical. Itâ€™s a product of many factors including medical cost management, SG&A focus and profitable growth.
Last quarter, I spoke about my satisfaction with the performance of the management team on executing and delivering the basics of the business and that certainly continued into this quarter.
More importantly, I expect this focus and execution to continue prospectively. Overall, all of our seven core businesses are performing at or ahead of plan. As you can see in press release, we experienced sequential organic growth in all of our core businesses. Our Fee-For-Service business grew as well with the exception of the fee-based business which was stable.
Turning to commercial risk, which is our largest business at about $5.4 billion in revenue. In Q2, we posted organic growth in the group risk business for the first time since Q4 2007. Our total commercial risk business grew 21,000 members or 1.4% sequentially.
As you may recall, we worked in 2009 to get the right managers in the right position. On important example was the appointment of a long-term employee Mike Bahr as the single leader and Executive Vice President of our Commercial Health business. In addition, we made the necessary internal process improvements and have much better integration and coordination between actuarial, underwriting and sales as entered into 2010.
As you would expect, weâ€™ve continued our relentless focus on a low cost structure to provide our customers with the best possible value proposition. Overall, on all metrics, our commercial risk business produced an outstanding result for the quarter.
Story is similar in Medicaid and Medicare, important businesses and as a part of our diversified portfolio as we look to the future. Some comments on Medicaid. Our Medicaid leadership put in place less than a year ago, has implemented a more thoughtful and effective cost structure and care management mindset which is absolutely critical in a current rate and state legit environment and certainly necessary to provide our state customers the cost and care management capabilities to produce the results they are seeking.
Our medical loss ratio has certainly outperformed than the past two quarters. As we look ahead, we are certainly a little more cautious here as the states are resting the budgetary pressure but that does not diminish how pleased we are with our internal accomplishments.
Despite the state-by-state challenges that are well known today, there is certainly a significantly longer term penetration opportunity, particularly for serving those segments of the population that are most in need of care management services.
We believe that opportunities exist for Coventry to provide state superior value proposition and we will continue to seek new opportunities in the Medicaid space. Along those lines, while weâ€™re better managing our existing business, weâ€™ve also been working on implementing our recent new market lengths. We went live in Southeastern Pennsylvania during Q2 and at this point, we already have 5,000 members.
Nebraska will go live August 1 and appears that we have enrolled at a minimum between 35,000 and 40,000 new members.
Turning the comments to Medicare; our Medicare Advantage Coordinated Care business and our Medicare Part D business both grew sequentially and performed very well in the quarter. I recall that we have HMO and PPO network-based product serving 192,000 members across 18 markets which are aligned with our locally-based health plans.
Our Company has been in this business for well over a decade and we strongly believe that itâ€™s the best way to care for seniors and weâ€™re dedicated to serving this population prospectively.
As outlined on previous calls, our initiatives to improve the cost structure, care management and value equation for the federal government and for seniors are on track and should serve us well as we recognize the tightening revenue reimbursement levels.
Immediately after we closed our Preferred Health System transaction in Kansas, we began developing a new Medicare Advantage product, which will be limited to the Preferred Health System.
The design included increased incentives for preferred employed to primary care physicians so that they can spend more time and resources with these Medicare patients along with us providing more information in other resources to help better care of the members.
While the approval is currently pending with CMS, we believe that a smaller, tighter network with significantly more resource is devoted to the care and management of the senior population is a direction that we will work toward with high-quality health care systems in the future.
Turning to Part D, we are at number-four in the national market position with a little more than 1.6 million members. Part D has performed well in each year since inception in 2006 and 2010 year-to-date performance is no exception. Both, Medicare Advantage in Part D are on track to produce our targeted margins for 2010.
Our fee business through which is three core businesses are workersâ€™ compensation service, rental network, and FEHBPs continue to produce very good results. As you can see, we ticked up the full-year management services or fee-based revenue guidance to a midpoint of $1.16 billion on the strength of the quarter.
While our fee business represents only about 10% of our companywide revenue, the margins as you might suspect are much more attractive, relative to the Companyâ€™s core risk businesses. We believe these businesses are well-positioned and itâ€™s important to remember they are non-insurance, non-risk, unregulated sources of revenue, earnings and cash flow.
Weâ€™re able to use our core network management, cost management and operational skills to provide our customers with an excellent value proposition in these businesses. These businesses are and will be an important part of a diversified portfolio.
Turning our attention to 2010 and forward, given the results for the first two quarters and the momentum we have on profitable growth, medical cost management, and SG&A management, we are pleased to provide increased EPS guidance of $2.90 to $3.05, excluding the litigation charge.
As you can see in the table in our press release, this includes $0.35 of EPS contribution from the run-out of our Private Fee-For-Service business, which we exited at the end of 2009. Our CFO, John Stelben will walk you through the guidance elements in more details, but once again, the improving performance spans all seven businesses.
This is now only been a year about improving the operations as evidenced by the first half of 2010 results. Itâ€™s been a year about investing for the future. In February 2010, we closed a transaction with Via Christi, an innovative Kansas-based health system, where we not only acquired their 120,000 member health plan, PHS, but also entered into a long-term contractual partnership.
Since we closed the transaction, weâ€™ve had ongoing dialog in collaboration on new products and method to align incentives around outcomes in care management such as the previously mentioned Medicare product in Wichita. We think this collaboration will be the norm not the exception as we look ahead and form product, contractual and financial alliances with health care systems.
At the end of the second quarter, announced the transaction with The Sisters of Mercy, a sophisticated health system spanning multiple Midwestern states with more than acute care hospitals, over 1,000 employed physicians and 35,000 employees in total. We entered into a definitive agreement to acquire their 180,000 member health plan, Mercy Health Plans and at equal importance to expand our relationship.
I met with their Chairman and with their CEO and itâ€™s obvious that we share a common view on the need for a closer alignments of health plans and providers as we both approach tomorrowâ€™s arena of health care reform. Weâ€™re going through the typical regulatory approval process and expect the transaction to close in Q4.
Mercy Health Plans is diversified across markets and products and has approximately 90,000 commercial risk members, 60,000 ASO members which is largely the system employees and over 30,000 Medicare Advantage network-based members in Springfield St. Louis and Northwest Arkansas.
As we indicated in our June 30 press release, this transaction builds on our core business competencies and we look forward to expanding the relationship with The Sisters of Mercy Health System.
In addition to using our capital in the M&A area to improve our business and positioning for the future, we are in discussions across many of our markets with key providers regarding accountable care organizations, medical homes and other models that better align incentives. This is where our Health Plan business and nimbleness should service very well in the future.
Weâ€™re in the process of redesigning products and making IT investments as well as we look to the future. We continue to recruit talented executives that will lead us through the winding road ahead and seizing opportunities presented in the health care reform arena. Our businesses are very sound and well positioned. We spend every day trying to improve our cost structure to provide the best value proposition for our members and customers.
You see some of these results in the past two quarters and we believe there is more to come in the next couple of years. Looking ahead to 2014 in a state-based exchange model, our low cost structure should service well as it has over the past decade.
Clearly, many of the regulations are yet to be written and as Drew Asher, who leads our M&A and Investor Relations area of the Company if following the same and thereâ€™s a lot of wood left to chop between now and 2014. Even so, I like the portfolio of well-positioned businesses that we have and really like the nimbleness of our management team and infrastructure to cease opportunities, which will be presented.
In fact, this is not an easy business and actually I donâ€™t know if there is such a thing, but managing the details and operational blocking and tackling while positioning the business for the future has really been the strength of this Company for most of the past 12 years. Believe we have the tools to succeed in the future, including personnel, capital, cost structure and a diversified state of well positioned businesses with an energized and thoughtful culture with the ability to adapt and execute.
Certainly, we take nothing for granted and come to work every day with the thought of improving our business and the Company will continue to operate in that way.
That concludes my comments, and our CFO, John Stelben, will now walk you through the financial details for the quarter. John?
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Thanks, Allen, and good morning. Our GAAP EPS for the second quarter is $0.01, which includes the previously disclosed non-recurring charge of $1.18 that we announced on July 2. Excluding the charge, EPS was $1.19. Itâ€™s a very strong result and better t",2250,"Thanks, Allen, and good morning. Our GAAP EPS for the second quarter is $0.01, which includes the previously disclosed non-recurring charge of $1.18 that we announced on July 2. Excluding the charge, EPS was $1.19. Itâ€™s a very strong result and better than our plan for the quarter.
In addition, as you have seen in the earnings release, we are increasing our full-year guidance, excluding the charge, to a range of $2.90 to $3.05 from the previous guidance range communicated July 2 of $2.75 to $2.90.
With that, Iâ€™ll provide some highlights on the quarter and some details on guidance for the full year. First, our Medicare Advantage Private Fee product line, which we exited January 1, produced $0.18 in the quarter and $0.35 for the year due primarily to prior-period reserve development.
While we set reserves with an expectation of favorable development, we did not and still do not incorporate any perspective private fee run out earnings and guidance. So the Q2 $0.18 is upside to the quarter and full-year expectations compared to the guidance provided on the Q1 call.
We experienced strong performance across all our core businesses. Equally important, the performance was pretty uniform across all our health plans. Whether it was membership revenue, clinical results, or SG&A, we were able to see improvements in all of these areas, which certainly bodes well for our ability to compete in the future.
While I would like to chalk all of this up to better focus and execution, there are some industry tailwinds such as lower utilization and a muted flu season, similar to that discussed by our peers that have also contributed to performance.
The Commercial Risk business had an excellent quarter in all fronts. Commercial Risk membership grew sequentially by 21,000 or 1.4% from Q1. Small group sales were more than 20% ahead of Q2, 2009 year-to-date results. This is really a result of focused sales execution and competitive products.
Group premium yields are in line with expectations and they are up 4.7% over the prior-year quarter. The commercial group medical loss ratio of 78.3% is also better than expected. Again, while there are the aforementioned tailwinds, this is not the whole story, as it still takes disciplined execution on product design, sales, and patient management, and so on to produce this strong result. The year-to-date MLR now stands at 79.3%.
COBRA results seem to plateau and were flat to prior quarter at about 1.8% of total commercial group membership. We are updating our view of fundamental trend to a range of 8.0% to 8.5% versus our previous view of 8.5% to 9%. The change is primarily due to reduced utilization in outpatient and physician services.
Medicare CCP results in Q2 were also better than expected. Recall that we exited certain products in markets which produced a 13,000 member drag coming into the year. We had an excellent sales result thus far and made up that drag plus an extra 6,000 members.
In establishing our initial incurred estimates in Q1 2010, we made adjustments for the 2010 benefit changes, but took a prudent approach in reflecting the demographic changes for our guess of the mix impact of these market and product exits on Q1 incurred estimates.
As Q1 IBNR completed during Q2, we saw higher level of restatement. This is really a long winded way of saying that the year-to-date loss ratio of 83.5 is more indicative of the true performance of this business along with some of the real improvements we are seeing in management our patients better. We are still forecasting full year MLR results in the mid 80s, which will enable us to withstand some back half of the year seasonality.
Medicare Part D results continue to run in line with expectations and remain on track with full year guidance of 1.6 million members in the mid 80s loss ratio. As Allen said, Medicaid produced another very good quarter with a loss ratio of 84.2% and a year-to-date result of 84.1%. The story here is pretty simple. Revenue PMPMs are in line with our expectations, so this is all a medical cost management story.
We have been in this business a long time but our patient care model has never been better. This is particularly important as we open our new Nebraska and Pennsylvania markets and bring our tool box so to speak to bear in those markets.
While there will be volume opportunity in this business post-reform, you have to assume revenues will always be tight, so carefully managing cost will be a key to success.
Turning to the balance sheet and cash flows, total cash and investments stand at $3.8 billion. Our investment portfolio is in a net unrealized gain position of $89 million at June 30, up from $66 million at March 31 and this is really primarily due to changes in treasury rates.
GAAP cash flow from operations for the quarter was $121 million. This result includes a $21 million outflow for the run-out of the Private-Fee product line. Adjusting for the Private-Fee run out, adjusted cash flow would have been $142 million of 94% of net income excluding the one-time charge. Remember that in Q2 we made two federal tax payments.
Year-to-date core cash flow from operations is 114% of net income, but more importantly free deployable cash at parent was $670 million versus $450 million at March 31, the main driver of the increase being receipt of dividends from our regulated subsidiaries.
Days in claims payable displayed in the press release exclude Private-Fee for all periods presented. The increase in DCP of 1.3 days of a prior quarter is due primarily to an increase in claims inventories related to the conversion of our Florida commercial business to our IDX platform at the beginning of June.
Debt-to-cap ratio now stands at 29.4%, down slightly from prior quarter and we did not repay any debt in the quarter.
Turning to 2010 guidance, we are forecasting GAAP EPS in the range of $1.72 to $1.87 including the class action charge of $1.18. Excluding the charge, guidance is in the range of $2.90 to $3.05, including $0.35 of year-to-date earnings generated by Private Fee, but again does not assume any further Private Fee earnings for the remainder of the year.
Our core view of EPS then is in the range of $2.55 to $2.70. Basically, we are adding our view of Q2 outperformance to the prior full-year guidance while adjusting for some revised use of the business in the back half of the year.
Weâ€™ve provided a table in the press release to roll forward our guidance changes. Iâ€™ll try to walk you through the table. When we announced the one-time charge in July 2, we increased our guidance, excluding the charge, to $2.75 to $2.90 from the previous guidance of $2.35 to $2.50. As outlined in the press release, we are increasing guidance, again based on June results, an additional $0.15.
Given that we did not provide the details to help you understand the July 2 guidance increase, weâ€™ll provide details of the current guidance versus the Q1 earnings call guidance, and hopefully this will be a little simpler to track.
Iâ€™ll walk through the guidance excluding the class action charge using the mid-point of the range for both prior and revised guidance. The mid-point of guidance given on the Q1 earnings call was $2.43, which included $0.17 of Private Fee earnings. So core earnings guidance would have been $2.26. The current guidance of $2.98 less the year-to-date Private Fee of $0.35 leaves $2.63 for the core, or an increase of $0.37 versus the April guidance.
You can think of the increase in three main buckets. Commercial Risk worth about $0.27, Medicaid worth about $0.02, and SG&A worth about $0.08. So let me provide a little more detail on those.
Starting with the Commercial Risk business, given our better-than-expected results to-date and sales momentum, we now expect same-store membership to be about flat to prior year. When we include the addition of approximately 100,000 Preferred Health Commercial Risk members, total growth would be nearly 7%.
Forecasted commercial group risk MLR is now expected to be 81% plus or minus 25 basis points, down from our Q1 view of 82% to 82.5%. This is a 125 basis point reduction from the previous guidance mid-point driven by Q2 results, our more completed view of Q1 and late 2009, as well as our revised view of fundamental trend of 8 to 8.5.
Our current guidance would assume higher loss ratios in the back half of the year as compared to year-to-date Q2. We are not assuming some of the previously mentioned tailwinds continue, and remember that in the back half of the year, loss ratios are pushed higher due to the satisfaction of deductibles in the first half of the year and other seasonal factors. Again, this is $0.27 of the increase guidance.
For Medicare CCP, our view of guidance is unchanged. Continue to expect the 2010 Medicare Advantage loss ratio to be in the mid-80s. Medical cost trend will continue to march forward as the year progresses, while revenue yield should remain relatively flat.
So while the first-half result was a little better than we had expected, weâ€™re still expecting a slightly higher MLR result in the back half of the year with the full year in the mid 80s.
Part D continues to perform in line with our expectation so far in 2010 and as a result, our annual view of this is unchanged from prior guidance with the membership in the 1.6 million and loss ratio in the mid 80s.
For Medicaid, our view of results for the back half of the year remain unchanged. Recall, the headwind we talked about previously in the second half of the year related to the less than expected rate increase in Missouri, which is worth about 2 points on almost half the business. While the Medicaid team continues to do an outstanding job in managing clinical care, weâ€™ll take a prudent posture in forecasting the business for the second half and just let the Q2 outperform its role through guidance. Again, that impact is worth about $0.02.
Our guidance does include the addition of the Southeast Pennsylvania and Nebraska markets. Weâ€™ve been live in Southeast PA since April and have a little over 5,000 members. We go live in Nebraska August 1 with an expectation of 35,000 to 40,000 members by year end. We expect a neutral impact to overall earnings in 2010 for these new Medicaid markets.
On SG&A, the midpoint of the 2010 guidance range is $1.94 billion, a reduction of $20 million from the previous guidance due to better performance on reducing costs. We do expect expenses in the back half of the year to increase for normal activity such as open enrollment and also for expenses related to reform preparedness. Even with that, this is an excellent result, which is particularly critical to succeed in the health care reform environment and demonstrates Coventryâ€™s ability to manage cost while growing the core businesses.
Weâ€™ve increased the midpoint of total revenue guidance to $260 million this year while guiding to lower SG&A. Full year SG&A guidance now sits at 17% of revenues, down 25 basis points from the prior guidance. This results in about $0.08 of improvement.
While we have not repurchased any shares year-to-date, our guidance at the high end of EPS would assume a modest amount of share repurchase. We are putting capital to use in the Preferred Health acquisition and the announced Mercy Health Plans transaction and have to take into account the uncertain resolution of the one-time charge.
So to recap the $0.37 change, $0.27 in Commercial Risk, $0.02 in Medicaid, $0.08 in SG&A, Medicare CCP Part D fee-based in all other items essentially net to zero.
As stated earlier, we have $670 million of deployable cash on hand. In addition, we expect the dividend out the capital supporting the Private Fee product which given year-to-date Q2 results would be approximately $275 million. We will seek to partially dividend this up in late â€˜10 with the remainder in the first half of 2011.
We still have our sights on a total of approximately $1 billion of capital, free deployable cash by mid 2011 of which less than one-third would be used to pay for Mercy Health Plans and again the uncertain resolution of the one-time litigation charge.
Our priorities for deployable cash continues to be growing the business through acquisition followed by opportunistic share repurchase and delivering.
Really to conclude, core earnings were strong in Q2 and a continuation of what we experienced in Q1. While there are clearly some tailwinds, we can see evidence of better management of the details across all our businesses. I am particularly encouraged by the continued strength of our small group sales engine, clinical management efforts, and the results we are seeing in controlling administrative cost.
In the future weâ€™ll have both challenges and opportunities, which are still being defined, and our comments will be limited in that regard. We believe the future success of Coventry, though, will always be determined by low cost and execution on the details as it has been in the past.
Fundamentals do matter and the takeaway for 2010 so far is that Coventry is executing better on improving its businesses, which ultimately provides a better competitive transition for the future.
Weâ€™ll open the call to questions.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","Thank you. (Operator instructions). Weâ€™ll go first to Doug Simpson with Morgan Stanley.",13,"Thank you. (Operator instructions). Weâ€™ll go first to Doug Simpson with Morgan Stanley.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Weâ€™re obviously all still waiting clarity around MLR regulations and there are uncertainties that how reform implementation are going play out in 2011 and just stepping back, all that being said, you guys are deploying capital on M&A with both Mercy and",95,"Weâ€™re obviously all still waiting clarity around MLR regulations and there are uncertainties that how reform implementation are going play out in 2011 and just stepping back, all that being said, you guys are deploying capital on M&A with both Mercy and PHS, and you obviously have a view of the value of those businesses in your own business going forward, so can you just walk us through, how do you get the confidence to make these types of investments and how are you thinking about that looking out to one to three years?
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, I think if you would take the last one, take the Mercy Health Plans acquisition, it does a number of things for us. Number one, we have a long-term contractual relationship, which improves our cost structure both for our existing business today, our",417,"Well, I think if you would take the last one, take the Mercy Health Plans acquisition, it does a number of things for us. Number one, we have a long-term contractual relationship, which improves our cost structure both for our existing business today, our Commercial business, our Medicaid business and our Medicare Advantage business.
Number two, we donâ€™t think thereâ€™s enough money to deliver care like we have in the past. The BJC System in St. Louis has a cost structure thatâ€™s significantly more than other high-quality systems, and we think that our product offering in the past will be both broad, but also narrow our system with high quality care. They have a presence in south central part of Missouri, which Coventry has not typically had, helps our network, rental business in terms of our cost structure. They have a presence in Arkansas, which not unlikely that some of our customers from the aircraft industry in Kansas will be moving some operations in that direction.
Not unlike the Kansas acquisition, I think that we have to have more strategic long-term relationships originally and together with our skill set and their skill set in caring for patients, do a much better job managing the patients, caring for the patients and improving the quality of care, and we have to stop arguing over nickel, so to speak, on a purely unit cost basis.
So the Mercy system, which is just the last one on my mind, began since the 90s. It had a mission, well, before that, but certainly from the 90s, weâ€™ve been looking for a partnership with health plan to execute on their mission to care for patients better. So, whether itâ€™s cost structure, whether itâ€™s plan design for the future, whether itâ€™s care management for the patients, whether itâ€™s a more competitive offering in terms of product and cost structure, and even with Mercy weâ€™re third in town; the Blues are first; UnitedHealth is second or whichever weâ€™re in.
So it helps us on all fronts. It helps earnings and helps us in offer what we think is going to be tomorrowâ€™s product, which goes back to what Iâ€™ve been saying for the last two years. Firstly, back as the CEO, so weâ€™re going to take better care of our members and better care means members are going to be better off and it means itâ€™s going to be more cost effective. So it filled a lot of holes that we needed in that area.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then maybe could you just discuss what youâ€™re seeing and what youâ€™re learning from differentials if any in the utilization trends across the commercial and the government sectors? I mean, weâ€™re hearing obviously and you touched on it earlier, we",125,"And then maybe could you just discuss what youâ€™re seeing and what youâ€™re learning from differentials if any in the utilization trends across the commercial and the government sectors? I mean, weâ€™re hearing obviously and you touched on it earlier, weâ€™re hearing a lot about soft utilization in the quarter and a lot of debate about what that means currently and potentially for the second half of the year, just given your experience in that kind of the industry, what do you take away from what youâ€™re seeing recently and is there anything to be discerned from differentials between the government side and the commercial side in terms of whatâ€™s really driving it and what weâ€™re likely to see over the next six months?
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","The answer to that is, we donâ€™t know. Weâ€™ve spent a lot of time thinking about it, talked to provider systems and certainly, the theory is that the deductibles and co-pays become so onerous that the discretionary medical care is evident more than it h",83,"The answer to that is, we donâ€™t know. Weâ€™ve spent a lot of time thinking about it, talked to provider systems and certainly, the theory is that the deductibles and co-pays become so onerous that the discretionary medical care is evident more than it has been in the past. In some of the markets where layoffs started a couple of years ago, the COBRA benefits have expired and that may have a role. But I think the real answer is, we donâ€™t know.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Maybe just last one last one. As you are thinking in a post-reform environment, is that going to impact the way you guys think about statutory capital levels at the subs? Is there going to be a specific change in the way you guys think about what an appro",96,"Maybe just last one last one. As you are thinking in a post-reform environment, is that going to impact the way you guys think about statutory capital levels at the subs? Is there going to be a specific change in the way you guys think about what an appropriate RBC level is? Ahead of some of your smaller competitors, how do you think they are going to think about their capital levels going forward? Obviously, with MLR floors it becomes a little hard to catch up if you have a bad year. Whatâ€™s your expectation there?
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","John will answer the capital question. But the thought process about the products moving forward is that, it goes back to earlier comments, the people in whatever form insured or ASO or smaller cases that maybe ASO with reinsurance or ultimately in tomorr",222,"John will answer the capital question. But the thought process about the products moving forward is that, it goes back to earlier comments, the people in whatever form insured or ASO or smaller cases that maybe ASO with reinsurance or ultimately in tomorrowâ€™s environment that weâ€™re thinking that number one is, cost structure and thatâ€™s how we care for the patient; number two, our own internal cost structure.
We also recognize and spend a lot of time internally thinking that the fine tuning and better a understanding with this cost structures and getting the premium right to be closer to the sweet spot on a minimum loss ratios for both the small and the larger cased business are going to be much more necessary. So in terms of our data information, our contracts for providers and our ability to fine tune on the loss ratio is going so thatâ€™s where weâ€™re spending our time.
In terms of smaller competitors, I think there is opportunities but itâ€™s going to be a more difficult environment than that has been in the past and were sloppy execution whether thatâ€™s rating or whether thatâ€™s product design or whether thatâ€™s customer service. Our feel is, if we donâ€™t do better, then we are out and I would say that about some of the smaller competitors as well.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Dough, this is John. What I would add there is that our RBC level in our health plans at year end was right around 400%. Our capital levels in the health plans certainly support our ratings. So thatâ€™s an important consideration there. We are evaluating",124,"Dough, this is John. What I would add there is that our RBC level in our health plans at year end was right around 400%. Our capital levels in the health plans certainly support our ratings. So thatâ€™s an important consideration there. We are evaluating our capital strategy as we go forward, but I think it would be premature to get more details on that. But I believe that we like to be well capitalized, because at the end of the day in those regulated subs, I mean that money is there to pay the claims of our members. So I think weâ€™ll maintain a strong capital position going forward, but more will come out on that as we know more about next year.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","Weâ€™ll now move on to Josh Raskin with Barclays Capital.",11,"Weâ€™ll now move on to Josh Raskin with Barclays Capital.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","First, just a quick question on the Private Fee-for-Service, and I understand thereâ€™s an elongated claim cycle there, but are we mostly done with the run out there?",28,"First, just a quick question on the Private Fee-for-Service, and I understand thereâ€™s an elongated claim cycle there, but are we mostly done with the run out there?
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","What I would tell you, Josh, is that we can see that the receipts, certainly at this point start tailing off, but youâ€™ve got filing limits that go through the end of this year, and as we said a couple of times, Iâ€™ve never run out of $3 billion block o",68,"What I would tell you, Josh, is that we can see that the receipts, certainly at this point start tailing off, but youâ€™ve got filing limits that go through the end of this year, and as we said a couple of times, Iâ€™ve never run out of $3 billion block of business, and so I think by the end of this year, it will certainly be predominantly going.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just in terms of maybe the cash flow drag, it was, for whatever reason, $25 million or so in the third quarter, should we assume itâ€™s going to be even lower than that I guess in the third quarter?",39,"Just in terms of maybe the cash flow drag, it was, for whatever reason, $25 million or so in the third quarter, should we assume itâ€™s going to be even lower than that I guess in the third quarter?
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I would expect it to be lower.",7,"I would expect it to be lower.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Josh, when you are saying mostly done, you would be correct, but then a couple of hundred basis points, we donâ€™t know what mostly means, but yes, it is after six months, seven months, it is mostly done.",38,"Josh, when you are saying mostly done, you would be correct, but then a couple of hundred basis points, we donâ€™t know what mostly means, but yes, it is after six months, seven months, it is mostly done.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then just getting back to the change in medical trend that you guys are seeing, understanding that the simple answers we donâ€™t know, is there a way to parse out what you think is industry factor versus Coventry improvement, sort of your past 18 mont",66,"And then just getting back to the change in medical trend that you guys are seeing, understanding that the simple answers we donâ€™t know, is there a way to parse out what you think is industry factor versus Coventry improvement, sort of your past 18 months have been a real focus on execution, is there a sense to how much of this is internal versus external?
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","The answer is, no. We obviously have given that a lot of thought and we can measure things that weâ€™ve done, changes weâ€™ve made here, and know that theyâ€™d produce a positive note, but we really donâ€™t know.",38,"The answer is, no. We obviously have given that a lot of thought and we can measure things that weâ€™ve done, changes weâ€™ve made here, and know that theyâ€™d produce a positive note, but we really donâ€™t know.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then I guess last question. With all of this going on, better trends in the first half, with the expectation of reverting back in the second half, plus some of the reform elements, how are you guys thinking about the pricing environment for 2011 as yo",72,"And then I guess last question. With all of this going on, better trends in the first half, with the expectation of reverting back in the second half, plus some of the reform elements, how are you guys thinking about the pricing environment for 2011 as you start renewing some of your risk book in the next couple of months? Whatâ€™s your message to customers and how are you thinking about pricing?
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Josh, I would say that at this point as you think about into next year, not much of the book would be priced and it would mostly be large group. We are based on the definitions that are at least out there now on reform, weâ€™re trying to understand what t",91,"Josh, I would say that at this point as you think about into next year, not much of the book would be priced and it would mostly be large group. We are based on the definitions that are at least out there now on reform, weâ€™re trying to understand what that means. There are a lot of moving pieces and in the absence of knowing the definition, weâ€™ll continue to price what we think is appropriate, and I couldnâ€™t give you a whole lot more details on that at this point.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","But back to the prior comments, we do think that the pendulum has swung back to the 80s where I began to manage care which is you started with managed care and you started with more limited networks and less choice and in theory, and in fact, less cost, p",169,"But back to the prior comments, we do think that the pendulum has swung back to the 80s where I began to manage care which is you started with managed care and you started with more limited networks and less choice and in theory, and in fact, less cost, people have demanded choice and that quickly moved in the early 90s, mid 90s moved to where you had a broad delivery system with high cost people in your delivery system as well as people that were lesser cost.
So part of what weâ€™re doing here with acquisitions and part of what weâ€™re doing with our existing networks is we will be offering products with more limited network, with high quality delivery system where we have been able to document their outcomes and results and quality is good or is better as anyone in the marketplace but with the lower of cost structure and offer products where people have to leave with a more limited delivery system for lesser cost.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I mean, my question was more an understanding that a lot of the book has been renewed at this point but its August coming Monday. So, as you think about the next two or three months, you are going to start the renewals, youâ€™re talking about a lower cost",80,"I mean, my question was more an understanding that a lot of the book has been renewed at this point but its August coming Monday. So, as you think about the next two or three months, you are going to start the renewals, youâ€™re talking about a lower cost trend than expected. So, should we think about flat pricing or do you think there is still enough tailwinds to cause that that you had expected to be higher pricing â€˜11?
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","The best answer I can give you is, we go through rate review process, market-by-market and block size-by-block size and as you can imagine, across all our markets theyâ€™re all little different. We will price to what we know and weâ€™re not going to guess",73,"The best answer I can give you is, we go through rate review process, market-by-market and block size-by-block size and as you can imagine, across all our markets theyâ€™re all little different. We will price to what we know and weâ€™re not going to guess. Our goal is to continue to improve our ability to manage the patients so that we can count more in the future to have the products be competitive.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","Weâ€™ll now move on to Ana Gupte with Sanford Bernstein.",11,"Weâ€™ll now move on to Ana Gupte with Sanford Bernstein.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just wanted to follow-up on the deals that youâ€™re doing with Mercy and Preferred Health. As you discover landscape, can you give us a sense for in this entire Commercial Risk, both group and possibly individual book, what percentage of the membership is",73,"Just wanted to follow-up on the deals that youâ€™re doing with Mercy and Preferred Health. As you discover landscape, can you give us a sense for in this entire Commercial Risk, both group and possibly individual book, what percentage of the membership is up for takeout to deals like this? Is there some threshold that you see on the size of the deal and the type of company provider owned or not?
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","We survey the landscape, I couldnâ€™t tell you offhand and we can follow-up how many are provider owned versus not provider owned. I think when we look at the landscape, we prefer looking at the provider-owned plans because what, Allen, said earlier, we w",93,"We survey the landscape, I couldnâ€™t tell you offhand and we can follow-up how many are provider owned versus not provider owned. I think when we look at the landscape, we prefer looking at the provider-owned plans because what, Allen, said earlier, we want to partner with people that can help us manage the patient better going forward, and as part of those types of acquisitions, you get predictable cost structure for a period of time. Plans that do not come with cost structure are of obviously a lot less interest to us.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think you could take some general comments, which we need to get Mercy closed. We would probably not be interested in a small block somewhere, letâ€™s say, small is under 50,000. We probably would not be interested in going into a new area of the countr",202,"I think you could take some general comments, which we need to get Mercy closed. We would probably not be interested in a small block somewhere, letâ€™s say, small is under 50,000. We probably would not be interested in going into a new area of the country that didnâ€™t help us with the existing geography that we have.
And as you might suggest, when we go to our Board and ask for approvals, what value it creates for the future and what the accretion is going to be is a subject, and so we have to I think prove to our directors and to me that the last two of these assuming that we get Mercy closed, that they have done what we thought they would do, and thatâ€™s kind of a long-winded way of saying.
On the commercial health plans, we are going to kind of digest what we have got and we will be looking for M&A opportunities in other areas, maybe some non-regulated businesses, certainly if a Medicaid opportunity represented itself. So we like these two a lot, but I wouldnâ€™t reach any conclusion from that thatâ€™s the only place that weâ€™re going to look to deploy our capital.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just to follow-up again on that, so it sounds like, I was projecting out and say, well if you did three to five of these deals like Mercy every year, you could technically have 1 million to 1.5 million more of Commercial Risk members, but probably youâ€™r",125,"Just to follow-up again on that, so it sounds like, I was projecting out and say, well if you did three to five of these deals like Mercy every year, you could technically have 1 million to 1.5 million more of Commercial Risk members, but probably youâ€™re sounding like youâ€™re doing a three year plan. Are you seeing other competitors coming in either public or private equity to some of the strategies like you?
And then on the cost structures is it mainly SG&A that you can take out or are the MLR synergies from this contracting viable even given large group loss ratio flows of 85% and Iâ€™m not sure how many of these are small group or anything in the 80% range?
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Lot of questions in this sentence. No, we donâ€™t see any private equity people buying the plans. Itâ€™s just too many IT issues, too many issues that would make that I think not productive, and to say this, you can find three to five, what is well suited",166,"Lot of questions in this sentence. No, we donâ€™t see any private equity people buying the plans. Itâ€™s just too many IT issues, too many issues that would make that I think not productive, and to say this, you can find three to five, what is well suited. They have to be well suited by geography and the culture of the organization and the thoughtfulness of management and I think we got pretty lucky to find two that were really in our sweet spot.
If opportunistically, if our luck continues, weâ€™d certainly look, but I would be very surprised if you would ever talk on a consistent basis doing three to five of these a year and it will make a little progress on SG&A, little progress on cost structure, little progress on patient management and it adds up to where we need to be, which is sort of as good or better than anyone else in those markets and the businesses that we are in.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","Weâ€™ll now move on to Matthew Borsch with Goldman Sachs.",11,"Weâ€™ll now move on to Matthew Borsch with Goldman Sachs.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","A question on your outlook on the Medicaid MCR relative to the Missouri rate increases. Am I correct that youâ€™re looking at 400 basis points higher MCR in the back half of the year than the first half? With that factor just seems like a big jump that yo",51,"A question on your outlook on the Medicaid MCR relative to the Missouri rate increases. Am I correct that youâ€™re looking at 400 basis points higher MCR in the back half of the year than the first half? With that factor just seems like a big jump that your guidance implies.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Our rate increase, I believe was 80 basis points, and the question then becomes in that marketplace can we hold medical trend at 80 basis points? There has been a lot of work there and I think that would mitigate a rate increase as non-consistent with tre",186,"Our rate increase, I believe was 80 basis points, and the question then becomes in that marketplace can we hold medical trend at 80 basis points? There has been a lot of work there and I think that would mitigate a rate increase as non-consistent with trend. And exactly Matt, whether how much weâ€™re able to absorb trend by better operations is just a little bit unclear. I believe, Missouri has been a really good partner of ours for a very long time, maybe 14 years or longer than state. They have, like a lot of states, â€˜09 over â€˜08, a double-digit reduction in revenue.
When Iâ€™m saying theyâ€™ve been a good partner, I think that we got a little bit sloppy in my view in managing our own costs and managing the patients, and I think weâ€™re doing better. Exactly how much better, weâ€™re not going to be certain about and I think it's a little bit naÃ¯ve and arrogant to think that we can hold trend to zero. So, weâ€™re going to do better than we have in the past, but itâ€™s still challenging.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Matt, I would add that we have other plans and we do have the new plans coming on board, which would push that loss ratio a little higher and weâ€™re taking on a prudent outlook on the back half of the year.",42,"Matt, I would add that we have other plans and we do have the new plans coming on board, which would push that loss ratio a little higher and weâ€™re taking on a prudent outlook on the back half of the year.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","That makes sense. If I could just ask one last question on it, different topic, which is, how are you thinking about the individual product at this stage given that seems to be the area of most potentially problematic for the minimum MLR rules? Is your co",62,"That makes sense. If I could just ask one last question on it, different topic, which is, how are you thinking about the individual product at this stage given that seems to be the area of most potentially problematic for the minimum MLR rules? Is your continued participation there contingent on a phase-in of those rules or can you comment on that?
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Sometimes it doesnâ€™t pay to be too straight forward, but I canâ€™t help myself. The product that we have today is as good as it needs to be for our member. The distribution cost is too high. Our internal underwriting and issue cost and our claim adjudic",151,"Sometimes it doesnâ€™t pay to be too straight forward, but I canâ€™t help myself. The product that we have today is as good as it needs to be for our member. The distribution cost is too high. Our internal underwriting and issue cost and our claim adjudication costs. So early on our IT area is and our product development, theyâ€™re really starting off with a clean piece of paper to have a better value equation so that we issue it where we have the best cost structure, where we do something about the distribution cost and our internal SG&A. So we think that the product that we have today is not at all competitive for tomorrow, startup clean piece of paper and Harvey DeMovick is with us today. He runs operations in IT as well as Medicare here. He can comment about where are we 60% down the road Harvey?
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","We need to continue to work closely with the product development people, well, say learn more, but yes on an IT front, weâ€™ve made a lot of progress in getting ourselves better positioned with more direct sales to customers and technology that will allow",54,"We need to continue to work closely with the product development people, well, say learn more, but yes on an IT front, weâ€™ve made a lot of progress in getting ourselves better positioned with more direct sales to customers and technology that will allow us to manage the process much more cost effectively internally.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Itâ€™s even more challenging than that the small group product may look a lot like the individual product. So, we have to get this right and we started the clean piece of paper a year ago and we are making progress.",42,"Itâ€™s even more challenging than that the small group product may look a lot like the individual product. So, we have to get this right and we started the clean piece of paper a year ago and we are making progress.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","Weâ€™ll now move on to Justin Lake with UBS.",10,"Weâ€™ll now move on to Justin Lake with UBS.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","A couple of questions here. Just first, I wanted to get your thoughts on the impact of health care reform and mandated benefits there that will start in the fourth quarter on cost trend and how you are thinking about pricing them for 2011? Any early indic",60,"A couple of questions here. Just first, I wanted to get your thoughts on the impact of health care reform and mandated benefits there that will start in the fourth quarter on cost trend and how you are thinking about pricing them for 2011? Any early indications from regulators on fourth quarter rates comings that might have those rates embedded?
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Justin, I heard the first part, I may have to ask you to repeat your last question, but on the mandated benefits, I would say that, that are going into effect September 23. I really think for 2010 the impact is immaterial to us. We probably have missed so",145,"Justin, I heard the first part, I may have to ask you to repeat your last question, but on the mandated benefits, I would say that, that are going into effect September 23. I really think for 2010 the impact is immaterial to us. We probably have missed some of our Q4 renewals on some of those, but again Q4 is only about 15% of our annual renewals and interestingly, enough some of our plans already had these benefit levels in some of their offerings.
So, I think for this year itâ€™s not material. I mean, going forward, all of these is probably in the range of a couple of points or so. What I would tell you is, it is one of the factors that we put into our pricing model along with everything else we put into pricing. What was your second -
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I was just asking, I would assume youâ€™re putting those into rate filings for the fourth quarter?",17,"I was just asking, I would assume youâ€™re putting those into rate filings for the fourth quarter?
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I was just wondering if youâ€™ve gotten any feedback or pushback from regulators there.",15,"I was just wondering if youâ€™ve gotten any feedback or pushback from regulators there.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","We have continuing dialogues on our rate filings. Weâ€™ve actually had some one-on-ones with some of the actuarial folks, but I can tell you that we have not had any rate filings denied and itâ€™s been a pretty reasonable process from our standpoint.",43,"We have continuing dialogues on our rate filings. Weâ€™ve actually had some one-on-ones with some of the actuarial folks, but I can tell you that we have not had any rate filings denied and itâ€™s been a pretty reasonable process from our standpoint.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then just one other question. In Pennsylvania Highmark has probably announced their shift in medical underwriting in small group. Given, I believe they were the only player in the state that wasnâ€™t medically underwriting I was wondering if you could",55,"And then just one other question. In Pennsylvania Highmark has probably announced their shift in medical underwriting in small group. Given, I believe they were the only player in the state that wasnâ€™t medically underwriting I was wondering if you could talk about how this might change the competitive dynamic in your western Pennsylvania market?
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Whether there is some pushback from the Insurance Department to Commonwealth of PA on that front, Iâ€™m not sure. Letâ€™s see, this is my 14th year here as CEO or non-Executive Chairman, Highmarkâ€™s been tough all 14 years, and theyâ€™ll be tough the nex",45,"Whether there is some pushback from the Insurance Department to Commonwealth of PA on that front, Iâ€™m not sure. Letâ€™s see, this is my 14th year here as CEO or non-Executive Chairman, Highmarkâ€™s been tough all 14 years, and theyâ€™ll be tough the next 14.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I would add to that that in our nice growth story we have in commercial risk this year, that Pennsylvania is our leader. So weâ€™re competing just fine there.",29,"I would add to that that in our nice growth story we have in commercial risk this year, that Pennsylvania is our leader. So weâ€™re competing just fine there.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","We would probably need to get back to you on that, because I know that Highmark expressed a desire to do that and there was pushback from the insurance, I donâ€™t know where it is, but either way, they are tough.",41,"We would probably need to get back to you on that, because I know that Highmark expressed a desire to do that and there was pushback from the insurance, I donâ€™t know where it is, but either way, they are tough.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","Weâ€™ll now move on to Christine Arnold with Cowen & Co.",12,"Weâ€™ll now move on to Christine Arnold with Cowen & Co.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","A couple of questions. I think your operating cash flow wouldâ€™ve been about $20 million higher had it not been for the run out for private fee-for-service, and I think if we add that to medical payables, we saw payables rising at a lesser rate than prem",65,"A couple of questions. I think your operating cash flow wouldâ€™ve been about $20 million higher had it not been for the run out for private fee-for-service, and I think if we add that to medical payables, we saw payables rising at a lesser rate than premiums. How do you think about that, where there one-time issues, timing things, how do you think about that?
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Christine, what I would say is that, it's part of why we increased the guidance and itâ€™s a view of lower trend and a view of, COBRA isnâ€™t going to be as severe as we originally thought this year. Iâ€™m not sure how else to answer that.",47,"Christine, what I would say is that, it's part of why we increased the guidance and itâ€™s a view of lower trend and a view of, COBRA isnâ€™t going to be as severe as we originally thought this year. Iâ€™m not sure how else to answer that.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So, you are lowering your reserve levels relative to prior period because costs are coming in lower and you anticipate they will stay lower?",24,"So, you are lowering your reserve levels relative to prior period because costs are coming in lower and you anticipate they will stay lower?
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I would tell you that our reserve process is stable and our prior period development is stable.",17,"I would tell you that our reserve process is stable and our prior period development is stable.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So in terms of the prior period development, youâ€™re saying that the prior period development that youâ€™re experiencing this year related to last year is consistent with the same period last year?",32,"So in terms of the prior period development, youâ€™re saying that the prior period development that youâ€™re experiencing this year related to last year is consistent with the same period last year?
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I would say itâ€™s a little higher than it was through the same period of last year and itâ€™ll be reflected in our Q.",25,"I would say itâ€™s a little higher than it was through the same period of last year and itâ€™ll be reflected in our Q.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then how do you think about the MLR floors? I donâ€™t know if Iâ€™m getting really specific, but if you could just update us with your thinking given where the NAIC is in definitions, thatâ€™ll be great?",38,"And then how do you think about the MLR floors? I donâ€™t know if Iâ€™m getting really specific, but if you could just update us with your thinking given where the NAIC is in definitions, thatâ€™ll be great?
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Weâ€™re sitting on all the calls we can, we are following this. Weâ€™re tracking where the definitions go and weâ€™re evaluating what that may do to our business market-by-market and how to react. But at this point, itâ€™s premature to talk about it.",44,"Weâ€™re sitting on all the calls we can, we are following this. Weâ€™re tracking where the definitions go and weâ€™re evaluating what that may do to our business market-by-market and how to react. But at this point, itâ€™s premature to talk about it.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","Thatâ€™s all the time we have for questions. Iâ€™ll turn the conference back over to our speakers for any additional or closing remarks.",24,"Thatâ€™s all the time we have for questions. Iâ€™ll turn the conference back over to our speakers for any additional or closing remarks.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","No closing remarks and thank you very much for your interest in joining us today.",15,"No closing remarks and thank you very much for your interest in joining us today.
"
27133,108966182,70852,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","That does conclude our conference. Thank you all for your participation.",11,"That does conclude our conference. Thank you all for your participation.

"
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","Good morning, and welcome to the Coventry Health Care Second Quarter 2010 Earnings Conference Call. [Operator Instructions] Todayâ€™s call will begin with opening remarks by the Chief Executive Officer of Coventry Health Care, Mr. Allen Wise, after a brie",50,"Good morning, and welcome to the Coventry Health Care Second Quarter 2010 Earnings Conference Call. [Operator Instructions] Todayâ€™s call will begin with opening remarks by the Chief Executive Officer of Coventry Health Care, Mr. Allen Wise, after a brief forward-looking statement read by Mr. John Kunkle.  Please go ahead, John."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties, including those described in the company's filings with the SEC on Form 10-K for the year ended December 31, 2009 and Form 10-Q for the quart",80,"Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties, including those described in the company's filings with the SEC on Form 10-K for the year ended December 31, 2009 and Form 10-Q for the quarter ended March 31, 2010 as maybe further updated from time to time in our quarterly reports on Form 10-Q, may materially impact those statements and could cause actual future results to differ materially from those anticipated and discussed. 
Allen?"
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Good morning, and thank you for your interest in Coventry Health Care. As you saw in our press release, the company's core operations produced another very strong quarter. My comments today will center around what I will call the adjusted results, excludi",2175,"Good morning, and thank you for your interest in Coventry Health Care. As you saw in our press release, the company's core operations produced another very strong quarter. My comments today will center around what I will call the adjusted results, excluding the one-time litigation charge that we communicated to you on our July 2 press release. 
We're still working hard in pursuing all avenues of appeal for the Louisiana court decision, which we believe is not supported by either the law or the facts. And you should refer to our SEC disclosures for the background on this case. 
Importantly, the fundamentals of our business are very, very strong. We've had sharper focus over the past 18 months, and the fruits of our labor has certainly been evident during the past couple of quarters. These strong results are company-wide across our seven core businesses, and I'll cover that in a minute. 
I believe we can best explain the extraordinarily strong results for the last six months in three ways. First, and most important, is our focus on making our seven businesses better over the last 18 months. The last few quarters for our business are simply better in almost every way, sales, SG&A, unit cost, patient management and all the fundamental building blocks that make a good business. 
The second piece of the description is the positive reserve run out in our Private Fee-for-Service business. It's not everyday that we close down a $3 billion block of business, and when we did so, we wanted to make certain that our reserve was adequate. The result of making certain left us with a significant prior period positive development.
Third way to explain this is medical utilization, which appears to be favorable across most, if not all, of our markets. We've analyzed this carefully and have some theories, but to be honest, we simply do not know why this is occurring. Some of the decrease utilization can be to attributed to our focus on taking better care of our members, but certainly, not all of it. Unfortunately, I don't know what the last half of this year will bring on the subject. My comments will cover the quarter and our businesses, and then I will provide some perspective on the remainder of 2010 and positioning for the future as we prepare for Phase 1 of healthcare reform. 
In Q2, the adjusted earnings of our businesses, excluding the litigation charge, was $1.19 per diluted share and $1.01 per share when you exclude the Private Fee-for-Service contribution. This is an outstanding result, and as typical, it's a product of many factors including medical cost management, SG&A focus and profitable growth. 
Last quarter, I spoke about my satisfaction with the performance of the management team on executing and delivering the basics of the business, and that certainly continued into this quarter. And more importantly, I expect this focus and execution to continue prospectively. Overall, all of our seven core business are performing at or ahead of plan. And as you can see in our press release, we experienced sequential organic growth in all of our core businesses. Our Fee-for-Service business grew as well, with the exception of the FEHBA business which was stable.
Turning to Commercial Risk, which is our largest business at about $5.4 billion in revenue, in Q2, we posted organic growth in the Group Risk business for the first time since Q4 2007. Our total Commercial Risk business grew 21,000 members or 1.4% sequentially. As you may recall, we worked in 2009 to get the right managers in the right position. One important example was the appointment of a long-term employee, Mike Bahr, as the single leader and Executive Vice President of our Commercial Health business. 
In addition, we made the necessary internal process improvements and have much better integration and coordination between actuarial, underwriting and sales as we entered into 2010. And as you would expect, we've continued our relentless focus on a low-cost structure to provide our customers with the best possible value proposition. Overall, on all metrics, our Commercial Risk business produced an outstanding result for the quarter.
The story is similar in Medicaid and Medicare, important businesses, and is a part of our diversified portfolio as we look to the future. Some comments on Medicaid. Our Medicaid leadership put in place less than a year ago has implemented a more thoughtful and effective cost structure and care management mindset, which is absolutely critical in the current rate and state budget environment, and certainly necessary to provide our state customers the cost and care management capabilities to produce the results they are seeking.
Our medical loss ratio has certainly outperformed in the past two quarters. As we look ahead, we're certainly a little more cautious here as the states are resting with budgetary pressure, but that does not diminish how pleased I am with our internal accomplishments.
Despite the state-by-state challenges that are well known today, there is certainly a significantly longer-term penetration opportunity, particularly for serving those segments of the population that are most in need of care management services. We believe that opportunity to exist for Coventry to provide states superior value proposition, and we will continue to seek new opportunities in the Medicaid space. 
Along those lines, while we're better managing our existing business, we've also been working on implementing our recent new market wins. We went live in Southeastern Pennsylvania during Q2, and at this point, we already have 5,000 members. Nebraska will go live August 1, and appears that we have enrolled, at a minimum, between 35,000 and 40,000 new members. 
Now turning the comments to the Medicare. Our Medicare Advantage Coordinated Care business and our Medicare Part D business both do sequentially and performed very well in the quarter. I recall that we have HMO and PPO network-based products serving 192,000 members across 18 markets, that which are aligned with our locally-based health plans.
Our company's been in this business for well over a decade, and we strongly believe that it's the best way to care for seniors, and we're dedicated to serving this population prospectively. As outlined in previous calls, our initiatives to improve the cost structure, care management and value equation for the Federal government and for seniors are on track and should serve us well as we recognize the tightening revenue reimbursement levels. 
Immediately after we closed our Preferred Health System transaction in Kansas, we began developing a new Medicare Advantage product which will be limited to the Preferred Health System. The design included increased incentives for preferred employed primary care physicians, so they can spend more time in resources with these Medicare patients, along with us providing more information and other resources to help better care for the members. While the approval is currently pending with CMS, we believe that a smaller, tighter network with significantly more resources devoted to care and management of the senior population is the direction that we will work toward with high-quality healthcare systems in the future.
Turning to Part D. We are number four in the national market position with a little more than 1.6 million members. Part D has performed well in each year since inception in 2006, and 2010 year-to-date performance is no exception. Both Medicare Advantage and Part D are on track to produce our targeted margins for 2010.
Our Fee business, to which is three core businesses, our Workers Compensation Service, Rental Network and FEHBA continued to produce very good results. As you can see, we ticked up the full year management services or fee-based revenue guidance to a midpoint of $1.6 billion on the strength of the quarter. And while our Fee business represent only about 10% of our company-wide revenue, the margins, as you might suspect, are much more attractive relative to the company's core Risk businesses. 
We believe these businesses are well-positioned. And it's important to remember, they are non-insurance, non-risk unregulated sources of revenue, earnings and cash flow. We're able to use our core network management, cost management and operational skills to provide our customers with an excellent value proposition in these businesses. These businesses are and will be an important part of a diversified portfolio.
Turning your attention to 2010 and forward. Given the results for the first two quarters and the momentum we have on profitable growth, medical cost management and SG&A management, we're pleased to provide increased EPS guidance of $2.90 to $3.05 excluding the litigation charge. And as you can see in the table in our press release, this includes $0.35 of EPS contribution from the run out of our Private Fee-for-Service business which we exited at the end of 2009. Our CFO, John Stelben, will walk you through the guidance elements in more details, but once again, the improving performance stands all seven businesses.
This has not only been a year about improving the operations, as evidenced by the first half of 2010 results, it's been a year about investing for the future. In February 2010, we closed a transaction with Via Christi, an innovative Kansas-based health system, where we not only acquired 120,000 member health plan PHS, but also entered into a long-term contractual partnership. 
Since we closed the transaction, we've had ongoing dialogue in collaboration of new products and method to align incentives around outcomes and care management, such as the previously mentioned Medicare product in Wichita. We think this collaboration will be the norm, not the exception, as we look ahead and form product, contractual and financial alliances with the healthcare systems. 
At the end of the second quarter, we announced the transaction with the Sisters of Mercy, a sophisticated health system spanning multiple Midwestern states with more than 20 acute care hospitals, over 1,000 employed physicians and 35,000 employees in total. 
We entered into a definite agreement to acquire their 180,000-member health plan, Mercy Health Plans, at an equal importance to expand our relationship. I have met with their Chairman and with their CEO, and it's obvious that we share a common view on the need for closer alignments of health plans and providers as we both approach tomorrow's arena of healthcare reform.  We're going through the typical regulatory approval process and expect the transaction to close in Q4. 
Mercy Health Plan is diversified across markets and products, and has approximately 90,000 commercial risk members, 60,000 ASO members, which is largely the system employees, and over 30,000 Medicare Advantage network-based members in Springfield, St. Louis and Northwest Arkansas. As we indicated in our June 30 press release, this transaction builds on our core business and competencies, and we look forward to the expanding the relationship with the Sisters of Mercy Health System. 
In addition to use of our capital in the M&A area to improve our business and positioning for the future, we are in discussions across many of our markets with key providers regarding accountable care organizations, medical homes and other models that better in-line incentives. This is where our Health Plan business and nimbleness should serve us very well in the future.
We're in the process of redesigning products and making IT investments as well, as we look to the future. We continue to recruit talented executives that will lead us to the winding road ahead and seizing opportunities presented in the health care reform arena. Our businesses are very sound and well-positioned. We spend every day trying to improve our cost structure, to provide the best value proposition for our members and customers. 
You see some of these results in the past two quarters, and we believe there's more to come in the next couple of years. Looking ahead to 2014, in a state-based exchange model, our low cost structures should serve us well as it has over the past decade. Clearly, many of the regulations are yet to be written. And as Drew Asher, who leads our M&A and Investor Relations area of the company's fond of saying, ""Allen, there's a lot of wood left to chop between now and 2014."" 
Even so, I'd like the portfolio of well-positioned businesses that we have, and I really like the nimbleness of our management team and in their structure to seize opportunities which will be presented. In fact, this is not an easy business and actually, I don't know if there's such a thing. But managing the details and operational blocking and tackling while positioning the business for the future really been the strength of this company for most of the past 12 years. Believe we have the tools to succeed in the future including personnel, capital, cost structure and a diversified stead of well-positioned businesses with an energized and thoughtful culture, with the ability to adapt and execute.
Certainly, we take nothing for granted and they come to work everyday with the thought of improving our business, and the company will continue to operate in that way. 
That concludes my comments, and our CFO, John Stelben, will now walk you through the financial details for the quarter. John?"
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Thanks, Allen, good morning. Our GAAP EPS for the second quarter is $0.01 which includes the previously disclosed non-recurring charge of $1.18 that we announced on July 2. Excluding the charge EPS of $1.19, it's a very strong result and better than our p",2242,"Thanks, Allen, good morning. Our GAAP EPS for the second quarter is $0.01 which includes the previously disclosed non-recurring charge of $1.18 that we announced on July 2. Excluding the charge EPS of $1.19, it's a very strong result and better than our plan for the quarter. In addition, as you have seen in the earnings release, we are increasing our full year guidance, excluding the charge, to a range of $2.90 to $3.05 from the previous guidance range communicated July 2 of $2.75 to $2.90. 
With that I'll provide some highlights on the quarter and some details on guidance for the full year. First, our Medicare Advantage Private Fee product line, which we exited January 1, produced $0.18 in the quarter and $0.35 for the year due primarily to prior period reserve development. While we set reserves with an expectation of favorable development, we did not and still do not incorporate any prospective Private Free run out earnings in guidance. So the Q2 $0.18 is upside to the quarter and full year expectations compared to the guidance provided on the Q1 call.
We experienced strong performance across all our core businesses. Equally important, the performance was pretty uniform across all our health plans. Whether it was membership, revenue, clinical results or SG&A, we were able to see improvement in all of these areas, which certainly bodes well for our ability to compete in the future. While I would like to chalk all of this up to better focus and execution, there are some industry tailwinds such as lower utilization and a muted flu season similar to that discussed by our peers that have also contributed to performance.
The Commercial Risk business had an excellent quarter on all fronts. Commercial Risk membership grew sequentially by 21,000 or 1.4% from Q1. Small group sales are more than 20% ahead of Q2 2009 year-to-date results. This is really a result of focused sales execution and competitive products. Group premium yields are in-line with expectations and are up 4.7% over the prior year quarter. 
The Commercial Group medical loss ratio of 78.3% is also better than expected. Again, while there are the aforementioned tailwinds, this is not the whole story, as it still takes disciplined execution on product design, sales, patient management and so on to produce this strong result. The year-to-date MLR now stands at 79.3%. COBRA results seem to plateau and were flat to prior quarter at about 1.8% of total Commercial Group membership. 
We are updating our view of fundamental trend to a range of 8.0% to 8.5% versus our previous yield of 8.5% to 9%. The change is primarily due to reduced utilization in outpatient and physician services.
Medicare CCP results in Q2 were also better-than-expected. Recall that we exited certain products and markets which produced a 13,000 member drag coming into the year. We have had an excellent sales result thus far, and made up that drag plus an extra 6,000 members. In establishing our initial incurred estimates in Q1 2010, we made adjustments for the 2010 benefit changes, but took a prudent approach in reflecting the demographic changes for our guess of the mixed impact of these market and product exits on Q1 incurred estimates.
As Q1 IBNR completed during Q2, we saw higher level of restatement. This is a really long-winded way of saying that the year-to-date loss ratio of 83.5% is more indicative of the true performance of this business, along with some of the real improvements we're seeing in managing our patients better. We are still forecasting full year MLR results in the mid-80s, which will enable us to withstand some back half of the year seasonality. Medicare Part D results continue to run in-line with expectations, and remain on track with full year guidance of 1.6 million members in the mid-80s loss ratio. 
As Allen said, Medicaid produced another very good quarter with a loss ratio of 84.2% and a year-to-date results of 84.1%. The story here is pretty simple. Revenue PMPMs are in line with our expectations, so this is all a medical cost management story. We have been in this business a long time, but our patient care model has never been better. This is particularly important as we open our new Nebraska and Pennsylvania markets and bring our toolbox, so to speak, to bear in those markets.  While there will be volume opportunity in this business post reform, you have to assume revenues will always be tight, so carefully managing costs will be a key to success.
Turning to the balance sheet and cash flows, total cash and investments stand at $3.8 billion. Our investment portfolio is in a net unrealized gain position of $89 million at June 30, up from $66 million at March 31, and this is really primarily due to changes in treasury rates. 
GAAP cash flow from operations for the quarter was $121 million. This results include the $21 million outflow for the run out of the Private Fee product line. Adjusting for the Private Fee run out, adjusted cash flow would have been $142 million or 94% of net income excluding the one-time charge.  Remember that in Q2, we made two Federal tax payments. 
Year-to-date core cash flow from operations is 114% of net income, but more importantly, free deployable cash at parent was $670 million versus $450 million at March 31. The main driver of the increase being receipts of dividends from our regulated subsidiaries.
Days in Claims Payable displayed in the press release exclude Private Fee for all periods presented. The increase in DCP of 1.3 days over prior quarter is due primarily to an increase in claims inventories related to the conversion of our Florida Commercial business to our IDX platform at the beginning of June. Debt-to-cap ratio now stands at 29.4%, down slightly from prior quarter, and we did not repay any debt in the quarter. 
Turning to 2010 guidance, we are forecasting GAAP EPS in the range of $1.72 to $1.87, including the class-action charge of $1.18. Excluding the charge, guidance is in the range of $2.90 to $3.05, including $0.35 of year-to-date earnings generated by Private Fee, but again, does not assume any further Private Fee earnings for the remainder of the year. Our core view of EPS then is in the range of $2.55 to $2.70. Basically, we're adding our view of Q2 outperformance to the prior full year guidance while adjusting for some revised use of the business in the back half of the year.
We provided a table in the press release to roll forward our guidance changes. I'll try to walk you through the table. When we announced the one-time charge in July 2, we increased our guidance, excluding the charge, to $2.75 to $2.90 from the previous guidance of $2.35 to $2.50. As outlined in the press release, we're increasing guidance again based on June results an additional $0.15.
Given that we do not provide the details to help you understand the July 2 guidance increase, we'll provide details of the current guidance versus the Q1 earnings call guidance, and hopefully, this will be a little simpler to track. I will walk through the guidance excluding the class-action charge using the midpoint of the range for both prior and revised guidance. The midpoint of guidance given on the Q1 earnings call was $2.43, which included $0.17 of Private Fee earnings, so core earnings guidance would have been $2.26. The current guidance of $2.98, less the year-to-date Private Fee of $0.35, leaves $2.63 for the core or an increase of $0.37 versus the April guidance. You can think of the increase in three main buckets: Commercial Risk worth about $0.27, Medicaid worth about $0.02 and SG&A worth about $0.08. So let me provide a little more detail on those. 
Starting with the Commercial Risk business, given our better than expected results to date and sales momentum, we now expect same-store membership to be about flat to prior year. When we include the addition of approximately 100,000 Preferred Health Commercial Risk members, total growth would be nearly 7%. Forecasted Commercial Group Risk MLRs are now expected to be 81% plus or minus 25 basis points, down from our Q1 view of 82% to 82.5%. This is 125 basis point reduction from the previous guidance midpoint driven by Q2 results, our more completed view of Q1 in late 2009, as well as our revised yield fundamental trend of 8% to 8.5%. Our current guidance would assume higher loss ratios in the back half of the year as compared to year-to-date Q2. We are not assuming some of the previously mentioned tailwinds continue. And remember that in the back half of the year, loss ratios are pushed higher due to the satisfaction of deductibles in the first half of the year and other seasonal factors. Again, this is $0.27 of the increased guidance.
For Medicare CCP, our view of guidance has unchanged. Continue to expect the 2010 Medicare Advantage loss ratio to be in the mid-80s. Medical cost trend will continue to march forward as the year progresses while revenue yields should remain relatively flat. So while the first half result was a little better than we had expected, we're still expecting a slightly higher MLR result in the back half of the year, with the full year in the mid-80s.
Part D continues to perform in-line with our expectations so far in 2010, and as a result, our annual view of this has unchanged from prior guidance, with membership in the 1.6 million range and a loss ratio in the mid-80s.
For Medicaid, our view of results for the back half of the year remained unchanged. Recall, the headwind we talked about previously in the second half of the year related to the less than expected rate increase in Missouri which is worth about two points or almost half of the business. While the Medicaid team continues to do an outstanding job in managing clinical care, we'll take a prudent posture in forecasting the business for the second half and just let the Q2 outperformance roll through guidance. Again, that impact is worth about $0.02.
Our guidance does include the addition of the Southeast Pennsylvania and Nebraska markets. We've been live in Southeast PA since April and have a little over 5,000 members. We go live in Nebraska August 1, with an expectation of 35,000 to 40,000 members by the year. We expect a neutral impact to overall earnings in 2010 for these new Medicaid markets.
On SG&A, the midpoint of the 2010 guidance range is $1.94 billion, a reduction of $20 million from the previous guidance due to better performance on reducing costs. We do expect expenses in the back half of the year to increase for normal activities such as open enrollment and also for expenses related to reform preparedness. 
Even with that, this is an excellent result which is particularly critical to succeed in the health care reform environment, and demonstrates Coventry's ability to manage costs while growing the core businesses. We've increased the midpoint of total revenue guidance $260 million this year while guiding to lower SG&A. Full year SG&A guidance now sits at 17% of revenues, down 25 basis points from the prior guidance. This results in about $0.08 of improvement.
While we have not repurchased any shares year-to-date, our guidance at the high end of EPS would assume a modest amount of share repurchase. We are putting capital to use in the Preferred Health acquisition and the announced Mercy Health Plans transaction and have to take into account the uncertain resolution of the one-time charge. 
So to recap the $0.37 change, $0.27 in Commercial Risk, $0.02 in Medicaid, $0.08 in SG&A, Medicare CCP Part D fee-based and all other items essentially net to zero.
As stated earlier, we have $670 million of deployable cash on hand. In addition, we expect to dividend out the capital supporting the Private Fee product, which, given year-to-date Q2 results would be approximately $275 million. We will seek to partially dividend this up in late '10 with the remainder in the first half of 2011. 
We still have our sights on a total of approximately $1 billion of capital, free deployable cash by mid-2011, of which less than 1/3 would be used to pay for Mercy Health Plans, and again, the uncertain resolution of the one-time litigation charge.  Our priorities for deployable cash continued to be growing the business through acquisition, followed by opportunistic share repurchase and delevering.
Really, to conclude, core earnings were strong in Q2 and a continuation of what we experienced in Q1. While there are clearly some tailwinds, we can see evidence of better management of the details across all our businesses. I am particularly encouraged by the continued strength of our small group sales engine, clinical management efforts and the results we're seeing in controlling administrative costs.
The future will have both challenges and opportunities, which are still being defined, and our comments will be limited in that regard. We believe the future success of Coventry though, will always be determined by low cost and execution on the details as it has been in the past. Fundamentals do matter, and the take away for 2010 so far is that Coventry is executing better on improving its businesses, which ultimately provides a better competitive foundation for the future.
We'll open the call to questions."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","[Operator Instructions] We'll go first to Doug Simpson with Morgan Stanley.",11,"[Operator Instructions] We'll go first to Doug Simpson with Morgan Stanley."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","We're obviously, still waiting clarity around MLR regulations and there's uncertainties that how reform implementation are going to play out in 2011. And just stepping back, all that being said, you guys are deploying capital on M&A with both Mercy and PH",92,"We're obviously, still waiting clarity around MLR regulations and there's uncertainties that how reform implementation are going to play out in 2011. And just stepping back, all that being said, you guys are deploying capital on M&A with both Mercy and PHS. You obviously, have a few of the value of those businesses and your own business going forward. So can you just walk us through, how do you get the confidence to make these types of investments, and how are you thinking about that looking out one to three years?"
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, I think, if you would take the last one, take the Mercy Health Plan acquisition, it does a number of things for us. Number one, we have a long-term contractual relationship, which improves our cost structure both for our existing business today, our",424,"Well, I think, if you would take the last one, take the Mercy Health Plan acquisition, it does a number of things for us. Number one, we have a long-term contractual relationship, which improves our cost structure both for our existing business today, our Commercial business, our Medicaid business and our Medicare Advantage business. Number two, we don't think there's enough money to deliver care like we have in the past. The BJC [BJC HealthCare] system in St. Louis has a cost structure that's significantly more than other high-quality systems. And we think that our product offering in the past will be both broad, but also a narrower system with high-quality care. They have a presence in South Central part of Missouri, which Coventry has not typically had. It helps our Network Rental business in terms of our cost structure. They have a presence in Arkansas, which not unlikely that some of the aircraft of our customers from the aircraft industry in Kansas will be moving some operations in that direction. And we actually, not unlike the Kansas acquisition, think that we have to have more strategic long-term relationships, so we joined together with our skill set and their skill set in caring for patients, do a much better job managing the patients, caring for the patients and improving the quality of care. And that we have to stop arguing over nickel, so to speak, on a purely unit-cost basis. So the Mercy system, which is just the last one on my mind, have begun, since the 90s, had a mission before that, but certainly, from the 90s, we've been looking for a partnership with Health Plan to execute on their mission to care for patients better. And so whether its cost structure, whether its planned design for the future, whether it's care management for the patients, whether it's a more competitive offering in terms of product and cost structure -- even with Mercy, we're third in town. The Blues are first, United the second or whichever. So it helps us on all fronts. It helps earnings, it helps us in offer what we think is going to be tomorrow's product, which goes back to what I've been saying for the last two years. First week back as a CEO, we're going to take better care of our members. And better care means that members are going to be better off and it means it's going to be more cost-effective. So it fulfilled a lot of the holes that we needed in that area."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then maybe, could you just discuss what you're seeing and what you're learning from differentials, if any, in the utilization trends across the commercial and the government sectors. I mean, we're hearing, obviously, and you touched on it earlier, we'",122,"And then maybe, could you just discuss what you're seeing and what you're learning from differentials, if any, in the utilization trends across the commercial and the government sectors. I mean, we're hearing, obviously, and you touched on it earlier, we're hearing a lot about soft utilization in the quarter and then how to debate about what that means currently and potentially for the second half of the year. Just given your experience and background in the industry, what do you take away from what you're seeing recently? Is there anything to be discerned from differentials between the government side and the commercial side in terms of what's really driving it and what we're likely to see over the next six months?"
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","The answer to that is we don't know. I have made -- we've spent a lot of time thinking about it, talk to provider systems, and certainly, the theory is that the deductibles and co-pays have become so onerous that the discretionary medical care is evident",89,"The answer to that is we don't know. I have made -- we've spent a lot of time thinking about it, talk to provider systems, and certainly, the theory is that the deductibles and co-pays have become so onerous that the discretionary medical care is evident more than it has been in the past. In some of the markets, the layoffs start a couple of years ago. The COBRA benefits have expired, and that may have a role. But I think the real answer is we don't know."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","As you're thinking in a post-reform environment, is that going to impact the way you guys think about the statutory capital levels of the subs? Is there going to be a specific change in the way you guys think about what an appropriate RBC level is? And if",96,"As you're thinking in a post-reform environment, is that going to impact the way you guys think about the statutory capital levels of the subs? Is there going to be a specific change in the way you guys think about what an appropriate RBC level is? And if you had to get inside ahead some of your smaller competitors, how do you think they're going to think about their capital levels going forward? Obviously, with MLR floors, it becomes a little hard to catch up if you have a bad year. What's your expectation there?"
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","John will answer the capital question, but the thought process about the products moving forward is that it goes back to earlier comments. The people in whatever form, insured or ASO or smaller cases that may be ASO, with reinsurance or ultimately, in tom",227,"John will answer the capital question, but the thought process about the products moving forward is that it goes back to earlier comments. The people in whatever form, insured or ASO or smaller cases that may be ASO, with reinsurance or ultimately, in tomorrow's environment that we're thinking that number one is cost structure, and that's how we care for the patient. Number two, our own internal cost structure. We also recognize and I've spent a lot of time internally thinking that the fine-tuning and a better understanding what this cost structure is and getting the premium right to be closer to the sweet spot on the minimum loss ratios, or will the small and the larger case business are going to be much more necessary. So in terms of our data information, contracts from providers and our ability to fine tune what the only loss ratio's going to be. That's where we're spending our time. I don't see in terms of smaller competitors, I think, there's opportunities, but it's going to be a more difficult environment than it has been in the past and where sloppy execution, whether that's rating or whether that's product design or whether that's customer service, it really -- our feel is we don't do better that we're out. And I would say that about some of the smaller competitors as well."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes, Doug, this is John. What I would add there is that our RBC level in our health plans at year end was right around 400%. Our capital levels in the health plans certainly support our ratings. So that's an important consideration there. We are evaluatin",124,"Yes, Doug, this is John. What I would add there is that our RBC level in our health plans at year end was right around 400%. Our capital levels in the health plans certainly support our ratings. So that's an important consideration there. We are evaluating our capital strategy as we go forward, but I think it would be premature to get more detail than that. But I believe that we like to be well-capitalized, because at the end of the day, in those regulated subs, I mean, that money is there to pay the claims of our members. So I think we'll maintain a strong capital position going forward. But more will come out on that as we know more about next year."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll move now to Josh Raskin with Barclays Capital.",10,"We'll move now to Josh Raskin with Barclays Capital."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just a quick question on the Private-Fee-For-Service, and I understand there's an elongated sort of claims cycle there, but are we mostly done with the run out there?",29,"Just a quick question on the Private-Fee-For-Service, and I understand there's an elongated sort of claims cycle there, but are we mostly done with the run out there?"
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","What I would tell you, Josh is that we can say that the receipts certainly, at this point, starts tailing off. But you've got filing limits that go through the end of this year. And as we said a couple of times, I've never run out of $3 billion block of b",68,"What I would tell you, Josh is that we can say that the receipts certainly, at this point, starts tailing off. But you've got filing limits that go through the end of this year. And as we said a couple of times, I've never run out of $3 billion block of business, and so I think by the end of this year, it will certainly, be predominantly gone."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just in terms of maybe the cash flow drag, with whatever, $25 million or so in the third quarter. Should we assume it's going to be even lower than that, I guess, in the third quarter?",36,"Just in terms of maybe the cash flow drag, with whatever, $25 million or so in the third quarter. Should we assume it's going to be even lower than that, I guess, in the third quarter?"
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I would expect it to be lower.",7,"I would expect it to be lower."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Josh, when you say mostly done, you will be correct, with a couple hundred basis points. We don't know what mostly means. But yes, it is after six months, seven months it is ""mostly done.""",35,"Josh, when you say mostly done, you will be correct, with a couple hundred basis points. We don't know what mostly means. But yes, it is after six months, seven months it is ""mostly done."""
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just getting back to the change in medical trend that you guys are seeing, understanding the simple answer is we don't know. Is there a way to parse out what you think is industry factor versus Coventry improvement sort of your past 18 months have been a",62,"Just getting back to the change in medical trend that you guys are seeing, understanding the simple answer is we don't know. Is there a way to parse out what you think is industry factor versus Coventry improvement sort of your past 18 months have been a real focus on execution. Is there extent as to how much is internal versus external?"
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Now the answer is no. We obviously have given it a lot of thought. And we can measure things that we've done and changes we've made here and know that it produce a positive development. But we really can't. We really don't know.",43,"Now the answer is no. We obviously have given it a lot of thought. And we can measure things that we've done and changes we've made here and know that it produce a positive development. But we really can't. We really don't know."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","With all of this going on, better trends in the first half with the expectation of a reversion back in the second half plus some of the reform elements, how are you guys thinking about the sort of pricing environment for 2011 as you start renewing some of",71,"With all of this going on, better trends in the first half with the expectation of a reversion back in the second half plus some of the reform elements, how are you guys thinking about the sort of pricing environment for 2011 as you start renewing some of your risk book in the next couple of months? What's sort of your message to customers and how are you thinking about pricing?"
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Josh, I would say that we're, at this point, as you think about into next year, not much of the book would be priced, and it would mostly be large group. Based on the definitions that are at least out there now in reform, we're trying to understand what t",90,"Josh, I would say that we're, at this point, as you think about into next year, not much of the book would be priced, and it would mostly be large group. Based on the definitions that are at least out there now in reform, we're trying to understand what that means. There are a lot of moving pieces, and in the absence of knowing the definition, we'll continue to price what we think is appropriate. And I couldn't give you a whole lot more detail than that at this point."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, we do. Back to our prior comments, we do think that the pendulum has swung back to the 80s where we began with managed care, which is you started with managed care and you started with more limited networks and less choice, and in theory and in fact",174,"Well, we do. Back to our prior comments, we do think that the pendulum has swung back to the 80s where we began with managed care, which is you started with managed care and you started with more limited networks and less choice, and in theory and in fact, less cost. People have demanded choice and that quickly moved in the early 90s. Mid- 90s, moved to where you had a broad delivery system with high cost, people in your delivery system, as well as people that were lesser cost. So part of what we're doing here, with the acquisitions and part of what we're doing with our existing networks is we will be offering products with more limited network with high-quality delivery system, where we have been able to document that their outcomes and results and quality is good or is better than anyone in the marketplace, but with the lower cost structure and offer products where people have to live with, they have more limited delivery system for lesser cost. So that's..."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I guess, I mean, just sort of my question was more, and understanding that a lot of the books hasn't renewed at this point. But it's all, I guess, coming Monday. And so as you think about the next two or three months, you're going to start the renewals. Y",87,"I guess, I mean, just sort of my question was more, and understanding that a lot of the books hasn't renewed at this point. But it's all, I guess, coming Monday. And so as you think about the next two or three months, you're going to start the renewals. You're talking about a lower cost trend than expected. So should we think about flat sort of pricing? Or do you think there's still enough tailwind to cost that you'd expect it to be higher priced at '11?"
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","The best answer I can give you is we go through rate review process market by market, and sort of block size by block size, and as you can imagine, across all our markets. They're all a little different. And we will price to what we know, and we're not go",82,"The best answer I can give you is we go through rate review process market by market, and sort of block size by block size, and as you can imagine, across all our markets. They're all a little different. And we will price to what we know, and we're not going to guess. And our goal is to continue to improve our ability to manage the patients, so that we can count more in the future to have the products be competitive."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll move now to our Ana Gupte with Sanford Bernstein.",11,"We'll move now to our Ana Gupte with Sanford Bernstein."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just wanted to follow up on the deals that you're doing with mostly in Preferred Health. As you scour the landscape, can you give us a sense for in this entire Commercial Risk Book Group and possibly, Individual book? What percentage of the membership is",76,"Just wanted to follow up on the deals that you're doing with mostly in Preferred Health. As you scour the landscape, can you give us a sense for in this entire Commercial Risk Book Group and possibly, Individual book? What percentage of the membership is up for take-out to deals like this? Is there some sort of threshold that you see on the size of the deal and the type of company, provider-owned or not?"
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I'll tell you this, Ana, that we survey the landscape. I couldn't tell you offhand and we can follow up, how many are provider-owned versus not provider-owned. I think when we look at the landscape, we prefer looking at the provider-owned plans because of",108,"I'll tell you this, Ana, that we survey the landscape. I couldn't tell you offhand and we can follow up, how many are provider-owned versus not provider-owned. I think when we look at the landscape, we prefer looking at the provider-owned plans because of what Allen said earlier. We want to partner with people that can help us manage the patient better going forward and as part of those types of acquisitions, you get cost structure, which is very important to us, predictable cost structure for a period of time. Plans that do not come with cost structure are of obviously, a lot less interest to us."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think you could take some general comments, which we need to get the Mercy closed. We would probably not be interested in a small block somewhere, unless let's say, small was under 50,000. We probably would not be interested in going into a new area of",204,"I think you could take some general comments, which we need to get the Mercy closed. We would probably not be interested in a small block somewhere, unless let's say, small was under 50,000. We probably would not be interested in going into a new area of the country that didn't help us with the existing geography that we have. And as you might suggest, when we go to our board and ask for approval, what value it creates for the future and what the accretion's going to be is a subject. And so we have to, I think, prove to our directors and to me that the last two of these, assuming we get Mercy closed that they have done what we thought they would do. And it's kind of a long-winded way of saying on the commercial health plan, in fact, we're going to kind of digest what we've got and we will be looking for M&A opportunities in other areas, maybe some non-regulated businesses, certainly, for Medicaid opportunity if it represented itself. And so we liked these two a lot, but I wouldn't reach any conclusion from that. That's the only place that we're going to look to deploy our capital."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just to follow up again, on that, so it sounds like -- I was projecting out in saying what would be the three to five of these deals like Mercy every year, you could technically have 1 million to 1.5 million more of Commercial Risk members. But that's not",130,"Just to follow up again, on that, so it sounds like -- I was projecting out in saying what would be the three to five of these deals like Mercy every year, you could technically have 1 million to 1.5 million more of Commercial Risk members. But that's not how you're sounding like you're viewing it through your plan. Are you seeing other competitors coming in either public or private equity to some of the strategies like you? And then on the cost structures, is it mainly SG&A that you can take out? Or are the MLR synergies from this contracting viable even given large group loss ratio floors of 85% and small group, and I'm not sure how many of these are small group or in the 80% range."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","A lot of questions in that sentence. No we don't see any of private equity people buying the plans. It's too many IT issues, too many issues that would make that, I think, not productive. And to say that you could find three to five that were as well-suit",167,"A lot of questions in that sentence. No we don't see any of private equity people buying the plans. It's too many IT issues, too many issues that would make that, I think, not productive. And to say that you could find three to five that were as well-suited, they have to be well-suited by geography and the culture of the organization and the thoughtfulness of management. And I think we got pretty lucky to find two that are really in our sweet spot. If opportunistically, if our luck continues, we'd certainly look. But I would be very surprised if you would ever talk on a consistent basis doing three to five of this a year, and we'd make a little progress on the SG&A, a little progress on cost structure, a little progress on patient management. And it adds up to where we need to be, which is sort of as good or better than anyone else in those markets and the businesses that we're in."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll go now to Matthew Borsch with Goldman Sachs.",10,"We'll go now to Matthew Borsch with Goldman Sachs."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","A question on your outlook on the Medicaid MCR relative to the Missouri rate increases, am I correct that you're looking at 400 basis points higher MCR in the back half of the year than the first half? With that factor, it just seems like a big jump that",52,"A question on your outlook on the Medicaid MCR relative to the Missouri rate increases, am I correct that you're looking at 400 basis points higher MCR in the back half of the year than the first half? With that factor, it just seems like a big jump that your guidance implies."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Our rate increase, I believe, was 80 basis points. And the question then becomes in that marketplace, can we hold medical trend to 80 basis points. There's been a lot of work there and a lot of activities that I think that would mitigate a rate increase t",197,"Our rate increase, I believe, was 80 basis points. And the question then becomes in that marketplace, can we hold medical trend to 80 basis points. There's been a lot of work there and a lot of activities that I think that would mitigate a rate increase that's not consistent with trend. And exactly, Matt, whether how much we were able to absorb trend by better operations is a little bit unclear. I believe Missouri has been a really good partner of ours for a very long time, maybe 14 years or longer in the state. They have, like a lot of states, '09 over '08 a double-digit reduction in revenue. Like I say, they've been a good partner. I think that probably we got enough rate, where we got a little bit sloppy in my view in managing our own costs and managing the patients, and I think we're doing better. Exactly how much better, we're not going to be certain about. And I think it's a little bit naive and arrogant to think that we could hold trend to zero. So we're going to better than we have in the past, but it's still challenging."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","And Matt, I would add that we have other plans and we do have the new plans coming on board, which would push that loss ratio a little higher. And we're taking a prudent outlook on the back half of the year.",42,"And Matt, I would add that we have other plans and we do have the new plans coming on board, which would push that loss ratio a little higher. And we're taking a prudent outlook on the back half of the year."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","One last question on a different topic, which is how are you thinking about the individual product at this stage, given that, that seems to be the area most potentially problematic for the minimum MLR rules? Is your continued participation there contingen",55,"One last question on a different topic, which is how are you thinking about the individual product at this stage, given that, that seems to be the area most potentially problematic for the minimum MLR rules? Is your continued participation there contingent on a phase in of those rules or can you comment on that?"
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Sometimes it doesn't pay to be too straightforward, but I can't help myself. The product that we have today is not a good value equation, as good as it needs to be for our member. The distribution cost is too high. Our internal underwriting and issue cost",160,"Sometimes it doesn't pay to be too straightforward, but I can't help myself. The product that we have today is not a good value equation, as good as it needs to be for our member. The distribution cost is too high. Our internal underwriting and issue cost and our claim adjudication cost. So early on, our IT area and our product development, they're really starting off with a clean piece of paper to have a better value equation, so that we issue it where we have the best cost structure, where we do something about the distribution cost than our internal SG&A. So we think that the product that we have today is not at all competitive for tomorrow, start off clean piece of paper. And Harv DeMovick is with us today, he runs operations and IT as well as Medicare here. He can comment about what percent the IT -- where are we, 60% down the road, Harv?"
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes, we need to continue to work closely with the product development people as they learn more. But yes, on an IT front, we've made a lot of progress in getting ourselves a better position, more direct sales to customers and technology that will allow us",55,"Yes, we need to continue to work closely with the product development people as they learn more. But yes, on an IT front, we've made a lot of progress in getting ourselves a better position, more direct sales to customers and technology that will allow us to manage the process much more cost effectively internally."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's even more challenging than that, and that the small group product may look a lot like the individual product. So we have to get this right. And we started a clean piece of paper a year ago, and we're making progress.",43,"It's even more challenging than that, and that the small group product may look a lot like the individual product. So we have to get this right. And we started a clean piece of paper a year ago, and we're making progress."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll go now to Justin Lake with UBS.",9,"We'll go now to Justin Lake with UBS."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just first, I wanted to get your thoughts on the impact of healthcare reform and the mandated benefits there that will start in the fourth quarter on cost trend, and how you're thinking about pricing for 2011. And any early indications from regulators on",53,"Just first, I wanted to get your thoughts on the impact of healthcare reform and the mandated benefits there that will start in the fourth quarter on cost trend, and how you're thinking about pricing for 2011. And any early indications from regulators on fourth-quarter rates coming that might have those rates embedded?"
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Justin, I heard the first part. I may have to ask you to repeat your last question. But on the mandated benefits, I would say that they're going into effect September 23. I really think for 2010, the impact is immaterial to us. We probably have missed som",153,"Justin, I heard the first part. I may have to ask you to repeat your last question. But on the mandated benefits, I would say that they're going into effect September 23. I really think for 2010, the impact is immaterial to us. We probably have missed some of our Q4 renewals on some of those. But again, Q4 is only about 15% of our annual renewals. And interestingly enough, some of our plans already had these benefit levels in some of their offerings. So I think for this year it's not material. I mean, going forward, you can think about it in a range. All of these is probably in the range of a couple of points or so. And what I would tell you is it is one of the factors that we put into our pricing model along with everything else we put into pricing. And what was your second?"
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I was just asking if the -- I would assume you're putting in for rate filings for the fourth quarter?",20,"I was just asking if the -- I would assume you're putting in for rate filings for the fourth quarter?"
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I just wondered if you've gotten any feedback or pushback from regulators there before the assumption [indiscernible].",18,"I just wondered if you've gotten any feedback or pushback from regulators there before the assumption [indiscernible]."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","We have continuing dialogues on our rate filings. We've actually had some one-on-ones with some of the actuarial folks. But I can tell you that we have not had any rate filings denied and it's been a pretty reasonable process from our standpoint.",43,"We have continuing dialogues on our rate filings. We've actually had some one-on-ones with some of the actuarial folks. But I can tell you that we have not had any rate filings denied and it's been a pretty reasonable process from our standpoint."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","In Pennsylvania, Highmark publicly announced that there's a shift in medical underwriting in small group. Given I believe, they were the only plan in the state that wasn't medically underwriting, I'm just wondering if you could talk about how this might c",50,"In Pennsylvania, Highmark publicly announced that there's a shift in medical underwriting in small group. Given I believe, they were the only plan in the state that wasn't medically underwriting, I'm just wondering if you could talk about how this might change the competitive dynamic in your Western Pennsylvania market?"
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","When there's some pushback from the insurance department at Commonwealth of PA on that front, I'm not sure. Highmark's been, let's see, this is my 14th year here as CEO or Non-Executive Chairman. Highmark's been tough all 14 years and they'll be tough t",47,"When there's some pushback from the insurance 
department at Commonwealth of PA on that front, I'm not sure. Highmark's been, let's see, this is my 14th year here as CEO or Non-Executive Chairman. Highmark's been tough all 14 years and they'll be tough the next 14."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I would add to that, that in our nice growth story we have in Commercial Risk this year, that Pennsylvania is our leader. So we're competing just fine there.",29,"I would add to that, that in our nice growth story we have in Commercial Risk this year, that Pennsylvania is our leader. So we're competing just fine there."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","We'll probably need to get back to you on that, because I know that Highmark expressed a desire to do that, and there was pushback from insurance front, so I don't know where it is. But either way, they're tough.",41,"We'll probably need to get back to you on that, because I know that Highmark expressed a desire to do that, and there was pushback from insurance front, so I don't know where it is. But either way, they're tough."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll go to Christine Arnold with Cowen and Company.",10,"We'll go to Christine Arnold with Cowen and Company."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I think the operating cash flow would've been about $20 million higher, had it not been for the run out for Private-Fee-For-Service. And I think, if we add that to medical payables, we still have payables rising at a lesser rate than premiums. How do you",62,"I think the operating cash flow would've been about $20 million higher, had it not been for the run out for Private-Fee-For-Service. And I think, if we add that to medical payables, we still have payables rising at a lesser rate than premiums. How do you think about that? Were there one-time issues, timing things, how do you think about that?"
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Christine, what I would say is that it's part of why we increased the guidance, and it's a view of lower trend and a view of COBRA isn't going to be as severe as we originally thought this year. So I'm not sure how else to answer that.",48,"Christine, what I would say is that it's part of why we increased the guidance, and it's a view of lower trend and a view of COBRA isn't going to be as severe as we originally thought this year. So I'm not sure how else to answer that."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So you're lowering your reserve levels relative to prior periods because costs are coming in lower and you anticipate they'll stay lower?",23,"So you're lowering your reserve levels relative to prior periods because costs are coming in lower and you anticipate they'll stay lower?"
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I would tell you that our reserve process is stable and our prior-period development is stable.",17,"I would tell you that our reserve process is stable and our prior-period development is stable."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So in terms of prior-period development, you're saying that the prior-period development that you're experiencing this year related to last year is consistent with the same period last year?",30,"So in terms of prior-period development, you're saying that the prior-period development that you're experiencing this year related to last year is consistent with the same period last year?"
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I would say it's a little higher than it was through the same period of last year, and it will be reflected in our Q.",26,"I would say it's a little higher than it was through the same period of last year, and it will be reflected in our Q."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","How do you think about the MLR floors? I know no one's getting really specific. But if you could just update us with your thinking, given where the NAIC is in the definitions, that would be great.",37,"How do you think about the MLR floors? I know no one's getting really specific. But if you could just update us with your thinking, given where the NAIC is in the definitions, that would be great."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","We sit in on all the calls we can. We're following this. We're tracking where the definitions go. And we're evaluating what that may do our business market by market, and how to react. But at this point, it's premature to talk about it.",44,"We sit in on all the calls we can. We're following this. We're tracking where the definitions go. And we're evaluating what that may do our business market by market, and how to react. But at this point, it's premature to talk about it."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","And that's all the time we have for questions. I'll turn the conference back over to our speakers for any additional or closing remarks.",25,"And that's all the time we have for questions. I'll turn the conference back over to our speakers for any additional or closing remarks."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","No closing remarks, and thank you very much for your interest in joining us today.",15,"No closing remarks, and thank you very much for your interest in joining us today."
27133,108966182,70882,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","That does conclude our conference. Thank you all for your participation.",11,"That does conclude our conference. Thank you all for your participation."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","Good morning, and welcome to the Coventry Health Care Second Quarter 2010 Earnings Conference Call. [Operator Instructions] Todayâ€™s call will begin with opening remarks by the Chief Executive Officer of Coventry Health Care, Mr. Allen Wise, after a brie",50,"Good morning, and welcome to the Coventry Health Care Second Quarter 2010 Earnings Conference Call. [Operator Instructions] Todayâ€™s call will begin with opening remarks by the Chief Executive Officer of Coventry Health Care, Mr. Allen Wise, after a brief forward-looking statement read by Mr. John Kunkle.  Please go ahead, John."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties, including those described in the company's filings with the SEC on Form 10-K for the year ended December 31, 2009 and Form 10-Q for the quart",80,"Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties, including those described in the company's filings with the SEC on Form 10-K for the year ended December 31, 2009 and Form 10-Q for the quarter ended March 31, 2010 as maybe further updated from time to time in our quarterly reports on Form 10-Q, may materially impact those statements and could cause actual future results to differ materially from those anticipated and discussed. 
Allen?"
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Good morning, and thank you for your interest in Coventry Health Care. As you saw in our press release, the company's core operations produced another very strong quarter. My comments today will center around what I will call the adjusted results, excludi",2173,"Good morning, and thank you for your interest in Coventry Health Care. As you saw in our press release, the company's core operations produced another very strong quarter. My comments today will center around what I will call the adjusted results, excluding the one-time litigation charge that we communicated to you on our July 2 press release. 
We're still working hard in pursuing all avenues of appeal for the Louisiana court decision, which we believe is not supported by either the law or the facts. And you should refer to our SEC disclosures for the background on this case. 
Importantly, the fundamentals of our business are very, very strong. We've had sharper focus over the past 18 months, and the fruits of our labor has certainly been evident during the past couple of quarters. These strong results are company-wide across our seven core businesses, and I'll cover that in a minute. 
I believe we can best explain the extraordinarily strong results for the last six months in three ways. First, and most important, is our focus on making our seven businesses better over the last 18 months. The last few quarters for our business are simply better in almost every way, sales, SG&A, unit cost, patient management and all the fundamental building blocks that make a good business. 
The second piece of the description is the positive reserve run out in our Private Fee-for-Service business. It's not everyday that we close down a $3 billion block of business, and when we did so, we wanted to make certain that our reserve was adequate. The result of making certain left us with a significant prior period positive development.
Third way to explain this is medical utilization, which appears to be favorable across most, if not all, of our markets. We've analyzed this carefully and have some theories, but to be honest, we simply do not know why this is occurring. Some of the decrease utilization can be to attributed to our focus on taking better care of our members, but certainly, not all of it. Unfortunately, I don't know what the last half of this year will bring on the subject. My comments will cover the quarter and our businesses, and then I will provide some perspective on the remainder of 2010 and positioning for the future as we prepare for Phase 1 of healthcare reform. 
In Q2, the adjusted earnings of our businesses, excluding the litigation charge, was $1.19 per diluted share and $1.01 per share when you exclude the Private Fee-for-Service contribution. This is an outstanding result, and as typical, it's a product of many factors including medical cost management, SG&A focus and profitable growth. 
Last quarter, I spoke about my satisfaction with the performance of the management team on executing and delivering the basics of the business, and that certainly continued into this quarter. And more importantly, I expect this focus and execution to continue prospectively. Overall, all of our seven core business are performing at or ahead of plan. And as you can see in our press release, we experienced sequential organic growth in all of our core businesses. Our Fee-for-Service business grew as well, with the exception of the FEHBA business which was stable.
Turning to Commercial Risk, which is our largest business at about $5.4 billion in revenue, in Q2, we posted organic growth in the Group Risk business for the first time since Q4 2007. Our total Commercial Risk business grew 21,000 members or 1.4% sequentially. As you may recall, we worked in 2009 to get the right managers in the right position. One important example was the appointment of a long-term employee, Mike Bahr, as the single leader and Executive Vice President of our Commercial Health business. 
In addition, we made the necessary internal process improvements and have much better integration and coordination between actuarial, underwriting and sales as we entered into 2010. And as you would expect, we've continued our relentless focus on a low-cost structure to provide our customers with the best possible value proposition. Overall, on all metrics, our Commercial Risk business produced an outstanding result for the quarter.
The story is similar in Medicaid and Medicare, important businesses, and is a part of our diversified portfolio as we look to the future. Some comments on Medicaid. Our Medicaid leadership put in place less than a year ago has implemented a more thoughtful and effective cost structure and care management mindset, which is absolutely critical in the current rate and state budget environment, and certainly necessary to provide our state customers the cost and care management capabilities to produce the results they are seeking.
Our medical loss ratio has certainly outperformed in the past two quarters. As we look ahead, we're certainly a little more cautious here as the states are resting with budgetary pressure, but that does not diminish how pleased I am with our internal accomplishments.
Despite the state-by-state challenges that are well known today, there is certainly a significantly longer-term penetration opportunity, particularly for serving those segments of the population that are most in need of care management services. We believe that opportunity to exist for Coventry to provide states superior value proposition, and we will continue to seek new opportunities in the Medicaid space. 
Along those lines, while we're better managing our existing business, we've also been working on implementing our recent new market wins. We went live in Southeastern Pennsylvania during Q2, and at this point, we already have 5,000 members. Nebraska will go live August 1, and appears that we have enrolled, at a minimum, between 35,000 and 40,000 new members. 
Now turning the comments to the Medicare. Our Medicare Advantage Coordinated Care business and our Medicare Part D business both do sequentially and performed very well in the quarter. I recall that we have HMO and PPO network-based products serving 192,000 members across 18 markets, that which are aligned with our locally-based health plans.
Our company's been in this business for well over a decade, and we strongly believe that it's the best way to care for seniors, and we're dedicated to serving this population prospectively. As outlined in previous calls, our initiatives to improve the cost structure, care management and value equation for the Federal government and for seniors are on track and should serve us well as we recognize the tightening revenue reimbursement levels. 
Immediately after we closed our Preferred Health System transaction in Kansas, we began developing a new Medicare Advantage product which will be limited to the Preferred Health System. The design included increased incentives for preferred employed primary care physicians, so they can spend more time in resources with these Medicare patients, along with us providing more information and other resources to help better care for the members. While the approval is currently pending with CMS, we believe that a smaller, tighter network with significantly more resources devoted to care and management of the senior population is the direction that we will work toward with high-quality healthcare systems in the future.
Turning to Part D. We are number four in the national market position with a little more than 1.6 million members. Part D has performed well in each year since inception in 2006, and 2010 year-to-date performance is no exception. Both Medicare Advantage and Part D are on track to produce our targeted margins for 2010.
Our Fee business, through which is three core businesses, our Workers Compensation Service, Rental Network and FEHBA continued to produce very good results. As you can see, we ticked up the full year management services or fee-based revenue guidance to a midpoint of $1.16 billion on the strength of the quarter. And while our Fee business represent only about 10% of our company-wide revenue, the margins, as you might suspect, are much more attractive relative to the company's core risk businesses. 
We believe these businesses are well-positioned. And it's important to remember, they are non-insurance, non-risk unregulated sources of revenue, earnings and cash flow. We're able to use our core network management, cost management and operational skills to provide our customers with an excellent value proposition in these businesses. These businesses are and will be an important part of a diversified portfolio.
Turning your attention to 2010 and forward. Given the results for the first two quarters and the momentum we have on profitable growth, medical cost management and SG&A management, we're pleased to provide increased EPS guidance of $2.90 to $3.05 excluding the litigation charge. And as you can see in the table in our press release, this includes $0.35 of EPS contribution from the run out of our Private Fee-for-Service business which we exited at the end of 2009. Our CFO, John Stelben, will walk you through the guidance elements in more details, but once again, the improving performance stands all seven businesses.
This has not only been a year about improving the operations, as evidenced by the first half of 2010 results, it's been a year about investing for the future. In February 2010, we closed a transaction with Via Christi, an innovative Kansas-based health system, where we not only acquired 120,000 member health plan PHS, but also entered into a long-term contractual partnership. 
Since we closed the transaction, we've had ongoing dialogue in collaboration on new products and method to align incentives around outcomes and care management, such as the previously mentioned Medicare product in Wichita. We think this collaboration will be the norm, not the exception, as we look ahead and form product, contractual and financial alliances with the healthcare systems. 
At the end of the second quarter, we announced the transaction with the Sisters of Mercy, a sophisticated health system spanning multiple Midwestern states with more than 20 acute care hospitals, over 1,000 employed physicians and 35,000 employees in total. 
We entered into a definite agreement to acquire their 180,000-member health plan, Mercy Health Plans, at an equal importance to expand our relationship. I've met with their Chairman and with their CEO, and it's obvious that we share a common view on the need for closer alignments of health plans and providers as we both approach tomorrow's arena of healthcare reform.  We're going through the typical regulatory approval process and expect the transaction to close in Q4. 
Mercy Health Plan is diversified across markets and products, and has approximately 90,000 commercial risk members, 60,000 ASO members, which is largely the system employees, and over 30,000 Medicare Advantage network-based members in Springfield, St. Louis and Northwest Arkansas. As we indicated in our June 30 press release, this transaction builds on our core business and competencies, and we look forward to the expanding the relationship with the Sisters of Mercy Health System. 
In addition to using our capital in the M&A area to improve our business and positioning for the future, we are in discussions across many of our markets with key providers regarding accountable care organizations, medical homes and other models that better in-line incentives. This is where our Health Plan business and nimbleness should serve us very well in the future.
We're in the process of redesigning products and making IT investments as well, as we look to the future. We continue to recruit talented executives that will lead us to the winding road ahead and seizing opportunities presented in the health care reform arena. Our businesses are very sound and well-positioned. We spend every day trying to improve our cost structure, to provide the best value proposition for our members and customers. 
You see some of these results in the past two quarters, and we believe there's more to come in the next couple of years. Looking ahead to 2014, in a state-based exchange model, our low cost structures should serve us well as it has over the past decade. Clearly, many of the regulations are yet to be written. And as Drew Asher, who leads our M&A and Investor Relations area of the company's fond of saying, ""Allen, there's a lot of wood left to chop between now and 2014."" 
Even so, I'd like the portfolio of well-positioned businesses that we have, and I really like the nimbleness of our management team and in their structure to seize opportunities which will be presented. In fact, this is not an easy business and actually, I don't know if there's such a thing. But managing the details and operational blocking and tackling while positioning the business for the future really been the strength of this company for most of the past 12 years. Believe we have the tools to succeed in the future including personnel, capital, cost structure and a diversified stead of well-positioned businesses with an energized and thoughtful culture, with the ability to adapt and execute.
Certainly, we take nothing for granted and they come to work everyday with the thought of improving our business, and the company will continue to operate in that way. 
That concludes my comments, and our CFO, John Stelben, will now walk you through the financial details for the quarter. John?"
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Thanks, Allen, good morning. Our GAAP EPS for the second quarter is $0.01 which includes the previously disclosed non-recurring charge of $1.18 that we announced on July 2. Excluding the charge, EPS was $1.19. It's a very strong result and better than our",2242,"Thanks, Allen, good morning. Our GAAP EPS for the second quarter is $0.01 which includes the previously disclosed non-recurring charge of $1.18 that we announced on July 2. Excluding the charge, EPS was $1.19. It's a very strong result and better than our plan for the quarter. In addition, as you have seen in the earnings release, we are increasing our full year guidance, excluding the charge, to a range of $2.90 to $3.05 from the previous guidance range communicated July 2 of $2.75 to $2.90. 
With that, I'll provide some highlights on the quarter and some details on guidance for the full year. First, our Medicare Advantage Private Fee product line, which we exited January 1, produced $0.18 in the quarter and $0.35 for the year due primarily to prior period reserve development. While we set reserves with an expectation of favorable development, we did not and still do not incorporate any prospective Private Free run out earnings in guidance. So the Q2 $0.18 is upside to the quarter and full year expectations compared to the guidance provided on the Q1 call.
We experienced strong performance across all our core businesses. Equally important, the performance was pretty uniform across all our health plans. Whether it was membership, revenue, clinical results or SG&A, we were able to see improvements in all of these areas, which certainly bodes well for our ability to compete in the future. While I would like to chalk all of this up to better focus and execution, there are some industry tailwinds such as lower utilization and a muted flu season similar to that discussed by our peers that have also contributed to performance.
The Commercial Risk business had an excellent quarter on all fronts. Commercial Risk membership grew sequentially by 21,000 or 1.4% from Q1. Small group sales are more than 20% ahead of Q2 2009 year-to-date results. This is really a result of focused sales execution and competitive products. Group premium yields are in-line with expectations and are up 4.7% over the prior year quarter. 
The Commercial Group medical loss ratio of 78.3% is also better than expected. Again, while there are the aforementioned tailwinds, this is not the whole story, as it still takes disciplined execution on product design, sales, patient management and so on to produce this strong result. The year-to-date MLR now stands at 79.3%. COBRA results seem to plateau and were flat to prior quarter at about 1.8% of total Commercial Group membership. 
We are updating our view of fundamental trend to a range of 8.0% to 8.5% versus our previous yield of 8.5% to 9%. The change is primarily due to reduced utilization in outpatient and physician services.
Medicare CCP results in Q2 were also better-than-expected. Recall that we exited certain products and markets which produced a 13,000 member drag coming into the year. We have had an excellent sales result thus far, and made up that drag plus an extra 6,000 members. In establishing our initial incurred estimates in Q1 2010, we made adjustments for the 2010 benefit changes, but took a prudent approach in reflecting the demographic changes for our guess of the mixed impact of these market and product exits on Q1 incurred estimates.
As Q1 IBNR completed during Q2, we saw higher level of restatement. This is a really long-winded way of saying that the year-to-date loss ratio of 83.5% is more indicative of the true performance of this business, along with some of the real improvements we're seeing in managing our patients better. We are still forecasting full year MLR results in the mid-80s, which will enable us to withstand some back half of the year seasonality. Medicare Part D results continue to run in-line with expectations, and remain on track with full year guidance of 1.6 million members in the mid-80s loss ratio. 
As Allen said, Medicaid produced another very good quarter with a loss ratio of 84.2% and a year-to-date results of 84.1%. The story here is pretty simple. Revenue PMPMs are in line with our expectations, so this is all a medical cost management story. We have been in this business a long time, but our patient care model has never been better. This is particularly important as we open our new Nebraska and Pennsylvania markets and bring our toolbox, so to speak, to bear in those markets.  While there will be volume opportunity in this business post reform, you have to assume revenues will always be tight, so carefully managing costs will be a key to success.
Turning to the balance sheet and cash flows, total cash and investments stand at $3.8 billion. Our investment portfolio is in a net unrealized gain position of $89 million at June 30, up from $66 million at March 31, and this is really primarily due to changes in treasury rates. 
GAAP cash flow from operations for the quarter was $121 million. This results include the $21 million outflow for the run out of the Private Fee product line. Adjusting for the Private Fee run out, adjusted cash flow would have been $142 million or 94% of net income excluding the one-time charge.  Remember that in Q2, we made two Federal tax payments. 
Year-to-date core cash flow from operations is 114% of net income, but more importantly, free deployable cash at parent was $670 million versus $450 million at March 31. The main driver of the increase being receipts of dividends from our regulated subsidiaries.
Days in Claims Payable displayed in the press release exclude Private Fee for all periods presented. The increase in DCP of 1.3 days over prior quarter is due primarily to an increase in claims inventories related to the conversion of our Florida Commercial business to our IDX platform at the beginning of June. Debt-to-cap ratio now stands at 29.4%, down slightly from prior quarter, and we did not repay any debt in the quarter. 
Turning to 2010 guidance, we are forecasting GAAP EPS in the range of $1.72 to $1.87, including the class-action charge of $1.18. Excluding the charge, guidance is in the range of $2.90 to $3.05, including $0.35 of year-to-date earnings generated by Private Fee, but again, does not assume any further Private Fee earnings for the remainder of the year. Our core view of EPS then is in the range of $2.55 to $2.70. Basically, we're adding our view of Q2 outperformance to the prior full year guidance while adjusting for some revised use of the business in the back half of the year.
We provided a table in the press release to roll forward our guidance changes. I'll try to walk you through the table. When we announced the one-time charge in July 2, we increased our guidance, excluding the charge, to $2.75 to $2.90 from the previous guidance of $2.35 to $2.50. As outlined in the press release, we're increasing guidance again based on June results an additional $0.15.
Given that we do not provide the details to help you understand the July 2 guidance increase, we'll provide details of the current guidance versus the Q1 earnings call guidance, and hopefully, this will be a little simpler to track. I will walk through the guidance excluding the class-action charge using the midpoint of the range for both prior and revised guidance. The midpoint of guidance given on the Q1 earnings call was $2.43, which included $0.17 of Private Fee earnings, so core earnings guidance would have been $2.26. The current guidance of $2.98, less the year-to-date Private Fee of $0.35, leaves $2.63 for the core or an increase of $0.37 versus the April guidance. You can think of the increase in three main buckets: Commercial Risk worth about $0.27, Medicaid worth about $0.02 and SG&A worth about $0.08. So let me provide a little more detail on those. 
Starting with the Commercial Risk business, given our better than expected results to date and sales momentum, we now expect same-store membership to be about flat to prior year. When we include the addition of approximately 100,000 Preferred Health Commercial Risk members, total growth would be nearly 7%. Forecasted Commercial Group Risk MLRs are now expected to be 81% plus or minus 25 basis points, down from our Q1 view of 82% to 82.5%. This is 125 basis point reduction from the previous guidance midpoint driven by Q2 results, our more completed view of Q1 in late 2009, as well as our revised yield fundamental trend of 8% to 8.5%. Our current guidance would assume higher loss ratios in the back half of the year as compared to year-to-date Q2. We are not assuming some of the previously mentioned tailwinds continue. And remember that in the back half of the year, loss ratios are pushed higher due to the satisfaction of deductibles in the first half of the year and other seasonal factors. Again, this is $0.27 of the increased guidance.
For Medicare CCP, our view of guidance has unchanged. Continue to expect the 2010 Medicare Advantage loss ratio to be in the mid-80s. Medical cost trend will continue to march forward as the year progresses while revenue yields should remain relatively flat. So while the first half result was a little better than we had expected, we're still expecting a slightly higher MLR result in the back half of the year, with the full year in the mid-80s.
Part D continues to perform in-line with our expectations so far in 2010, and as a result, our annual view of this has unchanged from prior guidance, with membership in the 1.6 million range and a loss ratio in the mid-80s.
For Medicaid, our view of results for the back half of the year remained unchanged. Recall, the headwind we talked about previously in the second half of the year related to the less than expected rate increase in Missouri which is worth about two points or almost half of the business. While the Medicaid team continues to do an outstanding job in managing clinical care, we'll take a prudent posture in forecasting the business for the second half and just let the Q2 outperformance roll through guidance. Again, that impact is worth about $0.02.
Our guidance does include the addition of the Southeast Pennsylvania and Nebraska markets. We've been live in Southeast PA since April and have a little over 5,000 members. We go live in Nebraska August 1, with an expectation of 35,000 to 40,000 members by the year. We expect a neutral impact to overall earnings in 2010 for these new Medicaid markets.
On SG&A, the midpoint of the 2010 guidance range is $1.94 billion, a reduction of $20 million from the previous guidance due to better performance on reducing costs. We do expect expenses in the back half of the year to increase for normal activities such as open enrollment and also for expenses related to reform preparedness. 
Even with that, this is an excellent result which is particularly critical to succeed in the health care reform environment, and demonstrates Coventry's ability to manage costs while growing the core businesses. We've increased the midpoint of total revenue guidance $260 million this year while guiding to lower SG&A. Full year SG&A guidance now sits at 17% of revenues, down 25 basis points from the prior guidance. This results in about $0.08 of improvement.
While we have not repurchased any shares year-to-date, our guidance at the high end of EPS would assume a modest amount of share repurchase. We are putting capital to use in the Preferred Health acquisition and the announced Mercy Health Plans transaction and have to take into account the uncertain resolution of the one-time charge. 
So to recap the $0.37 change, $0.27 in Commercial Risk, $0.02 in Medicaid, $0.08 in SG&A, Medicare CCP Part D fee-based and all other items essentially net to zero.
As stated earlier, we have $670 million of deployable cash on hand. In addition, we expect to dividend out the capital supporting the Private Fee product, which, given year-to-date Q2 results would be approximately $275 million. We will seek to partially dividend this up in late '10 with the remainder in the first half of 2011. 
We still have our sights on a total of approximately $1 billion of capital, free deployable cash by mid-2011, of which less than 1/3 would be used to pay for Mercy Health Plans, and again, the uncertain resolution of the one-time litigation charge.  Our priorities for deployable cash continued to be growing the business through acquisition, followed by opportunistic share repurchase and delevering.
Really, to conclude, core earnings were strong in Q2 and a continuation of what we experienced in Q1. While there are clearly some tailwinds, we can see evidence of better management of the details across all our businesses. I am particularly encouraged by the continued strength of our small group sales engine, clinical management efforts and the results we're seeing in controlling administrative costs.
The future will have both challenges and opportunities, which are still being defined, and our comments will be limited in that regard. We believe the future success of Coventry though, will always be determined by low cost and execution on the details as it has been in the past. Fundamentals do matter, and the take away for 2010 so far is that Coventry is executing better on improving its businesses, which ultimately provides a better competitive foundation for the future.
We'll open the call to questions."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","[Operator Instructions] We'll go first to Doug Simpson with Morgan Stanley.",11,"[Operator Instructions] We'll go first to Doug Simpson with Morgan Stanley."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","We're obviously, still waiting clarity around MLR regulations and there's uncertainties that how reform implementation are going to play out in 2011. And just stepping back, all that being said, you guys are deploying capital on M&A with both Mercy and PH",92,"We're obviously, still waiting clarity around MLR regulations and there's uncertainties that how reform implementation are going to play out in 2011. And just stepping back, all that being said, you guys are deploying capital on M&A with both Mercy and PHS. You obviously, have a few of the value of those businesses and your own business going forward. So can you just walk us through, how do you get the confidence to make these types of investments, and how are you thinking about that looking out one to three years?"
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, I think, if you would take the last one, take the Mercy Health Plan acquisition, it does a number of things for us. Number one, we have a long-term contractual relationship, which improves our cost structure both for our existing business today, our",424,"Well, I think, if you would take the last one, take the Mercy Health Plan acquisition, it does a number of things for us. Number one, we have a long-term contractual relationship, which improves our cost structure both for our existing business today, our Commercial business, our Medicaid business and our Medicare Advantage business. Number two, we don't think there's enough money to deliver care like we have in the past. The BJC [BJC HealthCare] system in St. Louis has a cost structure that's significantly more than other high-quality systems. And we think that our product offering in the past will be both broad, but also a narrower system with high-quality care. They have a presence in South Central part of Missouri, which Coventry has not typically had. It helps our Network Rental business in terms of our cost structure. They have a presence in Arkansas, which not unlikely that some of the aircraft of our customers from the aircraft industry in Kansas will be moving some operations in that direction. And we actually, not unlike the Kansas acquisition, think that we have to have more strategic long-term relationships, so we joined together with our skill set and their skill set in caring for patients, do a much better job managing the patients, caring for the patients and improving the quality of care. And that we have to stop arguing over nickel, so to speak, on a purely unit-cost basis. So the Mercy system, which is just the last one on my mind, have begun, since the 90s, had a mission before that, but certainly, from the 90s, we've been looking for a partnership with Health Plan to execute on their mission to care for patients better. And so whether its cost structure, whether its planned design for the future, whether it's care management for the patients, whether it's a more competitive offering in terms of product and cost structure -- even with Mercy, we're third in town. The Blues are first, United the second or whichever. So it helps us on all fronts. It helps earnings, it helps us in offer what we think is going to be tomorrow's product, which goes back to what I've been saying for the last two years. First week back as a CEO, we're going to take better care of our members. And better care means that members are going to be better off and it means it's going to be more cost-effective. So it fulfilled a lot of the holes that we needed in that area."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then maybe, could you just discuss what you're seeing and what you're learning from differentials, if any, in the utilization trends across the commercial and the government sectors. I mean, we're hearing, obviously, and you touched on it earlier, we'",122,"And then maybe, could you just discuss what you're seeing and what you're learning from differentials, if any, in the utilization trends across the commercial and the government sectors. I mean, we're hearing, obviously, and you touched on it earlier, we're hearing a lot about soft utilization in the quarter and then how to debate about what that means currently and potentially for the second half of the year. Just given your experience and background in the industry, what do you take away from what you're seeing recently? Is there anything to be discerned from differentials between the government side and the commercial side in terms of what's really driving it and what we're likely to see over the next six months?"
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","The answer to that is we don't know. I have made -- we've spent a lot of time thinking about it, talk to provider systems, and certainly, the theory is that the deductibles and co-pays have become so onerous that the discretionary medical care is evident",89,"The answer to that is we don't know. I have made -- we've spent a lot of time thinking about it, talk to provider systems, and certainly, the theory is that the deductibles and co-pays have become so onerous that the discretionary medical care is evident more than it has been in the past. In some of the markets, the layoffs start a couple of years ago. The COBRA benefits have expired, and that may have a role. But I think the real answer is we don't know."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","As you're thinking in a post-reform environment, is that going to impact the way you guys think about the statutory capital levels of the subs? Is there going to be a specific change in the way you guys think about what an appropriate RBC level is? And if",96,"As you're thinking in a post-reform environment, is that going to impact the way you guys think about the statutory capital levels of the subs? Is there going to be a specific change in the way you guys think about what an appropriate RBC level is? And if you had to get inside ahead some of your smaller competitors, how do you think they're going to think about their capital levels going forward? Obviously, with MLR floors, it becomes a little hard to catch up if you have a bad year. What's your expectation there?"
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","John will answer the capital question, but the thought process about the products moving forward is that it goes back to earlier comments. The people in whatever form, insured or ASO or smaller cases that may be ASO, with reinsurance or ultimately, in tom",226,"John will answer the capital question, but the thought process about the products moving forward is that it goes back to earlier comments. The people in whatever form, insured or ASO or smaller cases that may be ASO, with reinsurance or ultimately, in tomorrow's environment that we're thinking that number one is cost structure, and that's how we care for the patient. Number two, our own internal cost structure. We also recognize and I've spent a lot of time internally thinking that the fine-tuning and a better understanding what this cost structure is and getting the premium right to be closer to the sweet spot on the minimum loss ratios, for both the small and the larger case business are going to be much more necessary. So in terms of our data information, contracts from providers and our ability to fine-tune what the only loss ratio's going to be. That's where we're spending our time. I don't see in terms of smaller competitors, I think, there's opportunities, but it's going to be a more difficult environment than it has been in the past and where sloppy execution, whether that's rating or whether that's product design or whether that's customer service, it really -- our feel is we don't do better that we're out. And I would say that about some of the smaller competitors as well."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes, Doug, this is John. What I would add there is that our RBC level in our health plans at year end was right around 400%. Our capital levels in the health plans certainly support our ratings. So that's an important consideration there. We are evaluatin",124,"Yes, Doug, this is John. What I would add there is that our RBC level in our health plans at year end was right around 400%. Our capital levels in the health plans certainly support our ratings. So that's an important consideration there. We are evaluating our capital strategy as we go forward, but I think it would be premature to get more detail than that. But I believe that we like to be well-capitalized, because at the end of the day, in those regulated subs, I mean, that money is there to pay the claims of our members. So I think we'll maintain a strong capital position going forward. But more will come out on that as we know more about next year."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll move now to Josh Raskin with Barclays Capital.",10,"We'll move now to Josh Raskin with Barclays Capital."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just a quick question on the Private Fee-For-Service, and I understand there's an elongated sort of claims cycle there, but are we mostly done with the run out there?",30,"Just a quick question on the Private Fee-For-Service, and I understand there's an elongated sort of claims cycle there, but are we mostly done with the run out there?"
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","What I would tell you, Josh is that we can say that the receipts certainly, at this point, start tailing off. But you've got filing limits that go through the end of this year. And as we said a couple of times, I've never run out of $3 billion block of bu",67,"What I would tell you, Josh is that we can say that the receipts certainly, at this point, start tailing off. But you've got filing limits that go through the end of this year. And as we said a couple of times, I've never run out of $3 billion block of business, and so I think by the end of this year, it'll certainly, be predominantly gone."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just in terms of maybe the cash flow drag, with whatever, $25 million or so in the third quarter. Should we assume it's going to be even lower than that, I guess, in the third quarter?",36,"Just in terms of maybe the cash flow drag, with whatever, $25 million or so in the third quarter. Should we assume it's going to be even lower than that, I guess, in the third quarter?"
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I would expect it to be lower.",7,"I would expect it to be lower."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Josh, when you say mostly done, you would be correct, with a couple hundred basis points. We don't know what mostly means. But yes, it is after six months, seven months it is ""mostly done.""",35,"Josh, when you say mostly done, you would be correct, with a couple hundred basis points. We don't know what mostly means. But yes, it is after six months, seven months it is ""mostly done."""
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just getting back to the change in medical trend that you guys are seeing, understanding the simple answer is we don't know. Is there a way to parse out what you think is industry factor versus Coventry improvement sort of your past 18 months have been a",62,"Just getting back to the change in medical trend that you guys are seeing, understanding the simple answer is we don't know. Is there a way to parse out what you think is industry factor versus Coventry improvement sort of your past 18 months have been a real focus on execution. Is there a sense to how much is internal versus external?"
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Now the answer is no. We obviously have given it a lot of thought. And we can measure things that we've done, changes we've made here and know that it produce a positive development. But we really can't. We really don't know.",42,"Now the answer is no. We obviously have given it a lot of thought. And we can measure things that we've done, changes we've made here and know that it produce a positive development. But we really can't. We really don't know."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","With all of this going on, better trends in the first half with the expectation of a reversion back in the second half plus some of the reform elements, how are you guys thinking about the sort of pricing environment for 2011 as you start renewing some of",71,"With all of this going on, better trends in the first half with the expectation of a reversion back in the second half plus some of the reform elements, how are you guys thinking about the sort of pricing environment for 2011 as you start renewing some of your risk book in the next couple of months? What's sort of your message to customers and how are you thinking about pricing?"
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Josh, I would say that we're, at this point, as you think about into next year, not much of the book would be priced, so it would mostly be large group. Based on the definitions that are at least out there now in reform, we're trying to understand what th",90,"Josh, I would say that we're, at this point, as you think about into next year, not much of the book would be priced, so it would mostly be large group. Based on the definitions that are at least out there now in reform, we're trying to understand what that means. There are a lot of moving pieces, and in the absence of knowing the definition, we'll continue to price what we think is appropriate. And I couldn't give you a whole lot more detail than that at this point."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, we do. Back to our prior comments, we do think that the pendulum has swung back to the 80s where we began with managed care, which is you started with managed care and you started with more limited networks and less choice, and in theory and in fact",172,"Well, we do. Back to our prior comments, we do think that the pendulum has swung back to the 80s where we began with managed care, which is you started with managed care and you started with more limited networks and less choice, and in theory and in fact, less cost. People have demanded choice and that quickly moved in the early 90s. Mid-90s, moved to where you had a broad delivery system with high cost, people in your delivery system, as well as people that were lesser cost. So part of what we're doing here, with the acquisitions and part of what we're doing with our existing networks is we will be offering products with more limited network with high-quality delivery system, where we have been able to document that their outcomes and results and quality is good or is better than anyone in the marketplace, but with the lower cost structure and offer products where people have to live with a more limited delivery system for lesser cost. So that's..."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I guess, I mean, just sort of my question was more, and understanding that a lot of the books hasn't renewed at this point. But it's all, I guess, coming Monday. And so as you think about the next two or three months, you're going to start the renewals. Y",87,"I guess, I mean, just sort of my question was more, and understanding that a lot of the books hasn't renewed at this point. But it's all, I guess, coming Monday. And so as you think about the next two or three months, you're going to start the renewals. You're talking about a lower cost trend than expected. So should we think about flat sort of pricing? Or do you think there's still enough tailwind to cost that you'd expect it to be higher priced at '11?"
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","The best answer I can give you is we go through rate review process market by market, and sort of block size by block size. And as you can imagine, across all our markets, they're all a little different. And we will price to what we know, and we're not go",82,"The best answer I can give you is we go through rate review process market by market, and sort of block size by block size. And as you can imagine, across all our markets, they're all a little different. And we will price to what we know, and we're not going to guess. And our goal is to continue to improve our ability to manage the patients, so that we can count more in the future to have the products be competitive."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll move now to our Ana Gupte with Sanford Bernstein.",11,"We'll move now to our Ana Gupte with Sanford Bernstein."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just wanted to follow up on the deals that you're doing with mostly in Preferred Health. As you scour the landscape, can you give us a sense for in this entire Commercial Risk Book Group and possibly, Individual book? What percentage of the membership is",76,"Just wanted to follow up on the deals that you're doing with mostly in Preferred Health. As you scour the landscape, can you give us a sense for in this entire Commercial Risk Book Group and possibly, Individual book? What percentage of the membership is up for take-out to deals like this? Is there some sort of threshold that you see on the size of the deal and the type of company, provider-owned or not?"
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I'll tell you this, Ana, that we survey the landscape. I couldn't tell you offhand and we can follow up, how many are provider-owned versus not provider-owned. I think when we look at the landscape, we prefer looking at the provider-owned plans because of",108,"I'll tell you this, Ana, that we survey the landscape. I couldn't tell you offhand and we can follow up, how many are provider-owned versus not provider-owned. I think when we look at the landscape, we prefer looking at the provider-owned plans because of what Allen said earlier. We want to partner with people that can help us manage the patient better going forward and as part of those types of acquisitions, you get cost structure, which is very important to us, predictable cost structure for a period of time. Plans that do not come with cost structure are of obviously, a lot less interest to us."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think you could take some general comments, which we need to get the Mercy closed. We would probably not be interested in a small block somewhere, unless let's say, small was under 50,000. We probably would not be interested in going into a new area of",202,"I think you could take some general comments, which we need to get the Mercy closed. We would probably not be interested in a small block somewhere, unless let's say, small was under 50,000. We probably would not be interested in going into a new area of the country that didn't help us with the existing geography that we have. And as you might suggest, when we go to our board and ask for approval, what value it creates for the future and what the accretion's going to be is a subject. And so we have to, I think, prove to our directors and to me that the last two of these, assuming we get Mercy closed that they have done what we thought they would do. And it's kind of a long-winded way of saying on the commercial health plan, in fact, we're going to kind of digest what we've got and we will be looking for M&A opportunities in other areas, maybe some non-regulated businesses, certainly, if Medicaid opportunity represented itself. And so we liked these two a lot, but I wouldn't reach any conclusion from that. That's the only place that we're going to look to deploy our capital."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just to follow up again, on that, so it sounds like -- I was projecting out in saying, well if you three to five of these deals like Mercy every year, you could technically have 1 million to 1.5 million more of Commercial Risk members. But that's not how",129,"Just to follow up again, on that, so it sounds like -- I was projecting out in saying, well if you three to five of these deals like Mercy every year, you could technically have 1 million to 1.5 million more of Commercial Risk members. But that's not how you're sounding like you're viewing it through your plan. Are you seeing other competitors coming in,in either public or private equity to some of the strategies like you? And then on the cost structures, is it mainly SG&A that you can take out? Or are the MLR synergies from this contracting viable even given large group loss ratio floors of 85% and small group? And I'm not sure how many of these are small group or in the 80% range."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","A lot of questions in that sentence. No we don't see any of private equity people buying the plans. It's too many IT issues, too many issues that would make that, I think, not productive. And to say that you could find three to five that were as well-suit",167,"A lot of questions in that sentence. No we don't see any of private equity people buying the plans. It's too many IT issues, too many issues that would make that, I think, not productive. And to say that you could find three to five that were as well-suited, they have to be well-suited by geography and the culture of the organization and the thoughtfulness of management. And I think we got pretty lucky to find two that are really in our sweet spot. If opportunistically, if our luck continues, we'd certainly look. But I would be very surprised if you would ever talk on a consistent basis doing three to five of this a year, and we'd make a little progress on the SG&A, a little progress on cost structure, a little progress on patient management. And it adds up to where we need to be, which is sort of as good or better than anyone else in those markets and the businesses that we're in."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll go now to Matthew Borsch with Goldman Sachs.",10,"We'll go now to Matthew Borsch with Goldman Sachs."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","A question on your outlook on the Medicaid MCR relative to the Missouri rate increases, am I correct that you're looking at 400 basis points higher MCR in the back half of the year than the first half? With that factor, it just seems like a big jump that",52,"A question on your outlook on the Medicaid MCR relative to the Missouri rate increases, am I correct that you're looking at 400 basis points higher MCR in the back half of the year than the first half? With that factor, it just seems like a big jump that your guidance implies."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Our rate increase, I believe, was 80 basis points. And the question then becomes in that marketplace, can we hold medical trend to 80 basis points. There's been a lot of work there and a lot of activities that I think that would mitigate a rate increase t",197,"Our rate increase, I believe, was 80 basis points. And the question then becomes in that marketplace, can we hold medical trend to 80 basis points. There's been a lot of work there and a lot of activities that I think that would mitigate a rate increase that's not consistent with trend. And exactly, Matt, whether how much we were able to absorb trend by better operations is a little bit unclear. I believe Missouri has been a really good partner of ours for a very long time, maybe 14 years or longer in the state. They have, like a lot of states, '09 over '08 a double-digit reduction in revenue. Like I say, they've been a good partner. I think that probably we got enough rate, where we got a little bit sloppy in my view in managing our own costs and managing the patients, and I think we're doing better. Exactly how much better, we're not going to be certain about. And I think it's a little bit naive and arrogant to think that we could hold trend to zero. So we're going to better than we have in the past, but it's still challenging."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","And Matt, I would add that we have other plans and we do have the new plans coming on board, which would push that loss ratio a little higher. And we're taking a prudent outlook on the back half of the year.",42,"And Matt, I would add that we have other plans and we do have the new plans coming on board, which would push that loss ratio a little higher. And we're taking a prudent outlook on the back half of the year."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","One last question on a different topic, which is how are you thinking about the individual product at this stage, given that, that seems to be the area most potentially problematic for the minimum MLR rules? Is your continued participation there contingen",55,"One last question on a different topic, which is how are you thinking about the individual product at this stage, given that, that seems to be the area most potentially problematic for the minimum MLR rules? Is your continued participation there contingent on a phase in of those rules or can you comment on that?"
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Sometimes it doesn't pay to be too straightforward, but I can't help myself. The product that we have today is not a good value equation, as good as it needs to be for our member. The distribution cost is too high. Our internal underwriting and issue cost",160,"Sometimes it doesn't pay to be too straightforward, but I can't help myself. The product that we have today is not a good value equation, as good as it needs to be for our member. The distribution cost is too high. Our internal underwriting and issue cost and our claim adjudication cost. So early on, our IT area and our product development, they're really starting off with a clean piece of paper to have a better value equation, so that we issue it where we have the best cost structure, where we do something about the distribution cost than our internal SG&A. So we think that the product that we have today is not at all competitive for tomorrow, start off clean piece of paper. And Harv DeMovick is with us today, he runs operations and IT as well as Medicare here. He can comment about what percent the IT -- where are we, 60% down the road, Harv?"
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes, we need to continue to work closely with the product development people as they learn more. But yes, on an IT front, we've made a lot of progress in getting ourselves a better position, more direct sales to customers and technology that will allow us",55,"Yes, we need to continue to work closely with the product development people as they learn more. But yes, on an IT front, we've made a lot of progress in getting ourselves a better position, more direct sales to customers and technology that will allow us to manage the process much more cost effectively internally."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's even more challenging than that, and that the small group product may look a lot like the individual product. So we have to get this right. And we started a clean piece of paper a year ago, and we're making progress.",43,"It's even more challenging than that, and that the small group product may look a lot like the individual product. So we have to get this right. And we started a clean piece of paper a year ago, and we're making progress."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll go now to Justin Lake with UBS.",9,"We'll go now to Justin Lake with UBS."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just first, I wanted to get your thoughts on the impact of healthcare reform and the mandated benefits there that will start in the fourth quarter on cost trend, and how you're thinking about pricing for 2011. And any early indications from regulators on",53,"Just first, I wanted to get your thoughts on the impact of healthcare reform and the mandated benefits there that will start in the fourth quarter on cost trend, and how you're thinking about pricing for 2011. And any early indications from regulators on fourth-quarter rates coming that might have those rates embedded?"
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Justin, I heard the first part. I may have to ask you to repeat your last question. But on the mandated benefits, I would say that they're going into effect September 23. I really think for 2010, the impact is immaterial to us. We probably have missed som",153,"Justin, I heard the first part. I may have to ask you to repeat your last question. But on the mandated benefits, I would say that they're going into effect September 23. I really think for 2010, the impact is immaterial to us. We probably have missed some of our Q4 renewals on some of those. But again, Q4 is only about 15% of our annual renewals. And interestingly enough, some of our plans already had these benefit levels in some of their offerings. So I think for this year it's not material. I mean, going forward, you can think about it in a range. All of these is probably in the range of a couple of points or so. And what I would tell you is it is one of the factors that we put into our pricing model along with everything else we put into pricing. And what was your second?"
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I was just asking if the -- I would assume you're putting in for rate filings for the fourth quarter?",20,"I was just asking if the -- I would assume you're putting in for rate filings for the fourth quarter?"
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I just wondered if you've gotten any feedback or pushback from regulators there before the assumption [indiscernible].",18,"I just wondered if you've gotten any feedback or pushback from regulators there before the assumption [indiscernible]."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","We have continuing dialogues on our rate filings. We've actually had some one-on-ones with some of the actuarial folks. But I can tell you that we have not had any rate filings denied and it's been a pretty reasonable process from our standpoint.",43,"We have continuing dialogues on our rate filings. We've actually had some one-on-ones with some of the actuarial folks. But I can tell you that we have not had any rate filings denied and it's been a pretty reasonable process from our standpoint."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","In Pennsylvania, Highmark publicly announced that there's a shift in medical underwriting in small group. Given I believe, they were the only plan in the state that wasn't medically underwriting, I'm just wondering if you could talk about how this might c",50,"In Pennsylvania, Highmark publicly announced that there's a shift in medical underwriting in small group. Given I believe, they were the only plan in the state that wasn't medically underwriting, I'm just wondering if you could talk about how this might change the competitive dynamic in your Western Pennsylvania market?"
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","When there's some pushback from the insurance department at Commonwealth of PA on that front, I'm not sure. Highmark's been, let's see, this is my 14th year here as CEO or Non-Executive Chairman. Highmark's been tough all 14 years and they'll be tough t",47,"When there's some pushback from the insurance 
department at Commonwealth of PA on that front, I'm not sure. Highmark's been, let's see, this is my 14th year here as CEO or Non-Executive Chairman. Highmark's been tough all 14 years and they'll be tough the next 14."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I would add to that, that in our nice growth story we have in Commercial Risk this year, that Pennsylvania is our leader. So we're competing just fine there.",29,"I would add to that, that in our nice growth story we have in Commercial Risk this year, that Pennsylvania is our leader. So we're competing just fine there."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","We'll probably need to get back to you on that, because I know that Highmark expressed a desire to do that, and there was pushback from insurance front, so I don't know where it is. But either way, they're tough.",41,"We'll probably need to get back to you on that, because I know that Highmark expressed a desire to do that, and there was pushback from insurance front, so I don't know where it is. But either way, they're tough."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll go to Christine Arnold with Cowen and Company.",10,"We'll go to Christine Arnold with Cowen and Company."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I think the operating cash flow would've been about $20 million higher, had it not been for the run out for Private-Fee-For-Service. And I think, if we add that to medical payables, we still have payables rising at a lesser rate than premiums. How do you",62,"I think the operating cash flow would've been about $20 million higher, had it not been for the run out for Private-Fee-For-Service. And I think, if we add that to medical payables, we still have payables rising at a lesser rate than premiums. How do you think about that? Were there one-time issues, timing things, how do you think about that?"
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","Christine, what I would say is that it's part of why we increased the guidance, and it's a view of lower trend and a view of COBRA isn't going to be as severe as we originally thought this year. So I'm not sure how else to answer that.",48,"Christine, what I would say is that it's part of why we increased the guidance, and it's a view of lower trend and a view of COBRA isn't going to be as severe as we originally thought this year. So I'm not sure how else to answer that."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So you're lowering your reserve levels relative to prior periods because costs are coming in lower and you anticipate they'll stay lower?",23,"So you're lowering your reserve levels relative to prior periods because costs are coming in lower and you anticipate they'll stay lower?"
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I would tell you that our reserve process is stable and our prior-period development is stable.",17,"I would tell you that our reserve process is stable and our prior-period development is stable."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So in terms of prior-period development, you're saying that the prior-period development that you're experiencing this year related to last year is consistent with the same period last year?",30,"So in terms of prior-period development, you're saying that the prior-period development that you're experiencing this year related to last year is consistent with the same period last year?"
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","I would say it's a little higher than it was through the same period of last year, and it will be reflected in our Q.",26,"I would say it's a little higher than it was through the same period of last year, and it will be reflected in our Q."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Analysts","How do you think about the MLR floors? I know no one's getting really specific. But if you could just update us with your thinking, given where the NAIC is in the definitions, that would be great.",37,"How do you think about the MLR floors? I know no one's getting really specific. But if you could just update us with your thinking, given where the NAIC is in the definitions, that would be great."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","We sit in on all the calls we can. We're following this. We're tracking where the definitions go. And we're evaluating what that may do our business market by market, and how to react. But at this point, it's premature to talk about it.",44,"We sit in on all the calls we can. We're following this. We're tracking where the definitions go. And we're evaluating what that may do our business market by market, and how to react. But at this point, it's premature to talk about it."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","And that's all the time we have for questions. I'll turn the conference back over to our speakers for any additional or closing remarks.",25,"And that's all the time we have for questions. I'll turn the conference back over to our speakers for any additional or closing remarks."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Executives","No closing remarks, and thank you very much for your interest in joining us today.",15,"No closing remarks, and thank you very much for your interest in joining us today."
27133,108966182,71000,"Coventry Health Care Inc., Q2 2010 Earnings Call, Jul 30, 2010",2010-07-30,"Earnings Calls","Coventry Health Care, Inc.","Operator","That does conclude our conference. Thank you all for your participation.",11,"That does conclude our conference. Thank you all for your participation."
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Operator","Good morning and welcome to the Coventry Health Careâ€™s third quarter 2010 earnings conference call. Todayâ€™s conference is being recorded and all participants are in a listen-only mode. Todayâ€™s call will begin with opening remarks by the Chief Execut",63,"Good morning and welcome to the Coventry Health Careâ€™s third quarter 2010 earnings conference call. Todayâ€™s conference is being recorded and all participants are in a listen-only mode. Todayâ€™s call will begin with opening remarks by the Chief Executive Officer of Coventry Health Care, Mr. Allen Wise, and after a brief forward-looking statement read by Mr. Drew Asher. Please go ahead, Drew.
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties including those described in the Companyâ€™s filings with the SEC on Form 10-K for the year-ended December 31, 2009 and Form 10-Q for the quar",77,"Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties including those described in the Companyâ€™s filings with the SEC on Form 10-K for the year-ended December 31, 2009 and Form 10-Q for the quarter-ended June 30, 2010, as may be further updated from time-to-time in our quarterly reports on Form 10-Q may materially impact those statements and could cause actual future results to differ materially from those anticipated and discussed. Allen?
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","Good morning and thank you for your interest in Coventry Healthcare. Weâ€™re pleased to report another very strong quarter across our seven core businesses.  The fundamentals of our business continue to be strong and consistent with the last several quart",2127,"Good morning and thank you for your interest in Coventry Healthcare. Weâ€™re pleased to report another very strong quarter across our seven core businesses.  The fundamentals of our business continue to be strong and consistent with the last several quarters. Weâ€™re certainly operating in a unique and very favorable trend environment, but the core results over the last few quarters are also due to the focus and execution of this company, and its employees. 
Weâ€™re operating our businesses better, but more importantly I know there is room for continued improvement. Overall, as you can see in our press release, in Q3 we earned $1.29 which includes $0.05 of private fee for service run out. A significant driver of this very positive result is that both our commercial and our Medicare businesses continue to benefit from unusually low medical trend. 
However, as a practical matter, we continue to expect this low level of trend to be transitory. Given the companyâ€™s strong performance in the quarter, weâ€™ve updated 2010 full year guidance and provided details in our press release. Let me first touch on a few operational highlights in the quarter, and then more importantly, provide some perspective on the longer term, or as much as I can, given the continuing lack of clarity relating to certain aspects of health care reform in other areas. 
Our commercial risk business comprised of both group and individual grew again in the quarter, about 11,000 members, or just under 1% sequentially. Remember that Q2 2010 was the first quarter our commercial group business grew organically since Q4 2007, and we were able to continue that positive growth. This is a result of execution in our local markets and across our company, but just as important, the cost structure and positioning of our products and our health plan markets, all attributes which we believe will be critical for success when implementing health reform exchanges. 
As mentioned earlier, the commercial results were nothing short of outstanding.  Although we recognize that minimum loss ratio provisions will commence in 2011, with specific rules yet to be finalized, weâ€™re pleased to have a cost structure that enables us to produce this result and a product portfolio that enables to provide an attractive value proposition to our customers. 
Also in the area of commercial business, we continue to be pleased with results of our Preferred acquisition in Wichita, which as you recall, closed in February this year, and added approximately 120,000 members and $400 million in an annualized revenue to the company. 
Turning to our Medicare Advantage business, it grew slightly in the quarter and had very good results. We look forward to continuing to serve the senior population in 2011 and beyond, and are pleased with the positioning of our Medicare Advantage products and our local plan markets for 2011. Our footprint in 2011 is similar to 2010, as we are offering products in about the same number of counties for 2011. We continue to develop innovative programs in conjunction with provider system partners, and as an example, weâ€™re offering a product in Wichita including a new model of care for Medicare patients whereby thereâ€™s a tighter integration of care management, medical homes, coordination of care, data sharing and disease management with our partner Via Christie. 
We expect an acceleration of collaboration between providers and payers more broadly, and in our case especially in the Medicare and the Medicaid ABD populations. In Medicare part D, we had another quarter of on track performance. In 2010, Part D has been a consistent performer for the company for the fifth straight year.  It will be interesting to see how the landscape evolves in 2011, given the push by CMS to reduce the number of products offered by carriers. 
As you have likely seen, we are offering one basic and one enhanced product. We have qualified for 15 auto-assigned regions in 2011 versus 21 in 2010. Once we have more visibility on the open enrollment season ending in December, we will and can provide some more color on membership levels for 2011. For reasons I donâ€™t fully understand, CMS, at the last minute, did not approve our lowest cost Part D product, and as a result our Part D enrollment may suffer in 2011. 
Iâ€™m very pleased with the progress weâ€™ve made in Medicaid over the past year. The fruits of our labor are evident this quarter; with the inception of our Nebraska win effective August 1st.  Although we are still waiting for the membership to settle out, we are pleased that we achieved the high end of our forecast as of September, and had 47 new Nebraskans in our Medicaid program. 
Our Pennsylvania membership continues to grow, albeit at a measured pace.  We had 9,000 members at the end of Q3, and we expect that to continue to build. We are pursuing other Medicaid opportunities as a part of our diversified portfolio, and will provide details as the process develops. Weâ€™re interested in growing membership in the ABD area, and expect to add approximately 16,000 ABD members in West Virginia over 13 months, beginning in December of this year. 
Our other businesses, including our fee based businesses continue to perform well. As you may have noticed earlier in the year, we have twice increased the fee range guidance for 2010. These businesses, including our market leading worker compensation server business are important contributors to our diversified earnings and cash flow.  In fact, just with the EBITDA contribution from our unregulated fee businesses, we can fund our entire annual interest expense and then some. 
In the area of capital deployment, we closed our Mercy Health Plan transaction on schedule effective October 1st. Once again, not only did we acquire an attractive business, but perhaps even more important, we have forged a collaborative long term relationship with the Sisters of Mercy Health System which spans the Midwest, including Missouri, Oklahoma, and Arkansas. Beyond the transaction and long term provider contract, we are already off to the races, so to speak, jointly working on new products and shared incentive arrangements for the future. 
Our two acquisitions in 2010 are more than revenue and membership. Itâ€™s about our future cost structure and more important, our ability to improve care for members and develop long term strategic relationships with high quality health systems. I think itâ€™s worth a minute to stay with this topic.  We feel the best way to care for members and provide the best value proposition is by having collaborative relationships with provider systems and physicians and working to develop affordable products. 
These relationships are rooted in collaboration, including shared incentives, quality incentives, data sharing, and in some cases, more focused networks. We have and will continue to build these types of relationships whether as a part of an ACO model, medical home, or variation of both. We believe weâ€™re able to offer our provider partners creativity, flexibility, and local market commitment, whether itâ€™s part of an acquisition or a contractual collaborative relationship or both, in some cases. 
Weâ€™ll continue to focus on these types of mutually beneficial opportunities in the years to come. While Iâ€™m certainly pleased with the accomplishments of our management team during 2010, the hard work and the focus of our employees has contributed to the results you see today. Our Board of Directors takes management depth and succession planning very seriously, and I have spent significant time and effort in recruiting additional individuals to lead us in tomorrowâ€™s environment. 
In that context, Iâ€™m pleased to announce the addition of the following executives to our management team in the last quarter, and the forthcoming quarter. First, Ken Burdick; Ken joined our company in September and initially will be responsible for our Medicaid division as well as our behavioral business MHNet. After Amherst College and a law degree from the University of Connecticut, Ken spent 30 years in managed care. Some of us at Coventry knew Ken from our experience at Medford Health, as a part of United Healthcare, after they purchased Medford Health. Ken spent 15 years in various senior executive positions with United. 
Iâ€™m also pleased to announce that Kevin Conlin will be joining our company on January 3rd, and will serve in a diverse and broad role for our company.  Kevin will be responsible for our strategic direction with provider health systems, our unit cost, quality of care, and integrated cost structure and welfare of our patients. Kevin has 27 years of extensive healthcare management experience.  He spent the last six and a half years as President and CEO of the Via Christie Health System, a system that employs over 8500 individuals in Kansas and Oklahoma. After earning a degree in Biological Science from Rutgers, Kevin earned an MA in Health Administration from Duke University.  I met Kevin through our acquisition of the Via Christie Health Plan and over time became very impressed with his executive capacity, his insights in the high quality provider health systems, and how we need to partner with them in the future. 
In addition to Ken and Kevin, we plan on announcing another very key hire in Q4 of this year. These executives, coupled with our existing team, will help us navigate the shifting sands around our industry and Iâ€™m confident weâ€™ll make notable contributions in the years to come. In addition to this group, along with our existing seasoned team, has altered our plans for succession of my role.  Our plan today is to evaluate our internal management team, with the intent of picking my successor from the internal group, and as a result Iâ€™ve committed to remain an additional year with our company, which would be through 2012. Our intent is to pick my successor in late 2011 or early 2012, and for me to remain through 2012 to ensure a smooth transition. 
As you would imagine, many of our 14,000 employees are squarely focused on healthcare reform, the implications and the resulting opportunities. With respect to the near term, we have sophisticated models with many changing variables that are updated daily regarding 2011 projections and minimum loss ratio impact on line of business by legal entity and so on. But more importantly, we have multi-year project plans focused on delivering the products and the related cost structure so that the company is positioned to succeed regardless of the set of final rules. 
We have teams of internal subject matter expert modifying products, benefits, and implementing the operational and compliance requirements reform. Regarding the near term, we will look forward to giving you more clarity on 2011 when we have enough visibility to provide a credible and responsible set of estimates. Now, while today we lack the level of clarity we would like on a number of key issues for 2011, it is obvious to me that 2011 EPS will be less than our outstanding 2010 results. In the meantime, weâ€™ll focus on doing the right things to build long term value, regardless of external hurdles.  
This obviously starts with strong current underlying fundamentals across our seven core businesses.  Tail winds aside, 2010 will result in an outstanding year, and we accomplished a number of significant goals to set the stage for the future. First we added over $1 billion in annualized revenue from our two health plan acquisitions, when addition to revenue and membership will improve our care of members and allow attractive benefit plans for the future.  While future acquisitions, if done properly, canâ€™t be predicted, we have a history of acquiring and improving good businesses, and feel strongly that we can do more of this in the future. 
Second, we added significant additions to our leadership, which strengthens our future prospects, and itâ€™s going to make all the difference for the future.  I think in no order of importance, but third, weâ€™re organically growing our commercial membership. Itâ€™s a dramatic turnaround from prior years; weâ€™re gaining momentum on that front, and doing the right things to continue that for the future. 
Fourth, for the first time in years we added new Medicaid plans in Nebraska and Pennsylvania, and weâ€™ll continue to find opportunities in that area. Lastly, we made substantial SG&A progress by reducing staff by about 900 people on a same store basis, without compromising service. So we have seven solid businesses which will continue to improve.  Our balance sheet is strong and getting stronger, which allows us to actively seek new opportunities. While youâ€™re more interested in tomorrow than yesterday, and I understand that, I need to make a point, as John Stelban is fond of saying. Fundamentals do matter. With that, itâ€™s a good introduction for John, who will provide details on our financials followed by a brief question and answer session. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","Good morning.  As Allen mentioned, our GAAP EPS for Q3 is $1.29, which is comprised of core earnings of $1.24 and $0.05 related to the run out of the private fee business.  This was a strong quarter on all fronts, and a validation that the measures that w",1834,"Good morning.  As Allen mentioned, our GAAP EPS for Q3 is $1.29, which is comprised of core earnings of $1.24 and $0.05 related to the run out of the private fee business.  This was a strong quarter on all fronts, and a validation that the measures that we took to improve our seven businesses during 2009 and into 2010 are working. In addition, we are increasing the midpoint of our GAAP full year 2010 guidance from $1.80 to $2.79. 
Iâ€™ll start with a few highlights of the quarter. We again experienced strong results across our core businesses with better than expected performance, primarily driven by our commercial risk and Medicare CCP businesses. Our commercial risk business had an outstanding quarter by all measures. Commercial risk group membership grew sequentially by 4000 members over Q2, and the individual product grew 7000 members over Q2. 
Peeling back the covers, we show that our small group sales engine continues to perform very well. During Q3, we had about 19,000 member loss due to four large group accounts. However, these losses were more than offset by 23,000 members in new sales. Group premium yields were in line with expectations, given the mix of new sale and were up 3.8% over the prior year quarter, and 4.6% year to date. 
The commercial group medical loss ratio of 76.8% was also much better than expected, driven by a combination of care management and continuing utilization tail winds. Year to date, group MLR now stands at 78.4%. Our view of fundamental (inaudible) remains in the range of 8 to 8.5%.  We are about a year or more into lower than historical utilization trends, and while we see nothing to suggest a material or abrupt uptick in utilization, our forward view would expect utilization to increase. 
Medicare CCP results in Q3 were also better than expected. Reported loss ratio for the quarter of 77% was unusually low, due to a few out of period items. During Q3, we received final year end reconciliation payments related to 2009 as well as other intra-year payment adjustments that produced a below run rate MLR in the quarter. It is more instructive to look at the year to date reported MLR of 81.3%, which when adjusted for prior items, would produce a result at the 83% range for 2010.  It is more reflective of where this business is performing. 
Medicaid produced another very good quarter.  We commenced operations in Nebraska on August 1st, and currently have approximately 47,000 members, and in addition our Pennsylvania operations grew 4000 members over the prior quarter. While reported MLR for the quarter was 89%, same store MLR was much more consistent with the first half of the year, in the mid 80s. Year to date reported MLR of 85.8% is actually closer to 84% when adjusted for Nebraska and Pennsylvania. 
As Allen mentioned, we like this business a lot and are optimistic about its growth prospects. The key to success will be our cost structure and ability to manage patients. We have seen solid improvement in our same store businesses; will certainly apply our experience and lessons learned to the new markets. Turning to balance sheet and cash flows, total cash and investments stand at $4.08 billion, our investment portfolio is in excellent shape, and in a net unrealized gain position of $113 million on September 30, up from $89 million at June 30, primarily due to changes in Treasury rates. 
GAAP cash flow from operations for the quarter was $287 million or 151% of net income, inclusive of a negative $14 million impact from the run out of the private fee product line.  Year to date, core cash flow from operations, defined as GAAP cash flow, adjusted for private fee and the Q2 one time litigation charge was $553 million, or 136% of net income. 
More importantly, free deployable cash apparent was $650 million after accounting for the acquisition of Mercy Health plans, which was paid on October 1. In addition, we began the dividend process related to the return of capital for the private fee business and received $140 million in late October.  This would be additive to the $650 million of deployable cash at October 1. 
Days in claims payable displayed in the press release exclude private fee for all periods presented.  DCP stands at 51.7 days, versus 55.5 at June 30, and 49.5 at December 31. The decrease in DCO of 3.8 days versus prior quarter was due primarily to reduction in claims inventories related to the conversion of our Florida commercial business to our IDX platform at the beginning of June. 
Debt to cap ratio now stands at 28.3%, down slightly from prior quarter, due to earnings. We did not repay any debt in the quarter. Turning to updated 2010 guidance, we are forecasting GAAP EPS in the range of $2.74 to $2.84 including the Q2 litigation charge of $1.18. Excluding the charge, guidance is in the range of $3.92 to $4.02. This includes $0.40 of year to date earnings generated by private fee, but does not assume any further private fee earnings in Q4. 
Our core view of EPS, excluding both the class action charge and year to date private earnings is in the range of $3.52 to $3.62. Weâ€™re adding the Q3 outperformance to the prior full year guidance while adjusting for some improved utilization of business in Q4. As we did in Q2, thereâ€™s a table in the press release to roll forward the guidance changes. 
I will walk through the guidance, excluding the class action charge, using the midpoint of the range for both current and prior guidance. Midpoint of the guidance on the Q2 earnings call was $2.98, which included $0.35 of private fee earnings, leaving core earnings guidance at $2.63. The current guidance is $3.97, with year to date current fee of $0.40, leaves $3.57 of core earnings or an increase in core earnings guidance of $0.94 versus Q2. 
The lionâ€™s share of the increase is related to commercial risk, with about $0.45 and Medicare CCP worth about $0.27. So let me provide a little more detail on that; starting with the commercial group risk business, as previously guided in Q2, we expect same store membership to be about flat to prior year.  When we include the addition of our approximately 100,000 PHS commercial group risk members and 90,000 Mercy Health plan members, total growth would be roughly 14%. Forecasted 2010 commercial group risk MLR is now expected to be in the range of 79 to 79.5. This is a 200 basis points reduction from the previous guidance midpoint, driven by Q3 results and our more completed view of the first half of 2010. 
The guidance assumes some pressure in Q4, due to the progression of deductible satisfaction and other seasonal factors. All in, this would be about $0.41 of the increase guidance and core earnings for the group risk business. In addition, thereâ€™s another $0.04 related to an improved ratio outlook on individual business. We expect the individual loss ratio to be in the mid 60s, down from our previous yield of mid to high 60s. 
So total commercial risk improved outlook is worth $0.45. For Medicare CCP, given the reported Q3 results, we expect a 2010 Medicare Advantage loss ratio to be in the low 80s. Medical cost trim will continue to march forward into Q4, which will push MLR higher than year to date results. An improvement over previous guidance for the full year loss ratio in the range of 300 basis points would produce a $0.27 increase to previous guidance. 
On Part D, with three quarters under our belt, we expect Part D will perform a little better than previous guidance.  We still expect membership in the 1.6 million ranges, and a loss ratio in the mid 80s, albeit about 100 basis points lower in that range. This improved outlook produces $0.07 of increase to previous guidance. 
On SG&A the midpoint of the 2010 guidance range, excluding the impact of Mercy in Q4 is $1.93 billion, a reduction of $10 million from previous guidance, due to better performance on our cost initiatives. Q4 SG&A expense will increase versus Q3, primarily for expenditures related to the selling seasons for Medicare and commercial, as well as additional reform preparedness. 
Our results will also include an additional $20 million or so related to Mercy. If you thing about where we were this time last year, looking at picking out almost $200 million of SG&A due to determination of the private fee product, this has been an excellent result, as we exceeded that goal, plus grew same store revenues. 
The improvement in guidance results in (inaudible) improvement. The midpoint of our guidance range assumes a flat share count for the past three quarters; we are putting capital to use in the completed Mercy Health Plan transaction, and have to take into account the uncertain resolution of the Q2 one time litigation charge. Really, to recap all of that, the $0.94 improvement in core guidance breaks down as follows; commercial risk loss ratio improved outlook worth $0.45, Medicare CCP loss ratio improved outlook worth $0.27, Medicare Part D loss ratio improvement worth $0.07, SG&A guidance improves $0.04, and improved outlook in our fee based businesses adds $0.04, and a change in tax rate guidance by moving the midpoint of the range down 125 basis points is worth $0.06. 
As stated earlier, we have $650 million of deployable cash on hand. In addition, we expect to dividend out the capital supporting the private fee product, which we estimate to be approximately $275 million. We have received $140 million so far in Q4, and will seek to dividend up the remainder the first half of 2011. 
Even after paying for Mercy Health Plan, we are still on track with approximately $1 billion of capital by mid 2011, which would be used for deployment priorities and any necessary after tax payment to resolve the Q2 one time litigation charge. Our priorities for deployable cash continue to be growing the business through acquisition, followed by opportunistic share repurchase, and delivering. 
Really, the take away from this quarter and the improved outlook for 2010 is fundamentals do matter, as we head into the future. While there are certainly challenges as we think about reform, there will also be many opportunities. Going into the future with a pre-fundamental business practices, including sales execution, clinical management, improving cost structure and servicing our customers are all tangible signs that we have a solid foundation on which to grow profitably for the long term. Our two health plan acquisitions and our entrance into two new Medicaid markets demonstrate our ability to simultaneously improve the core business, while taking advantage of opportunities to grow. 
Our balance sheet and deployable cash position is strong and provides us the flexibility to be opportunistic as we deploy capital to profitably grow the company. I will now turn the call over for questions. </TAG>

"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Operator","Thank you, Sir. (Operator instructions.) And we will go first to Josh Raskin with  Barclays.",15,"Thank you, Sir. (Operator instructions.) And we will go first to Josh Raskin with  Barclays. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Hi, thanks, good morning.  I just wanted to follow up, Allen, your comments that EPS will be down next year, and I guess the two questions around that.  One, are we talking about EPS down below what youâ€™re calling that core adjusted, meaning excluding t",114,"Hi, thanks, good morning.  I just wanted to follow up, Allen, your comments that EPS will be down next year, and I guess the two questions around that.  One, are we talking about EPS down below what youâ€™re calling that core adjusted, meaning excluding the litigation charge and the private fee for service runoff? And then secondarily, maybe you could help us understand sort of where your MLRs are.  Obviously, you talked about the individual book, now running closer I think you said to the mid 60s, so that certainly sounds like itâ€™s going to be an issue for next year, and then maybe you can give us similar statistics for the small group? 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","The answer, Josh, to question number one is EPS will be down on the core business, excluding the litigation, good question. And I think the - weâ€™ve given you kind of what we know about given loss ratios, and commercial and individual business, and weâ€™",147,"The answer, Josh, to question number one is EPS will be down on the core business, excluding the litigation, good question. And I think the - weâ€™ve given you kind of what we know about given loss ratios, and commercial and individual business, and weâ€™re working on pricing and working on our distribution source and working on coming closer to the sweet spot to avoid writing any rebate checks and providing the best value and getting the best volume we can in the market for our cost structure, so itâ€™s a whole bunch of stuff is unknown.  Whether thereâ€™s any bypass on the individual and what our broker costs are going to be and so we - I donâ€™t know how we could responsibly given the process weâ€™re in now, do any better than we have in terms of where those businesses are going to turn out. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Is it fair to say your individual book is sort of mid single digit percentage of total revenues?",18,"Is it fair to say your individual book is sort of mid single digit percentage of total revenues? 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yeah, I think so. The individual business is about $300 million of our total revenues.",15,"Yeah, I think so. The individual business is about $300 million of our total revenues. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, even better. And then just a second question, you mentioned now a new executive youâ€™re going to be naming in Q4 to the team. Is that a CFO role, or is that a separate person?",36,"Okay, even better. And then just a second question, you mentioned now a new executive youâ€™re going to be naming in Q4 to the team. Is that a CFO role, or is that a separate person? 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","I just canâ€™t - if I could have announced that I would.  Weâ€™re in the middle of working through a resolution of a non-compete, so weâ€™ll have news soon.",30,"I just canâ€™t - if I could have announced that I would.  Weâ€™re in the middle of working through a resolution of a non-compete, so weâ€™ll have news soon. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, thanks.",2,"Okay, thanks. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Operator","And weâ€™ll take our next question from Justin Lake with UBS.",12,"And weâ€™ll take our next question from Justin Lake with UBS.
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Thanks, good morning.  Just first Iâ€™d like to flush out the commentary on the Part D side. Can you tell us what happened, specific around how much membership you think is at risk in that low price product?",38,"Thanks, good morning.  Just first Iâ€™d like to flush out the commentary on the Part D side. Can you tell us what happened, specific around how much membership you think is at risk in that low price product? 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, weâ€™re not sure.  What happened was that we had a preliminary indication that about 300,000 members at our lowest priced product, the product that people purchased off information from the CF website, a lower benefit, lower premium, probably by peo",118,"Well, weâ€™re not sure.  What happened was that we had a preliminary indication that about 300,000 members at our lowest priced product, the product that people purchased off information from the CF website, a lower benefit, lower premium, probably by people with less health issues, and we had preliminary indication that we would go from five plans to three, and very late in the process, CMS did not allow our low cost plan, so that means that 300,000 members are going to have to pick another plan, whether itâ€™s from us or someone else, and just donâ€™t know how that process will work out, until it happens. So itâ€™s a surprise and itâ€™s unfortunate, but thatâ€™s what happened. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, and on commissions, you mentioned something there, and I think thereâ€™s been some evidence in the market that you started actually addressing that issue and have been cutting commissions in some markets.  Can you give us any color on what youâ€™ve",59,"Okay, and on commissions, you mentioned something there, and I think thereâ€™s been some evidence in the market that you started actually addressing that issue and have been cutting commissions in some markets.  Can you give us any color on what youâ€™ve found there already and how much benefit you might expect to get from lower commissions in 2011? 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, I can give you some color on it.  Itâ€™s going to be different in every market place.  It depends on what our position is.  Thereâ€™s at least one market place which is Iowa which unrelated to anything in minimum loss ratios or reform we just didn",335,"Well, I can give you some color on it.  Itâ€™s going to be different in every market place.  It depends on what our position is.  Thereâ€™s at least one market place which is Iowa which unrelated to anything in minimum loss ratios or reform we just didnâ€™t get good coverage from brokers, we didnâ€™t get really any help from them, so several years ago we decided to go direct, and are selling direct in the Iowa marketplace, and doing better there. If you take the other end of the spectrum, which is places like Atlanta, where the competition is everybody, you know youâ€™re going to have to be sensitive to market conditions. So I think that for certain that weâ€™ll be feeling our way and doing what we hope is smart and best for our groups on a marketplace by marketplace basis. We have made some early cuts on what the implication of that may be, but itâ€™s still a work in progress. So the early reaction to the places where we have gone out with a new structure and a new plan has been okay, but the proofâ€™s going to be what happens in a few quarters and see what the quote level is, and where we are.  So anyone that has - that is in multiple marketplaces that doesnâ€™t have a plan thatâ€™s sensitive to who youâ€™re competing with and what they do and what your position is in the marketplace and how much of it is direct, I just donâ€™t understand. So I think weâ€™re feeling our way marketplace by marketplace and so far so good. You know, I donâ€™t think itâ€™ll be - and if you want to talk about dimension, itâ€™s not going to be draconian, itâ€™s not going to reduce our cost 40% or 30%, whether that ends up by doing some more direct in some areas and whether we end up saving on the commercial side something in the 10 to 15% area would be a good guess. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","And Justin, John, let me just clarify something.  On that low priced product, the majority of those will actually get mapped to our basic product that weâ€™ll have for next year. They would have to opt out.",37,"And Justin, John, let me just clarify something.  On that low priced product, the majority of those will actually get mapped to our basic product that weâ€™ll have for next year. They would have to opt out. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Oh, thatâ€™s good to know.  Just one last numbers question, just on the benefit in the quarter, from prior period development, and if you can give us a breakdown on intra-year, prior year, that would be great.  Thanks a lot.",40,"Oh, thatâ€™s good to know.  Just one last numbers question, just on the benefit in the quarter, from prior period development, and if you can give us a breakdown on intra-year, prior year, that would be great.  Thanks a lot. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","I would tell you that the majority of the prior period, call it 90% plus, is within 2010.",18,"I would tell you that the majority of the prior period, call it 90% plus, is within 2010. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Great, thank you.",3,"Great, thank you. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Operator","And weâ€™ll take our next question from Kevin Fischbeck from Bank of America.",14,"And weâ€™ll take our next question from Kevin Fischbeck from Bank of America. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay great, thank you. You sounded a little bit cautious on the Medicare selling season in the next year.  You had great results so far year to date, am I interpreting that right? Is that when companies come out and start giving indications of what member",65,"Okay great, thank you. You sounded a little bit cautious on the Medicare selling season in the next year.  You had great results so far year to date, am I interpreting that right? Is that when companies come out and start giving indications of what membership might trend next year, Iâ€™d love to hear why you think youâ€™re not ready to talk about that yet. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","The qualifications on the Part D product, not on the Medicare Advantage and Part D is just driven by the two pieces, the change in CMS and reducing the number of options for a lot of plans and then the specific concern here is not allowing the low cost pl",82,"The qualifications on the Part D product, not on the Medicare Advantage and Part D is just driven by the two pieces, the change in CMS and reducing the number of options for a lot of plans and then the specific concern here is not allowing the low cost plan that we had with 300,000 members, so I feel really good about our ability to compete in the Medicare Advantage, a little bit cautious and uncertain about the result of Part D. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, great. And then just going back to the capital deployment strategy sounds like acquisitions seem like a key focus here. But you just did two large transactions, how quickly would you be in position to do another transaction, and how do you think abo",52,"Okay, great. And then just going back to the capital deployment strategy sounds like acquisitions seem like a key focus here. But you just did two large transactions, how quickly would you be in position to do another transaction, and how do you think about health plans versus fee based type businesses? 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, weâ€™re looking all the time and letâ€™s talk about the two that we did, just briefly.  I mean, they are better than I expected when I started, very strategically thinking partners there.  Weâ€™re going to do some really interesting things in the ma",379,"Well, weâ€™re looking all the time and letâ€™s talk about the two that we did, just briefly.  I mean, they are better than I expected when I started, very strategically thinking partners there.  Weâ€™re going to do some really interesting things in the marketplace to take better care of the patients, and in turn more of the management of the patients over to provider partners, and provide input, provide data, provide maybe some nursing and clinical help, provide guidelines, and then when they take better care of the patients, then their census goes down, which invariably happens, weâ€™ll share the gain with them and put the money back in to caring better for the patients.  We really like that part of the world, and we would like more of those, as opposed to, as Iâ€™m fond of saying, arguing over nickels with providers on unit cost.  We need to take better care of the patients. We can do that, what you donâ€™t know is all the stuff that our acquisition team, headed by Drew Asher, and what we donâ€™t do. I saw a long list of 15 or 20 things we looked at, and didnâ€™t, because it wasnâ€™t strategic because it was too small, or because we didnâ€™t know how to make the business better. So I hope we disciplined, I think weâ€™re disciplined, but weâ€™re looking all the time and while we canâ€™t predict when the next opportunity is coming, weâ€™re going to do more in the way of acquisitions.  Weâ€™re going to do them right, and we have fully not converted them to the IDX system, but otherwise fully integrated these businesses and theyâ€™re going very well.  Weâ€™ve been doing this for a very long time, doing this for fifteen years, acquiring businesses that we know how to make better, having a lengthy disciplined process even before we decide what we need to do.  So weâ€™ve got the resources, we just need to find the right opportunities and whether thatâ€™s in commercial or Medicare Advantage or whatever we find, or Medicaid.  So we are going to - first choice has always been to grow the business with acquisitions, and if cash keeps growing and we canâ€™t keep up on the acquisition side, weâ€™ll do a share repurchase. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, then one last question. Those are pretty bullish comments on the Medicaid business, the very last part of the response, you mentioned Medicaid last, so I donâ€™t know - is the Medicaid opportunity in your view more of an organic opportunity or is ac",50,"Okay, then one last question. Those are pretty bullish comments on the Medicaid business, the very last part of the response, you mentioned Medicaid last, so I donâ€™t know - is the Medicaid opportunity in your view more of an organic opportunity or is acquisitions a large part of that? 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","I guess itâ€™s going to be a balance.  I would put it in three areas, yes, head count is yes, and itâ€™s organic.  Two, we like the opportunities in the ABD population and weâ€™re thinking on 16,000 members approximately, over 13 months, in West Virginia.",120,"I guess itâ€™s going to be a balance.  I would put it in three areas, yes, head count is yes, and itâ€™s organic.  Two, we like the opportunities in the ABD population and weâ€™re thinking on 16,000 members approximately, over 13 months, in West Virginia.  We have another piece that weâ€™re working on and hopefully we can announce an agreement in the quarter, Iâ€™m not really certain, and then there are new opportunities, like Louisiana was going to try and go live on April 1 and now itâ€™s been delayed, so itâ€™s a combination of the three, and if we could acquire, as far as something in the MA process, weâ€™d look at that too. So itâ€™s a combination. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay great, thanks.",3,"Okay great, thanks. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Operator","And weâ€™ll move on to our next question, from John Rex with JPMorgan.",14,"And weâ€™ll move on to our next question, from John Rex with JPMorgan.
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Thanks, just a comment on med reserves and (inaudible) development, I just wanted to get clear on that, so I think reserve balance on the - went down a bit over $100 million sequentially in the quarters, and you had mentioned claims paid out in Florida, r",70,"Thanks, just a comment on med reserves and (inaudible) development, I just wanted to get clear on that, so I think reserve balance on the - went down a bit over $100 million sequentially in the quarters, and you had mentioned claims paid out in Florida, reserve development.  Can you break out just kind of how much of that was paid on claims inventory versus favorable development in the Q?
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","John, in Q2 we tell you about the prior period development to last year, in Q3 it wasnâ€™t much at all.  So if you think about the vista pay down related to getting back to normal levels at the conversion, you know, itâ€™s a couple of days on average.  It",113,"John, in Q2 we tell you about the prior period development to last year, in Q3 it wasnâ€™t much at all.  So if you think about the vista pay down related to getting back to normal levels at the conversion, you know, itâ€™s a couple of days on average.  Itâ€™s probably in the range of that alone, and thereâ€™s a lot of factors in here, that alone is probably in the neighborhood of $40 million. We had an additional settlement of provider action thatâ€™s been on our books a long time, that produced another day and a half or so in the quarter. Again, that was in Florida and thatâ€™s most of it. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So, I mean, there was obviously some intra-year development also impacting that.  Is that correct?   So itâ€™s fair to think that maybe $15 million of intra-year development?",27,"So, I mean, there was obviously some intra-year development also impacting that.  Is that correct?   So itâ€™s fair to think that maybe $15 million of intra-year development?"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","John, we donâ€™t talk about the development quarter to quarter, it was - the development was all intra-year, and it was stable to prior quarter.",25,"John, we donâ€™t talk about the development quarter to quarter, it was - the development was all intra-year, and it was stable to prior quarter. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, but I can think about $40 million of the decline would be due to claim - of the $110 million would be to the inventory reduction in Florida.  Is that right?",32,"Okay, but I can think about $40 million of the decline would be due to claim - of the $110 million would be to the inventory reduction in Florida.  Is that right? 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","Plus the private fee going down -",6,"Plus the private fee going down -
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So another $11 million there, okay.",6,"So another $11 million there, okay. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","Itâ€™s private fee, thereâ€™s reserve stuff in there, thereâ€™s other reserves we have for other providers, private fee is more in the range of $25 million from a pure medical claim liability.",33,"Itâ€™s private fee, thereâ€™s reserve stuff in there, thereâ€™s other reserves we have for other providers, private fee is more in the range of $25 million from a pure medical claim liability. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, great. And then you made some commentary on cost trim, I think you said youâ€™re seeing it as 8 to 8.5%, is that what you are saying current trend?  Is that current trend or is that what youâ€™re saying your longer term outlook is?",45,"Okay, great. And then you made some commentary on cost trim, I think you said youâ€™re seeing it as 8 to 8.5%, is that what you are saying current trend?  Is that current trend or is that what youâ€™re saying your longer term outlook is? 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","Longer term outlook, its prospective trend. It includes a view that is utilization trailing, but transitory.",16,"Longer term outlook, its prospective trend. It includes a view that is utilization trailing, but transitory. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So how do you size 2010 trend right now?",9,"So how do you size 2010 trend right now? 

"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","You know, I think the best measure of that is probably looking at the financial statements, and looking at whatâ€™s coming through, and thatâ€™s going to be a combination of changes in business mix, itâ€™s going to be the impact of new business coming on",74,"You know, I think the best measure of that is probably looking at the financial statements, and looking at whatâ€™s coming through, and thatâ€™s going to be a combination of changes in business mix, itâ€™s going to be the impact of new business coming on this year.  Itâ€™s going to be the cost initiative that we have in place on care management and contracting.  And some of itâ€™s going to be some utilization tailwind. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So you think about year â€™11, are you pricing yourâ€™11 book with a view to 8.5% trend, then?",18,"So you think about year â€™11, are you pricing yourâ€™11 book with a view to 8.5% trend, then? 

"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","Our fundamental view of prospective trend is put one input into our pricing decision.",14,"Our fundamental view of prospective trend is put one input into our pricing decision. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, so I guess - my question being are you pricing the â€™11 book equivalent to your trend expectation, higher or lower?",22,"Okay, so I guess - my question being are you pricing the â€™11 book equivalent to your trend expectation, higher or lower? 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","Iâ€™m pricing the â€™11 book consistent with the fundamental trend we discussed, and I have to tell you thereâ€™s a lot of other factors, such as the ones that Allen mentioned earlier, but I donâ€™t want to go any further on that, because I donâ€™t want t",53,"Iâ€™m pricing the â€™11 book consistent with the fundamental trend we discussed, and I have to tell you thereâ€™s a lot of other factors, such as the ones that Allen mentioned earlier, but I donâ€™t want to go any further on that, because I donâ€™t want to get into talking about 2011. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, and itâ€™s hard to generalize because state by state, marketplace by marketplace, itâ€™s just very different.  If we have in some locations loss ratios that are 70ish and weâ€™re facing minimum loss ratios next year, the pricing may actually be redu",118,"Well, and itâ€™s hard to generalize because state by state, marketplace by marketplace, itâ€™s just very different.  If we have in some locations loss ratios that are 70ish and weâ€™re facing minimum loss ratios next year, the pricing may actually be reduced and may actually be negative, so itâ€™s complicated.  Itâ€™s marketplace by marketplace and you canâ€™t find a really simple answer, but itâ€™s in general we canâ€™t sustain the loss ratios that we have so generally weâ€™ll try to figure out what a trend is and (inaudible ) so that we donâ€™t write big rebate checks and we stay where weâ€™re competitive in the marketplace, to grow our book organically, thatâ€™s what weâ€™re working our way through. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Right, okay, so it would be fair kind of as you look toward the 2011 and you think about rebates and such, it would be fair to say that one of the alternatives would be that you price below, and Allen, I think you said you want to kind of minimize the reb",90,"Right, okay, so it would be fair kind of as you look toward the 2011 and you think about rebates and such, it would be fair to say that one of the alternatives would be that you price below, and Allen, I think you said you want to kind of minimize the rebate checks youâ€™re cutting, so it would be fair to say that you may take a view of pricing below trend, given where your margins are in â€™10, in a number of markets?  Is that a fair assumption? 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think so, if you think about our position.  Being less competitive in the marketplace and giving rebate checks is just not good business.  If I had to philosophically, and this is always dangerous, but philosophically say would I rather end up at 78 or",82,"I think so, if you think about our position.  Being less competitive in the marketplace and giving rebate checks is just not good business.  If I had to philosophically, and this is always dangerous, but philosophically say would I rather end up at 78 or 82, Iâ€™d rather end up at 82 and acquire and grow the businesses and so if we have less margin, we better grow our volumes and thatâ€™s what weâ€™re about and thatâ€™s what weâ€™re going to do. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, great. Thank you.",4,"Okay, great. Thank you.
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Operator","And weâ€™ll move on to our next question, from Doug Simpson - Morgan Stanley",15,"And weâ€™ll move on to our next question, from Doug Simpson - Morgan Stanley
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Thanks, could you talk about the geography of the health plan business on a market by market basis, with respect to credibility adjustments? How much does that factor into your thought process, and how much of that business of CVHs business could that aff",44,"Thanks, could you talk about the geography of the health plan business on a market by market basis, with respect to credibility adjustments? How much does that factor into your thought process, and how much of that business of CVHs business could that affect? 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","Doug, when you break down and look at all our strategies state by state, weâ€™re certainly going to have credibility adjustments in many of those markets and it varies.  I canâ€™t really give you an average off the top of my head, but again, as we alluded",158,"Doug, when you break down and look at all our strategies state by state, weâ€™re certainly going to have credibility adjustments in many of those markets and it varies.  I canâ€™t really give you an average off the top of my head, but again, as we alluded to earlier, when you think about pricing for next year, there are multiple factors that go into how we think about this, and because - trend is one, credibility is one, what I call blind mass, and weâ€™ll see how the rules eventually get approved, but we have multiple factors in there and we also look at the competitive balance in the market, what are other people doing, so thereâ€™s multiple things that go into that decision.  Credibility is one of them, but you know, depending on the size of that actual stat entity, and the membership in it, it can range from nothing to a couple of points or more. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","The difference is - well, thatâ€™s not new.  Weâ€™ve always known, but the difference is if you in the past were too conservative and you gave up some market share in return for very attractive margins, it worked okay.  That doesnâ€™t work for tomorrow.",203,"The difference is - well, thatâ€™s not new.  Weâ€™ve always known, but the difference is if you in the past were too conservative and you gave up some market share in return for very attractive margins, it worked okay.  That doesnâ€™t work for tomorrow.  Tomorrow youâ€™re going to have to have more real time information, youâ€™re going to have to come closer to the magic minimum loss ratio and if you canâ€™t miss by 900 basis points on the negative side, youâ€™re going to give up too much market share, and then write checks too. So the only thing that has changed is weâ€™re going to have to be closer to the sweet spot and if we err weâ€™re going to err a little bit north of the sweet spot in return for market share. Our cost structure, where we elect to do business and where we do it is second to - not to anyone that we compete with, it shows in our margins, itâ€™s shown in our margins for decades, for the most part.  So weâ€™ve got good cost structure and weâ€™re going to turn that into better volumes and being more competitive in the market place, but with higher loss ratios. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, and then thereâ€™s a lot of attention to Q4, the utilization left, just because of the seasonality of benefits, the benefit buy downs and how that affects seasonality. As you think about what youâ€™re seeing in the market today, looking to 2011 acro",83,"Okay, and then thereâ€™s a lot of attention to Q4, the utilization left, just because of the seasonality of benefits, the benefit buy downs and how that affects seasonality. As you think about what youâ€™re seeing in the market today, looking to 2011 across the industry, should we see a more dramatic seasonality next year, such that Q4 to Q1 you see a bigger step down, and then a bigger ramp over the course of 2011? Or would that stabilize do you think?
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","Iâ€™m - itâ€™s an educated guess, but weâ€™ve got financial people in the room here, but I donâ€™t see a dramatic change.  I think the deductibles and co-pay equation to the benefit structures has about reached its maximum, so I donâ€™t see a dramatic cha",46,"Iâ€™m - itâ€™s an educated guess, but weâ€™ve got financial people in the room here, but I donâ€™t see a dramatic change.  I think the deductibles and co-pay equation to the benefit structures has about reached its maximum, so I donâ€™t see a dramatic change. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","Doug, you know for us, about a little over 50% has a deductible of $1000. So it could get higher from there, it could, but a good chunk of the book is already at high deductible.",36,"Doug, you know for us, about a little over 50% has a deductible of $1000. So it could get higher from there, it could, but a good chunk of the book is already at high deductible.
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, and then thinking about G&A spend this year, trying to get at your run rate, I apologize if you gave this number earlier, but if you think about the sort of double hit on MA marketing and then reformulated (inaudible ) cost, obviously youâ€™re going",77,"Okay, and then thinking about G&A spend this year, trying to get at your run rate, I apologize if you gave this number earlier, but if you think about the sort of double hit on MA marketing and then reformulated (inaudible ) cost, obviously youâ€™re going to have some of that next year as well, but is there any way to size what the dollar spend was this year, what a more normal rate might look like? 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","You know, historically on the Medicare Advantage side, about three-quarters of the membership gains were usually in the annual enrollment period, the other 25% in the open enrollment period, so we are accelerating some of that spend, which is why weâ€™re",115,"You know, historically on the Medicare Advantage side, about three-quarters of the membership gains were usually in the annual enrollment period, the other 25% in the open enrollment period, so we are accelerating some of that spend, which is why weâ€™re up quarter over quarter, and you know, we look at our benefits and we look at where weâ€™re hot and weâ€™ll allocate resources that way, but coming out of this year weâ€™re going to continue to work - G&A is one of the levers we can throw to  mitigate the impact of minimum MLR, so I donâ€™t want to get into guidance here, but you know, our goal is to continue to improve G&A. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","Historically we manage our costs and weâ€™re going to be around in the future.  We have to redouble our efforts and think about how we structure our business and how we engineer our business and the caliber of people we have and what weâ€™re working on, a",91,"Historically we manage our costs and weâ€™re going to be around in the future.  We have to redouble our efforts and think about how we structure our business and how we engineer our business and the caliber of people we have and what weâ€™re working on, and weâ€™ll make some progress and more to come on what thatâ€™s going to be.  But itâ€™s the focus every day here.  We can do better, and we will, just how much we can and invest for the future is yet to be determined. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, great, thanks.",3,"Okay, great, thanks. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Operator","And weâ€™ll move to our next question from Charles Boorady with Credit Suisse.",14,"And weâ€™ll move to our next question from Charles Boorady with Credit Suisse.
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Thanks, good morning, and Allen, thanks for the color on succession planning and congratulations on the new hires.  Have you set a target retirement date for yourself?  And am I right, your employment agreement goes through the end of 2011, as I recall?",43,"Thanks, good morning, and Allen, thanks for the color on succession planning and congratulations on the new hires.  Have you set a target retirement date for yourself?  And am I right, your employment agreement goes through the end of 2011, as I recall? 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","Just to the extent that we disclosed today, Iâ€™m staying another year, the - havenâ€™t done the contract work yet, but thatâ€™ll all come in due time.  The plan from the Board of Directors, the Nominating Committee and my plan is to evaluate the seasoned",125,"Just to the extent that we disclosed today, Iâ€™m staying another year, the - havenâ€™t done the contract work yet, but thatâ€™ll all come in due time.  The plan from the Board of Directors, the Nominating Committee and my plan is to evaluate the seasoned people we have internally and evaluate the new staff they introduced today, plus the one addition which we likely to announce, and to pick my successor in late 2011, and I would stay then through 2012 to ensure a smooth transition.  So committed for another year and think that our nominating committee and our Board of Directors feels like between the existing group we have and the new group that weâ€™re bringing on, that weâ€™ll have a good choice internally. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Thatâ€™s great, and you talked about change in provider pay relationships, back into your decision maybe related to Kevin Conlin, and Iâ€™m wondering if you can elaborate on that?  What changes youâ€™re really seeing in the trenches this year, and negotia",61,"Thatâ€™s great, and you talked about change in provider pay relationships, back into your decision maybe related to Kevin Conlin, and Iâ€™m wondering if you can elaborate on that?  What changes youâ€™re really seeing in the trenches this year, and negotiating with providers and is it legislation around accountable care organizations or something else that youâ€™re seeing, driving these changes? 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","Iâ€™ll try and sum in some way that we have time for.  It comes from a belief in watching where we make progress and where we donâ€™t in caring for patients over 15 to 20 year periods, and understanding that there are limitations from that, and it comes f",528,"Iâ€™ll try and sum in some way that we have time for.  It comes from a belief in watching where we make progress and where we donâ€™t in caring for patients over 15 to 20 year periods, and understanding that there are limitations from that, and it comes from a belief of arguing over providers solely based on unit cost and the limitations that that has.  It comes from a belief that where integrated systems have employed physicians, and to pay them properly and to incent them properly, getting the proper information is really an improved and better way to go.  I think - and it comes from a belief that in some of our markets we canâ€™t afford to have only a broad delivery system.  If you think back to the â€˜80s when managed care exploded, it was smaller delivery systems, smaller deductibles, or no deductibles, small copays, then the â€˜90s everyone wanted choice, they wanted unlimited everything, and the only problem is that ultimately we couldnâ€™t pay for it.  Employers couldnâ€™t, employees couldnâ€™t, municipalities and states canâ€™t, and finally the Federal Government, so we think weâ€™re going to return in some places to narrow delivery systems, more cost effective systems. We have major contracts and major systems and major cites whereâ€™s thereâ€™s a 35% differential in the cost, and you cannot differentiate the quality in a discernable way at all. So if you add all this stuff together, we want more collaborative contracts with well run systems to take better care of the patients and what I would characterize as a gain sharing basis, if theyâ€™re incented and theyâ€™re  -- the primary care docs are incented to avoid unnecessary expenditures and just spend more time with the patients, and pay the physicians for that, and when that brings reduced costs to turn it back in terms of more favorable benefit plans, to drive membership to those systems, and in terms of economic arrangements that arenâ€™t just unit cost, but that shares the gain in the width of its system, weâ€™re taking better care of the patients.  So itâ€™s - we did the first one with Medicare population for 2011 with Via Christie, when we had extensive discussions with the Mercy system, even before we closed, it was obvious that since the early â€˜90s part of their mission was take better care of the patients and they were ecstatic about having a partner that wanted to do the same thing, so itâ€™s easy to talk about and hard to do on a broad area, but weâ€™re increasing believe that we have to help the people who are responsible for taking care of the patients anyway. And thereâ€™ll be more on that.  Weâ€™ll announce more of the arrangements as we get them signed and recognizing that how we do that is kind of proprietary, but itâ€™s going to - the new models for the future lend themselves to this better than a unit cost negotiation and our trying to manage the patients from the outside. Iâ€™m happy to spend some time in a smaller group explaining how we feel about that, when weâ€™ve got more time, too. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Let me just wrap it up with a quick number question that you talked about. You talked about a lot of different things in 2010 and a little bit on 2011.  Can you just kind of bullet for us and quantify where you can as we try to build and refine our 2011 m",177,"Let me just wrap it up with a quick number question that you talked about. You talked about a lot of different things in 2010 and a little bit on 2011.  Can you just kind of bullet for us and quantify where you can as we try to build and refine our 2011 models, so we donâ€™t get too far ahead of what youâ€™re thinking.  You said it would be down, but weâ€™ve got the private fee for service this year not next year, weâ€™ve got the minimum loss ratio regulations which are still a bit of a wildcard, weâ€™ve got the prior period reserve developments that were at unusual levels this year, and maybe donâ€™t want to model to the same extent next year, and youâ€™ve got the PDP low price product where some of those lives will be able to recapture in a different product and others you wonâ€™t.  Are those the main factors?  Am I missing something?  Could you put parameters around any of them for us? In particular the minimum loss ratio reg? 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","Itâ€™s that and whether or not thereâ€™s going to be any concessions on how individuals implement it and finding what we can do about our broker cross if anything and what we can do about SG&A and how much we can grow the place.  So I think it would be, w",248,"Itâ€™s that and whether or not thereâ€™s going to be any concessions on how individuals implement it and finding what we can do about our broker cross if anything and what we can do about SG&A and how much we can grow the place.  So I think it would be, with all the moving parts, and I donâ€™t know what my government enrollment is going to be.  I think it would be irresponsible for me to guess the number and I know that doesnâ€™t make your job any easier, but youâ€™re going to have to guess without me and when I know something that we can tell you responsibly we will.  Thereâ€™s just so many moving parts and so much we donâ€™t know yet about the final outcome on a number of things, we just canâ€™t. On the other hand, I look at the foundation we have, the business is solid and if we improve the cost and weâ€™re going to improve SG&A, weâ€™re going to improve our management team here.  Weâ€™re doing all the stuff thatâ€™s going to make a good company. I know thereâ€™s going to be some (inaudible ) but I canâ€™t do the - an estimate on EPS in a responsible way except to say itâ€™s going to be less for sure, for the reasons you said.  Weâ€™re not going to go away, itâ€™s not going to be a disaster either, and weâ€™ll tell you more when we can in a responsible way. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Alright, great. Thanks.",3,"Alright, great. Thanks. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","One more question, please if you have one.",8,"One more question, please if you have one. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Operator","And todayâ€™s final question is from Tom Carroll with Steifle.",11,"And todayâ€™s final question is from Tom Carroll with Steifle. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Hey good morning.  Thanks for slipping me in here at the end.  Just two quick questions, one, on your Medicare Advantage business.  Are you comfortable with the size of that business today? Or might we see it rise again as a percentage of revenue?  Especi",72,"Hey good morning.  Thanks for slipping me in here at the end.  Just two quick questions, one, on your Medicare Advantage business.  Are you comfortable with the size of that business today? Or might we see it rise again as a percentage of revenue?  Especially given your M&A strategy and ample liquidity.  And then secondly, on your commercial book, how much of that is priced for 2011 so far? Iâ€™ll stop there. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","Iâ€™ll answer the first and let John answer the second question. In the MA business when people exited with balanced budget in the late â€˜90s or â€™97, whenever it was there, we exited a few counties, wish they would have done more to grow it after that,",211,"Iâ€™ll answer the first and let John answer the second question. In the MA business when people exited with balanced budget in the late â€˜90s or â€™97, whenever it was there, we exited a few counties, wish they would have done more to grow it after that, wish we had more, if we found the right fit as the world evolves here, we would definitely be interested from an M&A perspective, if itâ€™s the right fit.  We think there will be opportunities; youâ€™re going to have to do better on a star system than most of us who have done it today, to get paid properly. CMS has got to use the star system as an outlier and do corrective actions plans.  Long winded way of saying that thereâ€™s some people out there who may not have the systems and the wherewithal, they may have a good block of business, but may not be able to feel very good about being successful in future, so I continue to believe in that.  I continue to believe itâ€™s the best way to care for the patients. I continue to believe it works with the model that we talked about for providers and if we found the right opportunity, we would do more. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","And Tom, on the commercial book, around 40% of the book is priced, and thatâ€™s predominantly large group.",18,"And Tom, on the commercial book, around 40% of the book is priced, and thatâ€™s predominantly large group. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Great. Thank you.",3,"Great. Thank you. 
"
27133,113620839,86226,"Coventry Health Care Inc., Q3 2010 Earnings Call, Nov 05, 2010",2010-11-05,"Earnings Calls","Coventry Health Care, Inc.","Executives","Thanks for joining us today and thanks for your interest.",10,"Thanks for joining us today and thanks for your interest. 

"
